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Abstract 
Small RNA silencing pathways regulate development, viral defense, and 
genomic integrity in all kingdoms of life. An Argonaute (Ago) protein, guided by a 
tightly bound, small RNA or DNA, lies at the core of these pathways. Argonaute 
uses its small RNA or DNA to find its target sequences, which it either cleaves or 
stably binds, acting as a binding scaffold for other proteins. We used 
Co-localization Single-Molecule Spectroscopy (CoSMoS) to analyze target 
binding and cleavage by Ago and its guide. We find that both eukaryotic and 
prokaryotic Argonaute proteins re-shape the fundamental properties of 
RNA:RNA, RNA:DNA, and DNA:DNA hybridization: a small RNA or DNA bound 
to Argonaute as a guide no longer follows the well-established rules by which 
oligonucleotides find, bind, and dissociate from complementary nucleic acid 
sequences. Counter to the rules of nucleic acid hybridization alone, we find that 
mouse AGO2 and its guide bind to microRNA targets 17,000 times tighter than 
the guide without Argonaute. Moreover, AGO2 can distinguish between 
microRNA-like targets that make seven base pairs with the guide and the 
products of cleavage, which bind via nine base pairs: AGO2 leaves the cleavage 
products faster, even though they pair more extensively.  
This thesis presents a detailed kinetic interrogation of microRNA and RNA 
interference pathways. We discovered sub-domains within the previously 
  vii 
defined functional domains created by Argonaute and its bound DNA or RNA 
guide. These sub-domains have features that no longer conform to the 
well-established properties of unbound oligonucleotides. It is by re-writing the 
rules for nucleic acid hybridization that Argonautes allow oligonucleotides to 
serve as specificity determinants with thermodynamic and kinetic properties 
more typical of RNA-binding proteins than that of RNA or DNA. Taken 
altogether, these studies further our understanding about the biology of small 
RNA silencing pathways and may serve to guide future work related to all 
RNA-guided endonucleases. 
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CHAPTER I: INTRODUCTION 
  
  
2 
Small Regulatory RNAs: The discovery of something ‘small’ that is BIG for 
Biology 
Small Regulatory RNA silencing pathways are present in all kingdoms of life and 
are involved with cellular processes of development, post-transcriptional 
regulation, viral defense, and genome integrity (Ameres and Zamore, 2013; 
Swarts et al., 2014b). The discovery of double-stranded RNA triggering a gene 
silencing effect is attributed to the seminal work of Fire and Mello where they 
showed that injecting long double-stranded RNA into the nematode 
Caenorhabditis elegans (C. elegans) led to silencing of genes that bear sequence 
similarity to the injected RNA (Fire et al., 1998). This method of gene silencing 
was coined as RNA interference (RNAi) and it explained previously reported 
phenomena in plants, fungi, and worms where exogenously introduced 
transgenes led to repression of genes with similarity and the observation when 
either antisense or sense RNA was injected into worm it led to repression 
(Napoli et al., 1990; van der Krol et al., 1990; Matzke and Matzke, 1995; Powell-
Coffman et al., 1996; Rocheleau et al., 1997).  
Just prior to the discovery that dsRNA was realized to silence gene 
expression, it converged with another emerging area of C. elegans biology. 
Small endogenous RNAs, (called at the time small temporal RNAs (stRNAs), lin-4 
and let-7 had been shown to temporally control developmental timing and 
became intertwined with RNAi (Lee et al., 1993; Wightman et al., 1993; Reinhart 
  
3 
et al., 2000). The importance of these stRNAs soon was realized as something 
not just restricted to nematodes but also having conservation in multiple 
organisms, including plants and mammals (Hamilton and Baulcombe, 1999; 
Pasquinelli et al., 2000). Concordant with the identification of stRNA sequences, 
there was a flurry of research to understand the biogenesis of the small RNAs in 
both the stRNA and RNAi pathways. The convergence of stRNA and RNAi 
occurred with the finding that they shared a common enzyme called Dicer; this 
enzyme is responsible for producing small interfering RNA (siRNA) in the RNAi 
pathway that induced gene silencing or was responsible for the stRNA to control 
gene expression (Fagard et al., 2000; Pasquinelli et al., 2000; Yang et al., 2000; 
Ambros, 2001; Bernstein et al., 2001; Hutvágner et al., 2001). To reign in the 
identification of small regulatory RNAs, a specific set of guidelines was devised 
to distinguish between endogenous stRNAs and siRNAs that were derived from 
exogenous sources (e.g., viral long dsRNA); the stRNAs were renamed to 
microRNAs (miRNAs) and they came with specific criteria to validate them 
experimentally (Ambros et al., 2003). The increase and improvement of 
sequencing techniques led to the discovery of additional classes of small 
regulatory RNAs found in several organisms in all kingdoms of life (Bartel, 2004). 
Fueled by high-throughput sequencing, another class of small RNAs was 
discovered called endogenous siRNAs (endo-siRNAs) that are found in fungi, 
protists, plants, and animals – including humans (Yang and Kazazian, 2006; 
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Czech et al., 2008; Ghildiyal et al., 2008; Okamura et al., 2008a; Tam et al., 
2008; Watanabe et al., 2008) (Mochizuki et al., 2002; Volpe et al., 2002; Xie et 
al., 2004; Chung et al., 2008; Okamura et al., 2008b). Another class of small 
regulatory RNAs discovered was the germline-specific class that mapped to 
repeat associated regions of the genome (known as rasiRNAs, now called 
PIWI-interacting RNAs (piRNAs)); It is believed that these small RNAs help 
repress transposon activity and protect genome integrity (Aravin et al., 2001; 
Aravin et al., 2006; Girard et al., 2006; Grivna et al., 2006b; Lau et al., 2006; 
Saito et al., 2006; Vagin et al., 2006; Batista et al., 2008; Das et al., 2008; 
Grimson et al., 2008). The piRNA and endo-siRNA classes of small RNAs have 
specialized functions related to regulation of transposons and/or genome 
integrity in specific cells, whereas miRNAs are believed to regulate protein 
coding genes in almost all cells (Bartel, 2009; Ameres and Zamore, 2013). No 
matter the tissue location or cellular process, small RNA regulatory pathways 
share a common theme — using a small nucleic acid in complex with a protein 
to drive genomic regulation; this regulation can include temporal regulation of 
gene expression in animals, genome re-arrangement in protists, 
post-transcriptional silencing in fungi, defense against genetic information 
encoded by a virus, and/or protection from selfish genetic elements such as 
transposons. The level of regulation by these small RNAs is controlled and 
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carried out by an assembly of specialized proteins that produce and bind the 
small RNAs in order for regulation of their cellular targets to take place. 
Components of Small Regulatory RNA Silencing Pathways in Mammals 
The most important part of the small RNA pathway is the small RNA itself that 
interacts with an endonuclease in the Argonaute superfamily of proteins that 
regulate cellular targets. All three types of small RNAs — siRNAs, miRNAs, and 
piRNAs —have respective protein components that can be broken into 
3 categories: biogenesis, factors involved with the formation and association 
with an Argonaute protein, and then the subsequent regulation of the cellular 
target. 
Biogenesis of miRNAs 
The transcription of miRNAs, like all endogenous small RNAs, begins as 
an RNA polymerase II transcript where the small RNA then undergoes further 
nuclear processing and export to the cytoplasm (Figure 1.1A–C; Lee et al., 
2004a; Li et al., 2013a; Kim et al., 2009). The transcription product or primary-
miRNA (pri-miRNA) is processed in a stepwise fashion to form a smaller hairpin 
(Lee et al., 2002). The pri-miRNA transcript containing a large hairpin is 
recognized by the microprocessor complex that contains the RNase III 
endonuclease Drosha and its binding partner DGCR8, where it is cropped to a 
hairpin known as the pre-miRNA (Lee et al., 2003; Gregory et al., 2004; Han et 
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al., 2004). The pre-miRNA that is formed by the microprocessor complex bears 
important features like a 5′ phosphate and 2 nt 3′ end overhang; both are 
crucial for interaction downstream in miRNA biogenesis (Han et al., 2004; Zeng 
and Cullen, 2004; Zhang et al., 2004; Park et al., 2011). The pre-miRNA 
associates with the nuclear export protein exportin-5 and it is exported to the 
cytoplasm (Yi et al., 2003; Bohnsack et al., 2004; Lund et al., 2004). Prior to 
nuclear export, there are several examples of miRNA specific regulators that 
control the microprocessor cleavage steps in addition to miRNA specific factors 
that can associate with the pre-miRNA prior to export (Ha and Kim, 2014). Once 
the pre-miRNA is exported to the cytoplasm the RNase III endonuclease Dicer 
along with its dsRNA-binding protein partner TRBP (HIV Transactivating 
Response RNA-Binding Protein), bind the pre-miRNA hairpin and cleave off the 
hairpin loop to form a miRNA duplex of 21–23 nt in length (Figure 1.1A; 
Bernstein et al., 2001; Hutvágner et al., 2001; Haase et al., 2005). This duplex is 
now able to interact with an Argonaute protein to form RISC, the RNA-induced 
silencing complex (Figure 1.1A).
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Figure 1.1: miRNA and endogenous siRNA biogenesis, assembly, and regulation pathways in mammals 
(A) The biogenesis of miRNAs is primarily transcribed by RNA polymerase II where 50% come from their own 
gene and typically are part of polycistronic transcription unit. (B) Other miRNAs (~40%) are transcribed from 
intronic or intergenic locations. (C) A smaller sub-set of miRNAs (~10%) come the excised introns after splicing. 
After transcription, the pri-miRNAs are processed by the nuclear dsRNA processing complex called the 
microprocessor complex — Drosha and its binding partner, DGCR8. The newly formed pre-miRNA is exported to 
the cytoplasm where it can interact with Dicer and its double-stranded binding protein partner, TRBP. The 
stem-loop of the hairpin is cleaved to form the miRNA/miRNA* duplex. This duplex is assembled into an active 
AGO protein where the miRNA* strand is ejected and miRNA AGO-RISC is formed. miRNA-RISC partially pairs to 
its targets where it acts as a scaffold for regulatory factors such as TNRC6A and deadenylation/mRNA regulatory 
proteins. (D) Endogenous siRNA pathway found in mammals. Endo-siRNAs typically come from transposons, 
intergeneic regions, or genes/pseudogenes pairs that form a RNA duplex. The long dsRNA is exported to the 
cytoplasm where it is processed by Dicer-TRBP to form siRNAs. The siRNAs can complex with an active AGO2 
protein that will form mature RISC. Endogenous siRNAs that have extensive complementarity to their target can 
cleave the mRNA thus leaving it susceptible for cellular exonucleases that are commonly found in the exosome 
(e.g., XRN-1 and RRP44). Figure is adapted with permission from Macmillan Publishers Ltd: Nature Reviews 
Molecular Cell Biology and Nature Review Genetics (Kim et al., 2009; Ha and Kim, 2014; Jonas and Izaurralde, 
2015) © 2009–2015. 
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Biogenesis of siRNAs 
The presence of siRNAs in mammals can be broken into two broad 
categories, those coming from an endogenous or exogenous source. Typically, 
in the vernacular, siRNAs are referred to as an RNA duplexes ~21 nt in length 
that are chemically synthesized and introduced exogenously for functional 
genomic experiments or therapeutic applications (Dorsett and Tuschl, 2004). 
Endogenous siRNAs (endo-siRNAs) are a specialized class of small RNA found 
in the germline of mammals, including humans, that are typically derived from 
transposons that will form dsRNA transcripts (Watanabe et al., 2006; Yang and 
Kazazian, 2006; Watanabe et al., 2008; Song et al., 2011). The formation of 
endo-siRNAs is dependent upon the Dicer protein, where loss of Dicer leads to 
an increase in transposon expression and significant decrease in the levels of 
endo-siRNAs (Tam et al., 2008; Watanabe et al., 2008). Unlike miRNAs, endo-
siRNAs do not get processed in the nucleus by the microprocessor complex, 
but they do follow the same processing pathway as miRNAs in the cytoplasm — 
cleavage by Dicer to form an RNA duplex with 5′ phosphate and 2 nt 3′ end 
overhangs (Kim et al., 2009). The endo-siRNA duplex is then is able to interact 
with Argonaute to form RISC (Figure 1.1D). For siRNAs that come from 
exogenous sources there is no requirement for Dicer processing and they can 
directly associate with Argonaute to go onto forming RISC (Bernstein et al., 
2003; Salomon et al., 2010; Betancur and Tomari, 2012). 
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Biogenesis of piRNAs 
The process in which PIWI-interacting small RNAs are made is unlike the 
Dicer-dependent pathways of miRNAs or endo-siRNAs. The precursor of a 
piRNA is ssRNA and it is typically only found in the germline of animals 
(Figure 1.2, model shown in male mouse germline; Vagin et al., 2006; Iwasaki et 
al., 2015b). In addition to being processed in a Dicer-independent fashion, the 
length of piRNAs are slightly longer than siRNAs and miRNAs, where they are 
typically 24–31 nt in length and the 3′ terminal nucleotide bears a 2′-O-methyl 
modification (Aravin et al., 2006; Girard et al., 2006; Grivna et al., 2006a; Lau et 
al., 2006; Vagin et al., 2006). The generation of a mature piRNA is not as clear as 
the miRNA or endo-siRNA pathways due to the lack of good extracts that can 
recapitulate the pathway in vitro. However, genetic and high-throughput 
sequencing have informed us a great deal about some of the functions and 
biogenesis in the pathway. The precursor for a piRNA is long RNA transcript 
produced by RNA polymerase II and the primary transcript is then fragmented 
by the phospholipase /endonuclease PLD6 (commonly referred to as Zucchini, 
name of the fly mutant) where the precursor fragments have enrichment for the 
5′ most nucleotide to be a uridine (Girard et al., 2006; Ipsaro et al., 2012; Voigt 
et al., 2012; Li et al., 2013a; Li et al., 2013b). These fragments are loaded into a 
PIWI protein, a specialized, germline-specific Argonaute where the 3′ end of the 
RNA is further trimmed and the terminal nucleotide is modified to a 2′-O-methyl 
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by the ribose methyltransferase HEN1 (Figure 1.2; Vagin et al., 2006; Ohara et 
al., 2007; Kawaoka et al., 2011; Horwich et al., 2007; Saito et al., 2007; 
Kamminga et al., 2010). In addition to piRNAs having a distinct biogenesis 
pathway from miRNAs or endo-siRNAs, they also differ in RISC formation as 
they have a ssRNA trigger rather than a small RNA duplex. Furthermore, 
additional piRNAs are made through a secondary piRNA biogenesis pathway 
that self-amplifies the small RNAs between two different PIWI-Argonaute 
proteins (Figure 1.2, bottom right). This pathway uses the primary piRNAs to 
cleave complementary transcripts that then become new piRNAs (secondary 
piRNAs) that then cleave another primary transcript to form another piRNA with 
the same sequence as the primary piRNA (Brennecke et al., 2007; Gunawardane 
et al., 2007; Roovers et al., 2015). Unlike miRNAs and siRNAs, piRNAs 
biogenesis and assembly with Argonaute proteins are closely related where the 
mature piRNA is not actually formed until it is bound to a PIWI Argonaute protein 
(Iwasaki et al., 2015b). 
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Figure 1.2: Model of the piRNA pathway in mammals 
The piRNA pathway in mammals have a specialized function in the germline for removal mRNA in 
spermatogenesis, silencing of L1 retrotransposon, and directing CpG DNA methylation on transposons (Aravin et 
al., 2007; Aravin et al., 2008; Kuramochi-Miyagawa et al., 2008; De Fazio et al., 2011; Reuter et al., 2011). This 
figure represents a model of the piRNA biogenesis and function in the male germline as it relates to 
spermatogenesis in the pre-pachytene and pachytene stage. During the pre-pachytene stage, primary piRNAs 
that were already loaded in MILI can self-amplify to produce secondary piRNAs with the help of MIWI2 in a ‘ping-
pong’-like amplification loop (right side). The piRNAs in MIWI2 can participate in de novo DNA methylation at 
non-annotated and transposons regions of the genome. The pachytene class of piRNAs takes place during 
meiosis and spermatogenesis. The piRNAs are derived from intergeneic regions where their biogenesis is not well 
understood. The current model has Pol II transcripts (transcription factor A-Myb regulated shown, left side) that 
are spliced and exported to the specialized compartment of the cytoplasm known as nuage. The transcripts will 
get processed by PLD6/Zucchini that cleaves the transcript and enriches for 5′ uridine. The fragments are loaded 
into MIWI where it regulates transcripts via a slicing mechanism to decrease mRNA levels, such as L1 
retrotransposon. Figure uses elements with permission from Macmillan Publishers Ltd: Nature Reviews Molecular 
Cell Biology, (Ha and Kim, 2014) © 2014.
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Assembly of the siRNA and miRNA RNA-induced Silencing Complexes 
The complex formation of a small RNA duplex and the formation of RISC 
— an Argonaute bound with a single-stranded small RNA — can be broken into 
two steps, pre-RISC and mature RISC formation (Kawamata and Tomari, 2010; 
Kobayashi and Tomari, 2015). The formation of pre-RISC and AGO protein 
association in mammals appears to be the same for both miRNAs and siRNAs, 
this is in contrast to the fruit fly Drosophila melanogaster that is able to 
discriminate between the two classes of small RNAs (Tomari et al., 2007; Yoda 
et al., 2010). An example of how flies sort their small RNA is seen in RNAi, where 
there is a formal RISC loading complex (RLC), made up of Dicer-2 and R2D2 
and is a required for RISC formation (Tomari et al., 2007; Czech et al., 2009; 
Ghildiyal et al., 2010). The siRNA duplex is ‘handed off’ to fly AGO2 (the 
RNAi specific AGO protein) and flies that are null for dcr2 or r2d2 have their 
RNAi activity abolished (Lee et al., 2004b; Liu et al., 2006). For fly miRNAs, it is 
less clear if there is a formal RLC but fly AGO1 (miRNA-associated AGO) prefers 
to bind miRNA duplexes that contain central mismatches and these small RNA 
duplexes are specifically generated from pre-miRNAs by Dicer-1/Loquacious 
(Forstemann et al., 2005; Forstemann et al., 2007; Tomari et al., 2007). In 
mammals, there is only one Dicer protein that can generate siRNAs or miRNAs 
and there appears to be no specificity to having the small RNA duplex interact 
with one AGO protein over another (mammals have 4 AGO proteins, Figure 1.3 
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and Appendix A1; Yoda et al., 2010; Bernstein et al., 2001). Unlike RNAi in flies, 
Dicer processing is uncoupled from the formation of pre-RISC in mammals 
(Yoda et al., 2010; Betancur and Tomari, 2012). Even dsRNA that is cleaved by 
mammalian Dicer shows no association with the process of pre-RISC formation 
and then subsequent mature RISC (Yoda et al., 2010). Both mammals and flies 
require ATP to form the pre-RISC complex — AGO bound to the RNA duplex 
(Kobayashi and Tomari, 2015). This process first starts with the selection of one 
of the strands from the small RNA duplex to become the guide strand 
associated with the AGO protein. Selection is not a random event; rather it is 
mediated by the thermodynamic stability of the 5′ ends of small RNA duplex, 
where the least stable 5′ end is preferentially associated with AGO (Khvorova et 
al., 2003; Schwarz et al., 2003; Tomari et al., 2004). For fly RNAi, strand 
asymmetry is determined by the RLC whereas in mammals the strand selection 
is believed to be mediated by the AGO protein itself and the protein’s 5′ 
phosphate-binding pocket (Tomari et al., 2004; Ma et al., 2005; Parker et al., 
2005). For miRNA duplexes in flies and mammals (small RNA duplexes that are 
typically imperfect and contain central mismatches, Figure 1.1), the strand that 
has a lower 5′ end thermodynamic stability becomes the guide in AGO (referred 
to as the miRNA strand) while the strand with a more stable 5′ end does not 
associate with AGO, the miRNA* strand (Okamura et al., 2009; Yoda et al., 2010; 
Kobayashi and Tomari, 2015). 
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The exact mechanism of converting pre-RISC, AGO bound to a small 
RNA duplex, to become mature RISC, AGO bound to a single-stranded RNA, is 
not completely clear but the process is one that involves several heat-shock 
chaperone proteins that hydrolyze ATP (Kobayashi and Tomari, 2015). An early 
model proposed by Tomari and colleagues attributed the roles of the 
chaperones to assisting with AGO negotiating the bound RNA duplex in 
pre-RISC formation, and this model was referred to as the ‘rubber band’ model 
(Iwasaki et al., 2010; Kawamata and Tomari, 2010). Recently, ensemble and 
single-molecule biochemical experiments led Tomari and colleagues to revise 
this model so that it is in line with new structural data (Iwasaki et al., 2010; 
Elkayam et al., 2012; Nakanishi et al., 2012; Schirle and MacRae, 2012; Iwasaki 
et al., 2015a; Iwasaki et al., 2015b). When AGO is loaded with a siRNA or miRNA 
duplex the action of a passenger strand (complementary to the guide strand in 
an siRNA duplex) or miRNA* strand removal does not require ATP hydrolysis 
(Iwasaki et al., 2010; Iwasaki et al., 2015a). The first steps involved with 
passenger or miRNA* strand removal involve the N-domain of the AGO protein 
wedging in-between one end of the RNA duplex (Kwak and Tomari, 2012). This 
wedging activity of the N-domain is thought to disrupt the base pairing past the 
16th nucleotide of the guide strand (g16) (guide positions are noted by “g” and 
the nucleotide number is respective to the 5′ end of RNA; Kwak and Tomari, 
2012; Wang et al., 2009). Proper N-domain activity and wedging action is critical 
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for the subsequent ejection of the passenger or miRNA* strand (Kwak and 
Tomari, 2012). The final steps in passenger or miRNA* strand removal involve a 
cleavage-dependent or cleavage-independent process. For miRNAs, they 
typically contain central mismatches that prevent duplex cleavage by a 
cleavage-competent AGO proteins (mammalian AGO2 is the only cleavage 
competent AGO) which, when combined with specific features found in different 
domains of AGO, lead to the destabilization of the miRNA/miRNA* duplex and 
eventual disassociation of the miRNA* strand (Hock and Meister, 2008; 
Kawamata et al., 2009; Yoda et al., 2010; Kawamata et al., 2011). Mammalian 
AGO1, 3, and 4 along with fly AGO1, do not have in vivo cleaving activity and/or 
do not contain catalytic residues to be a cleavage-competent AGO protein 
(Figure 1.3). When a non-cleaving AGO is presented with a siRNA duplex it 
typically does not form mature RISC or does so very slowly (Kawamata et al., 
2009). For fly AGO2 and mammalian AGO2 that have cleavage activity they can 
cleave the passenger strand of the siRNA duplex in a Mg2+-dependent fashion 
after wedging (Matranga et al., 2005; Miyoshi et al., 2005; Rand et al., 2005; 
Shin, 2008). After cleavage of the siRNA duplex, base pairing is now unstable 
which allows for the cleaved passenger strand to be ejected. It was reported 
that the mega endonuclease complex, C3PO, made up of an octamer of Trax 
and Translin proteins degrades the cleaved passenger strand to accelerate 
mature RISC formation (Liu et al., 2009; Ye et al., 2011).  
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Figure 1.3: Argonaute proteins are categorized into specific clades.  
Amino acid sequences of Argonaute proteins were aligned using ClustalX. 
Phylogenetic tree was generated by taking aligned sequences and using Phylip 
for bootstrapping, calculation of protein distance, and to generate consensus 
tree (Larkin et al., 2007; Goujon et al., 2010; Wee, 2013). Bootstrap percentages 
greater than 50% are indicated at the forks. Aa: Aquifex aeolicus, A. aegypti: 
Aedes aegypti Af: Archaeoglobus fulgidus At: Arabidopsis thaliana, Ce: 
Caenorhabditis elegans, Dm: Drosophila melanogaster, Hs: Homo sapiens, Kp: 
Kluyveromyces polysporus Mm: Mus musculus, Nc: Neurospora crassa, Pf: 
Pyrococcus furiosus, Sp: Schizosaccharomyces pombe, Tt: Thermus 
thermophilus, Twi: Tetrahymena Piwi Argonaute. Scissors represent presence of 
catalytic activity or catalytic residues within the PIWI domain. Human and 
mouse AGO3 have the catalytic residues in the PIWI domain but they cannot 
cleave RNA due to the absence of structural features in the N domain (Meister et 
al., 2004b; Hauptmann et al., 2013).  
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It is unclear how this protein complex degrades the short, cleaved passenger 
strand given its active site is in the center of the protein complex and it is nearly 
double the size of AGO (Ye et al., 2011). These processes are all ATP-
independent however there is a clear requirement for ATP in both miRNA and 
siRNA RISC maturation. The new model proposed by Tomari and colleagues 
places the role of the ATP-consuming heat shock chaperone proteins to keeping 
unloaded AGO proteins in an active state so that they can accept a small RNA 
duplex rather than assisting in negotiation and/or ejection of the passenger 
strand (Kobayashi and Tomari, 2015). This model places the chaperones role 
further upstream than the previous one (‘rubber band’ model) and equates the 
ATP hydrolysis by heat shock proteins to making sure AGO remains in an 
‘active’ conformation to accept a duplex that will then lead to the anchoring of 
the 5′ and 3′ ends of the eventual guide or miRNA strand (Kobayashi and 
Tomari, 2015). Future structural studies will be needed to confirm this model, in 
particular a structure of the pre-RISC complex — chaperone proteins 
associated with AGO as the small RNA duplex binds. 
miRNA-mediated target regulation 
After the miRNA complexes with an AGO protein to form a microRNA-
RISC it is now licensed for post-transcriptional regulation of RNA targets in the 
cell. The role of miRNA in regulation is integral to many biologic processes and 
they participate in a network of gene regulation with other miRNA and 
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RNA-binding proteins (Gurtan and Sharp, 2013; Jonas and Izaurralde, 2015). It is 
predicted that there are nearly 1,500 miRNAs found in humans and that they can 
regulate over half of all protein coding genes (Friedman et al., 2009; Chiang et 
al., 2010). The miRNA-RISC binds to its target through partial complementarity 
which is typically to nucleotides g2–g8 of the miRNA guide (Lewis et al., 2003; 
Rajewsky and Socci, 2004; Krek et al., 2005; Lewis et al., 2005; Lim et al., 2005). 
The AGO protein when bound to a small RNA changes the shape of the small 
RNA where g2–g8 are arranged in a pre-helical formation to increase target 
finding efficiency — this is referred to as the ‘seed’ of the guide strand 
(described in detail later in this chapter ; Ma et al., 2004; Parker et al., 2005; 
Wang et al., 2008a; Parker et al., 2009; Elkayam et al., 2012; Schirle and 
MacRae, 2012; Nakanishi et al., 2012).  
When miRNA-RISC binds to its target it acts as a scaffold for other 
proteins that will regulate the target through destabilization and consequentially 
repress translation of the mRNA (Figure 1.1; Jonas and Izaurralde, 2015). The 
GW182 family of proteins (in mammals, Tri-nucleotide repeat-containing 
proteins, TNRC6A, TNRC6B, and TNRC6C) are one of the co-factors associated 
with AGO that promotes destabilization of the target (Eulalio et al., 2008; Eulalio 
et al., 2009; Lian et al., 2009). The GW182 proteins contain an AGO-binding 
domain (ABD) along with several Tryptophan (W)-containing motifs that bind 
several protein in the deadenylase complex (Rehwinkel et al., 2005; 
  
22 
Behm-Ansmant et al., 2006; Takimoto et al., 2009; Braun et al., 2011; 
Chekulaeva et al., 2011; Fabian et al., 2011). GW182 along with AGO becomes a 
scaffold for destabilizing factors that will shorten the polyA tail which is 
predicted to lower translation efficiency (Jonas and Izaurralde, 2015). 
Furthermore, decreasing the polyA tail length reduces the binding of PABP 
(polyA-binding protein) that interacts with the 5′ end of the mRNA to promote 
RNA stability (Bernstein et al., 1989; Mangus et al., 2003; Eichhorn et al., 2014). 
The lost interaction of the 5′ cap and the 3′ end polyA tail accelerates mRNA 
degradation by decreasing the stability of the cap binding complex and 
promoting association with the decapping protein complex (Yamashita et al., 
2005; Jonas and Izaurralde, 2013). Loss of the cap makes the mRNA 
susceptible to exonucleolytic enzymes like XRN1 (5′→3′ exonuclease) and thus 
degradation of the transcript (Braun et al., 2012; Jonas and Izaurralde, 2015). 
siRNA-mediated regulation 
After a siRNA binds to a catalytically active Argonaute to form a RISC it 
can then direct endonucleolytic cleavage of its RNA target (Figure 1.1D). Similar 
to miRNA-RISC, siRNA-RISC uses the seed, g2–g8 of it bound guide to find 
targets (Haley and Zamore, 2004; Brennecke et al., 2005; Wee et al., 2012). 
Unlike miRNA-RISC, the guide stand needs to have extensive complementarity 
to its RNA target in order to cleave its target (Ding et al., 2003; Haley and 
Zamore, 2004; Martinez and Tuschl, 2004; Schwarz et al., 2006). In mammals, 
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AGO2 is the only catalytically active AGO protein (Figure 1.3; Meister et al., 
2004b; Liu et al., 2004; Hutvagner and Simard, 2008). When AGO2 binds to a 
target with extensive complementarity it is believed to undergo a protein 
conformation change that allows for cleavage of the bound RNA target (Wang et 
al., 2009; Sasaki and Tomari, 2012; Schirle and MacRae, 2012). The idea of a 
protein conformation preceding target cleavage was described in the ‘two-state’ 
model proposed by Tomari and Zamore (Tomari and Zamore, 2005). The 
‘two-state’ model, before the full structure of AGO was solved, was an effort to 
explain why the 5′ end nucleotides were more important for target binding over 
nucleotides in the 3′ end (Tomari and Zamore, 2005). Furthermore, it was 
proposed that the 3′ end of the guide would then release from AGO2’s PAZ 
domain and allow it to base pair with the target as this was shown biochemically 
lead to more efficient target cleavage (Haley and Zamore, 2004; Tomari and 
Zamore, 2005; Sasaki and Tomari, 2012; Wee et al., 2012). This model was later 
supported by the crystal structures of Thermus thermophilus Argonaute with 
and without a target where it was shown that the catalytic residues of AGO that 
coordinate a magnesium ion to catalyze the cleavage reaction are not properly 
positioned when AGO is not bound to a target (Wang et al., 2008a; Wang et al., 
2009). AGO2-mediated target cleavage is achieved by three different structural 
features: a catalytic tetrad in the PIWI domain, the PL3 loop also in the PIWI 
domain, and the N-domain (Boland et al., 2011; Faehnle et al., 2013). The 
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cleaved target is now subject to degradation by cellular exonucleases and RNA 
surveillance machinery like XRN-1 (5′→3′ exonuclease) and RRP44 (3′→5′ 
exonuclease) associated with the exosome complex (Orban and Izaurralde, 
2005). 
Argonaute — the core of small regulatory RNA pathways 
The Argonaute protein is at the core of the RNA silencing machinery, when 
bound to a small RNA it creates RISC, the complex that is the effector for 
regulating an RNA target. The superfamily of Argonaute proteins is broken into 
3 clades: AGO, PIWI, and worm-specific AGO proteins (Figure 1.3; Hutvagner 
and Simard, 2008; Cenik and Zamore, 2011). Mammals typically have 8 
Argonaute proteins, 4 AGO-like and 4 PIWI-like Argonautes (mice have 3 PIWI-
like proteins whereas humans and non-human primates have 4 PIWI-like 
proteins) (Hock and Meister, 2008). PIWI-like AGO proteins are associated with 
the piRNA pathway and AGO-like Argonautes are associated with the miRNA 
and siRNA pathways (Meister, 2013). Mammalian AGO2 can participate in either 
the miRNA or siRNA pathway since it is catalytically active (Liu et al., 2004; 
Meister et al., 2004b; Hutvagner and Simard, 2008). Mouse and human AGO2 
share about 99% amino acid homology (see Appendix A2 for sequence 
alignment) where there are only seven amino acids that differ at the N-terminal 
region of the protein, two of which are closely related. AGO proteins consist of 
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four distinct domains:  N, PAZ, MID, and PIWI (Figure 1.4). Additionally, there are 
two long linkers (L1 and L2) between the N-PAZ domains and PAZ-MID domains 
(Figure 1.4; Kuhn and Joshua-Tor, 2013). The structure of Argonaute is well 
conserved by virtue of the overall structure of each domain between human 
AGOs and the thermophilic eubacterium Thermus thermophilus AGO (Sasaki 
and Tomari, 2012). 
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Figure 1.4: Structure of Human AGO2-RISC bound to a short miRNA target 
Highlights of some of the prominent structural features of human Argonaute-2. 
The crystal structure (PDB: 4W5Q, AGO2-RISC with a defined guide strand (red) 
bound to a short RNA target (blue) that pairs to g2–g8), was solved by Schirle 
and colleagues (Schirle et al., 2014). Callouts are alignments or displays of the 
solved structure to highlight detail. Top: α helix 7 of L2 linker moves 4 Å upon 
binding a miRNA target. Alignment of crystal structures 4W5N 
(AGO2-RISC bound to no target) and 4W5Q (bound to a target with 
complementarity to g2–g8) (Schrödinger, 2010). Movement of AGO2-RISC α 
helix 7 is shown in the unbound state (tan) clashing with the RNA target where 
as in the target bound state (cyan) α helix 7 moves to accommodate the target. 
Top left: Nucleotide g1 at the 5′ end of the guide strand is ‘flipped out’ making 
contacts within the binding pocket of the MID domain. This nucleotide does not 
participate in target pairing as it reserved to anchor the 5′ end of the guide 
strand. Bottom left: Target position 1 (t1) does not pair with the guide strand but 
adenosine will make water mediated contacts with the MID and L2 domains 
(Schirle et al., 2015). Bottom center: The pre-helical structure of the seed 
(target not shown). Argonaute changes the shape of the guide strand to create 
the seed (g2–g8) and anchors the 5′ end with g1. The half turn of the helix is 
shown where the bases are pre-organized to pre-pay the entropic penalty 
associated with nucleic acid hybridization.  
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N-terminal domain 
The N-terminal domain may have been one of the most under 
appreciated domain of the AGO until several recent structural studies emerged 
with domain swapping experiments to make non-catalytic AGOs catalytically 
active (Faehnle et al., 2013; Hauptmann et al., 2013). The first full-length 
structural studies with Thermus thermophilus AGO showed that it blocked 
duplex propagation between the guide strand and target past the 
16th nucleotide, respective to the 5′ end of the guide (Wang et al., 2009). 
Systematic analysis and biochemical experiments with human AGO2 revealed 
that the N-domain had an important role in RISC maturation where it acted as a 
‘wedge’ to help pry apart the siRNA duplex for RISC formation (Kwak and 
Tomari, 2012). The N-domain is required for the cleavage of a siRNA duplex and 
it is required for duplex unwinding of stable miRNAs duplexes (Kwak and 
Tomari, 2012). Furthermore, N-domain mutants are not capable of unwinding 
nicked duplexes from AGO2 or catalytic dead AGO2 (Kwak and Tomari, 2012). 
This result supports previous loading experiments with AGO1, AGO3, and AGO4 
where they all remain in pre-RISC with a siRNA duplexes or nicked duplexes 
(Yoda et al., 2010; Kobayashi and Tomari, 2015). The N-domain mutants, 
however, did not have any impact on product release or turnover of AGO2-RISC 
after target cleavage (Kwak and Tomari, 2012). This observation shows that 
although duplex removal and product release are similar in the molecular 
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actions there may be interactions with the target that are distinct from that of 
interaction with an siRNA or miRNA duplex. The catalytic activity of Argonaute is 
more than just containing the catalytic tetrad in the PIWI domain, rather it is the 
combination of the N-domain along with the catalytic tetrad; AGO3 is 
catalytically inactive for cleaving RNA both in vitro and in vivo even though it 
contains all of the catalytic residues (Meister et al., 2004b; Hauptmann et al., 
2013). Domain swapping revealed that in addition to having a catalytic tetrad in 
the PIWI domain that mediates Mg2+-dependent cleavage, the N terminal 
domain plays a critical in slicing activity (Schwarz et al., 2004; Faehnle et al., 
2013; Hauptmann et al., 2013). When the N-domain in non-catalytic AGOs is 
replace with the AGO2 N-domain it then confers catalytic activity in combination 
with having all catalytic residues along with a conserved Phe residue found in 
the AGO2 PIWI domain (Faehnle et al., 2013; Hauptmann et al., 2013). The role 
for the N terminal domain in slicing activity appears to be involved with proper 
positioning of the guide and target to help align the central cleft of the protein 
that cleaves target. Further structural studies with AGO2 in the pre-RISC state 
and when bound to a perfect target will help confirm the insights gleamed from 
biochemical studies with the N-domain. 
PAZ domain 
The PAZ (PIWI-Argonaute-Zwille) domain of AGO2 binds RNA and 
contains 2 subdomains; one with a five-stranded open β-barrel with two helices 
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on one end of the barrel and an additional strand on the outer part of the barrel, 
the second subdomain contains a β-hairpin followed by an α-helix (Lingel et al., 
2003; Song et al., 2003; Yan et al., 2003). The first subdomain is similar to other 
single-stranded nucleic acid binding proteins with an oligonucleotide and 
oligosaccharide-binding fold (Song et al., 2003). The AGO2-PAZ domain when 
expressed and purified from Escherichia coli was reported to have 
heterogeneous populations RNA, highly suggestive that it is responsible for 
AGO2’s binding to RNA in vivo (Song et al., 2003). Although PAZ binds nucleic 
acid, in vitro binding assays showed that its KD is in the low micromolar range 
whereas full-length AGO2 binds miRNAs at a low nanomolar affinity (Song et al., 
2003; Lima et al., 2009; Tan et al., 2009). The PAZ domain of AGO is important 
for anchoring the 3′ end of the bound guide RNA where it interacts with the 
2′ hydroxyl of the terminal nucleotide (Lingel et al., 2004b; Ma et al., 2004; Wang 
et al., 2008b; Schirle et al., 2014). This differs from the PAZ domain of PIWI 
proteins that are able to accommodate guides that contain a 3′ end with the 
terminal nucleotide containing a 2′-O-methyl (Simon et al., 2011; Tian et al., 
2011). 
 The PAZ domain in combination with the N-domain creates a narrow 
channel that the 3′ end of the guide strand threads through from g14–g18 
(Schirle et al., 2014). This channel is dynamic as its conformation is impacted 
when AGO2 binds to a miRNA target (Schirle et al., 2014). After seed pairing, the 
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channel widens and allows for supplemental pairing to occur between the guide 
strand and target (if complementarity exists) (Schirle et al., 2014). This widening 
action of the channel repositions the 3′ half of the guide (g11–g16) to adopt a 
near A-form conformation that can aid in either supplemental or siRNA-like 
pairing (Schirle et al., 2014). The A-form conformation is disrupted after g16 or 
g17 by the N-domain as previously described by the wedging effects of this 
domain (Wang et al., 2009; Kwak and Tomari, 2012; Schirle et al., 2014). For 
siRNA targets, the widening of the N-PAZ channel does not just accommodate 
base pairing but repositions the guide into the central cleft of PIWI to allow for 
proper coordination of catalytic residues that stimulate endonucleolytic cleavage 
(Schirle et al., 2014; Kobayashi and Tomari, 2015). It is predicted that the 3′ end 
of the guide most likely dissociates from the PAZ domain in order to 
accommodate the target induced protein conformation change (Wang et al., 
2009; Schirle et al., 2014; Zander et al., 2014). 
PIWI domain 
 The PIWI domain is the heart of all Argonaute proteins and it is the 
domain that contains catalytic residues that are required for RNAi along with 
structural features that change the shape of the bound small RNA (Figure 1.4). A 
protein domain comparison combined with the structure of prokaryotic 
Argonaute from Pyrococcus furiosus and biochemical identification as AGO2 as 
the slicer for RNAi led to a redefinition of the AGO protein PIWI domain (Cerutti 
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et al., 2000; Liu et al., 2004; Song et al., 2004). The core of the PIWI domain 
contains an RNaseH-like fold with a five-stranded mixed β-sheet that are 
surrounded by helices and connected to the rest of the protein by an insertion 
between the last sheet and the helix (Song et al., 2004). The topology of PIWI is 
similar to other known endonucleases such as: RuvC, a holiday junction 
endonuclease, Mu and Tn5, transposases, along with the closest match being to 
the RNase HI and RNase HII enzymes (Katayanagi et al., 1993; Ariyoshi et al., 
1994; Rice and Mizuuchi, 1995; Davies et al., 2000; Lai et al., 2000; Song et al., 
2004). Like other RNase H enzymes, the PIWI domain coordinates an Mg2+ ion in 
a catalytic center (Yang and Steitz, 1995; Chapados et al., 2001; Liu et al., 2004; 
Rivas et al., 2005). Mammalian AGO2 uses a catalytic tetrad of Asp-Glu-Asp-His 
residues to coordinate the Mg2+ ion so that it can generate hydroxide ions from 
water and cause in-line nucleophilic attack on the scissile phosphate of the RNA 
target across from g10 and g11 of the guide RNA (Martinez and Tuschl, 2004; 
Schwarz et al., 2004). This cleavage reaction leaves a 5′ phosphate and 3′ 
hydroxyl on the RNA target, characteristic of other RNase H mediated cleavage 
reactions (Martinez and Tuschl, 2004; Schwarz et al., 2004). 
 One of the most important features of the PIWI domain are the 
interactions it has with the small RNA guide. There are several amino acid 
contacts (van der Waals, hydrophobic, hydrogen bonds) with the phosphate 
backbone and sugars of the small RNA guide (Wang et al., 2008b; Elkayam et 
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al., 2012; Schirle and MacRae, 2012). These interactions act like a ‘cradle’ that 
the small RNA sits in to form an A-form, pre-helical shape that creates the seed 
(Figure 1.4; Schirle and MacRae, 2012; Elkayam et al., 2012). One notably 
difference in the structures of prokaryotic Argonautes and eukaryotic 
Argonautes is an alpha helical insertion in the PIWI domain that interrupts seed 
base stacking (Elkayam et al., 2012; Schirle and MacRae, 2012). This structural 
feature appears to play a role in miRNA target interrogation as it moves 
approximately 4Å upon target binding (Figure 1.4 ;Schirle et al., 2014). This 
protein feature is discussed in Chapter III as it relates to the biochemical 
mechanisms of target finding. 
 Recently, further comparison of the PIWI domain structure of human 
AGO1 was solved and compared to human AGO2 (Elkayam et al., 2012; Schirle 
and MacRae, 2012; Faehnle et al., 2013; Nakanishi et al., 2013). Besides the 
missing one of the catalytic residues (AGO1 has an Arg instead of a His), there is 
an insertion segment in the cS7 loop (Faehnle et al., 2013; Nakanishi et al., 
2013). The introduction of this loop is predicted to prevent full guide pairing and 
thus not allowing the RNA target to position correctly for endonucleolytic 
cleavage (Faehnle et al., 2013; Nakanishi et al., 2013). Creation of AGO1 PIWI 
domain mutants that create an active catalytic tetrad plus removal of the kink 
introduced by cS7 loop of AGO1 gave rise to cleavage activity albeit not to the 
same level of AGO2 (Nakanishi et al., 2013). These results along with AGO2 
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N domain swapping experiments show an importance of both the PIWI and 
N domains on cleavage and turnover activity (Faehnle et al., 2013; Hauptmann 
et al., 2013).  
MID Domain 
The MID domain contains 4 alternating α-helices and β-strands which 
resembles a Rossmann fold (Boland et al., 2010; Frank et al., 2010). The β-
strands constitute the core of the domain which creates an extended β-sheet 
that is surrounded by α-helices; the overall architecture of the MID domain is 
evolutionarily conserved in homologs from human to prokaryotes with some 
variation in loops and secondary structure (Song et al., 2004; Ma et al., 2005; 
Wang et al., 2008a; Boland et al., 2010; Frank et al., 2010). The structure of the 
human MID domain revealed a binding pocket with increased affinity for uracil or 
adenine over cytosine and guanine (Frank et al., 2010). Different Argonaute 
proteins show specific nucleotide preferences in the MID domain through 
specificity loops (Frank et al., 2010). This structural feature helps explain the 
nucleotide biases in flies and worms where there appears to be specificity for 
specific small RNAs that begin with one nucleotide over another (Lau et al., 
2001; Ghildiyal et al., 2008; Ghildiyal et al., 2010). In addition to nucleotide 
affinity, the interface between the MID and PIWI domains creates a 5′ 
phosphate-binding pocket for the small RNA — an anchor point for all small 
RNAs (Parker et al., 2004). There is a network of amino acid interactions that 
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secure the 5′ phosphate and in turn the end of the small RNA (Figure 1.4; Wang 
et al., 2008b; Schirle and MacRae, 2012; Elkayam et al., 2012; Faehnle et al., 
2013). These interactions cause the first nucleotide to ‘flip-out’ and thus it does 
not participate in base pairing to the target or the pre-helix formed by the seed 
(Figure 1.4; Wang et al., 2008b; Schirle and MacRae, 2012; Elkayam et al., 2012; 
Faehnle et al., 2013). 
 In addition to the interactions the MID domain makes with the small RNA 
bound to Argonaute, a recent structure of human AGO2 bound to a miRNA 
target shows specific interaction to the target itself. This data explains 
computational analyses in vertebrates showing that many miRNA target sites 
begin with an adenosine at target position 1 even though g1 of the small RNA 
cannot base pair (Lewis et al., 2005). The structure of human AGO2 with a 
miRNA target revealed that there is a surface binding pocket between MID and 
L2 domains of AGO2 that could accommodate the t1 nucleotide of a miRNA 
target site yet the preference for adenosine was not fully realized (Schirle et al., 
2014). The specificity that gives rise to miRNA targets with a t1A is mediated by 
water and the N6 amine of adenosine that makes specific contacts with the 
binding cleft on the MID-L2 surface (Figure 1.4; Schirle et al., 2015). 
The anatomy of the small RNA guide strand 
When a small RNA or DNA binds to an Argonaute it is not just simply a protein-
nucleic acid complex. The Argonaute protein changes the shape of the bound 
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small RNA or DNA to create specific functional domains within the guide strand 
that contribute to target finding and the overall mechanism of target regulation. 
The small RNA can be broken into distinct regions: anchor (g1), seed (g2–g8), 
central (g9–g12), supplementary (g13–g16), 3′ end (g17–g21) (Figure 1.5; Wee et 
al., 2012). 
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Figure 1.5: Argonaute creates functional domains within its bound small 
RNA guide.  
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Anchor 
The anchor domain of the small RNA guide interacts with the MID and 
PIWI domains to secure the 5′ end (Ha and Kim, 2014). This is mediated through 
a network of amino acid interactions with the phosphate, sugar, and base (Wang 
et al., 2008b; Elkayam et al., 2012; Schirle and MacRae, 2012; Faehnle et al., 
2013). In mammals, there is a preference from adenosine and uracil nucleotides 
since they have a greater affinity to the MID nucleotide-binding pocket (Bartel, 
2009; Frank et al., 2010). Nucleotide preference is mediated by the specificity 
loops of the MID domain and it allows some organisms (e.g., D. melanogaster) 
to sort their small RNAs into specific Argonautes (Boland et al., 2010; Frank et 
al., 2010; Ghildiyal et al., 2010; Zha et al., 2012). Arabidopsis thaliana 
Argonautes associate with miRNAs that contains one nucleotide over another 
but if MID specificity loops are swapped the miRNA will associate with a 
different Argonaute (Zha et al., 2012). More than just miRNA sorting, the first 
nucleotide’s 5′ phosphate appears to be a most critical anchoring feature 
(Figures 1.4 and 1.5). Studies with single-stranded RNA guides that bear a 
5′ OH instead of a 5′ P were less stable in AGO2 and showed slippage in the 
cleavage position (Rivas et al., 2005). Kinetic studies show that the anchor (g1) 
has little to no impact on RISC affinity toward its target and no impact on 
cleavage activity when it is mismatched to the target (Wee et al., 2012). 
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Seed 
The seed region of the small RNA guide (g2–g8) is responsible for target 
finding. Structural and kinetic studies have predicted that RISC will find its target 
faster than nucleic acid alone due to the pre-helical shape the protein puts the 
RNA in. This pre-helical arrangement and stacking of the bases pre-pays the 
entropic penalty associated with the hybridization of nucleic acids (Figures 1.4 
and 1.5). The seed not only contributes to the affinity for the target but for 
catalytic Argonautes, seed mismatches could impact the KM of target cleavage 
as much as 64-fold (KM does not equal KD for Argonautes, KD = (kcat + koff) / kon; 
Wee et al., 2012). 
Central 
The central nucleotides of the small RNA guide (g9–g12) are required to 
base pair for RNAi activity (Ding et al., 2003; Haley and Zamore, 2004; Martinez 
and Tuschl, 2004; Schwarz et al., 2006). The cleavage of the target takes place 
at the phosphodiester bond across from g10 and g11 of the guide strand 
(Elbashir et al., 2001b). Mismatches in this region have the largest impact on kcat 
in RNAi and a g11/g12 mismatch reduces cleavage activity to non-detectable 
levels (Wee et al., 2012). Although catalytic activity is greatly impacted by central 
mismatches, there is little or no change in RISC affinity toward the target — 
further emphasis that the seed is responsible for target finding and RISC affinity 
(Ameres et al., 2007; Wee et al., 2012). 
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Supplementary 
The supplementary region pairing (g13–g16) is found in a small subset of 
miRNAs and is thought to provide increased stability to the miRNA-target 
interaction, especially with weak seeds (Brennecke et al., 2005; Grimson et al., 
2007; Bartel, 2009). The contribution to affinity when compared to the seed 
region is less important; for example, the let‑7a miRNA has no increased affinity 
over the seed only pairing when compared to seed + 3′ supplementary pairing 
(Wee et al., 2012). In addition to miRNA modes of regulation, efficient RNAi 
activity requires base pairing through the central AND supplementary regions 
(Haley and Zamore, 2004; Wee et al., 2012). Stretches of mismatches through 
the supplementary region can abolish RNAi activity and similar to seed 
dinucleotide mismatches, may have pronounced effects on KM (Wee et al., 
2012). 
Tail 
The tail or 3′ end region (g17–g21) serves as another anchor point for the 
guide strand interacting with the PAZ domain (Lingel et al., 2003; Song et al., 
2003; Yan et al., 2003; Lingel et al., 2004a; Lingel et al., 2004b). There are 
specific interactions with the 3′ terminal nucleotide of the guide strand. In 
mammals, there is no terminal 2′-O-methyl modification of the sugar, which 
allows for hydrogen bond interactions to take place at both the 2′ and 3′ 
positions (Elbashir et al., 2001a; Hutvágner et al., 2001; Wang et al., 2008b; 
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Elkayam et al., 2012; Faehnle et al., 2013). Additionally, there are van der Waals 
interactions with the sugar that help it stack along the amino acids (Elkayam et 
al., 2012; Faehnle et al., 2013; Schirle et al., 2014). These interactions are 
thought to protect the small RNA from exonucleases as nuclease treatment of 
AGO2 bound to a small RNA protects it from micrococcal nuclease digestion 
(De et al., 2013). Similar to other non-seed regions of the guide strand, the tail 
region has little to no impact on RISC affinity toward its target and mismatches 
show no changes in KD (Haley and Zamore, 2004; Wee et al., 2012). Mismatches 
between the tail and target have been reported to increase product release and 
subsequently kcat after RNAi, although in some cases this increase is modest 
(Haley and Zamore, 2004; Wee et al., 2012; De et al., 2013). The sequence 
composition of the 3′ end tail may play a larger role on the product release step, 
especially with the N domain acting as a wedge to prevent base pairing past 
g18 (Kwak and Tomari, 2012; Faehnle et al., 2013; Hauptmann et al., 2013). 
Nucleic Acid Hybridization 
An underlying biophysical interaction in the mechanism of small regulatory RNAs 
is the association and dissociation between RNA targets. RISC uses nucleic 
acid hybridization to discriminate target sites in the transcriptome in order to 
regulate a complementary target. The principles of both nucleic acid-nucleic 
acid and protein-nucleic acid interactions factor into the mechanistic workings 
of small regulatory RNAs.  
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Numerous studies have looked into the hybridization rates of nucleic 
acids in a variety of solvents, temperatures, and ionic strengths (Wetmur, 1976). 
Under physiologic conditions, the temperature and ionic strength strongly favor 
for nucleic acids to hybridize (Herschlag, 1991). The rate of RNA and/or DNA 
hybridization is limited by the rate of successful collisions that convert into 
stable binding events (Ross and Sturtevant, 1960; Ross and Sturtevant, 1962; 
Nygaard and Hall, 1964; Wetmur and Davidson, 1968). Fundamental studies of 
nucleic acid association and dissociation have relied upon the spectral 
properties of nucleic acid where the absorbance at 260 nm increases when 
denatured and decreases when the bases are stacked in a helix (renatured), this 
is known as hyperchromicity and hypochromicity, respectively (Wetmur, 1976). 
The study of renaturation kinetics revealed that this reaction is second-order 
and concentration dependent (Hutton and Wetmur, 1973; Wetmur, 1976). An 
exception is when one strand is in way excess of the other strand, this makes 
the reaction pseudo first-order (Galau et al., 1977). The reaction is not 
diffusion-controlled, where there are many non-productive (non-helix forming) 
collisions that precede a productive nucleation event that will lead to the fast 
‘zippering’ of the nucleic acid to form the helix (Figure 1.6; Chang et al., 1974; 
Wetmur and Davidson, 1968; Berg and von Hippel, 1985). The reaction of 
nucleic acid hybridization is slow, where in addition to non-productive 
inter-molecular associations there are non-productive intra-molecular events. 
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The entropy of nucleic acid bases (as illustrated in Figure 1.6) causes a 
thermodynamic penalty for productive association whereas it is inferred that 
seed region created by AGO and its bound small RNA or DNA pre-pays this 
penalty (Wee et al., 2012). 
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Figure 1.6: Representation of Nucleic Acid Hybridization 
Prior to duplex formation, there are many non-productive binding events between single strands of RNA or DNA. 
The entropy of the individual nucleotides combined intra-molecular interactions contributes to the characteristic 
slow association kinetics for nucleic acid. When several nucleotides are oriented correctly for base pairing this 
decreases the dissociation rate of the two strands so that they may ‘zipper’ and form a duplex. The reverse 
reaction after duplex formation is very slow under physiologic conditions and temperatures.
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Once a duplex is formed there are well-established thermodynamic 
parameters that can be used to predict the stability at a given temperature 
and/or ionic strength (Xia et al., 1998). The Nearest-neighbor model is based 
upon empirical measurements of the stability of single base pairs within a 
duplex relative to the neighboring nucleotides and/or position within the duplex 
(i.e., terminal nucleotides, bulges, adjacent to an overhang, etc., Nelson et al., 
1981; Sugimoto et al., 1987; Longfellow et al., 1990; O'Toole et al., 2005; Xia et 
al., 1998). These predictions take into account a nucleic acid-nucleic acid 
interaction but do not and were not intended to take into account how a protein 
can influence nucleic acid pairing. In the case of small regulatory RNAs, Wee 
and colleagues showed that different AGO proteins have distinct kinetic 
properties that can influence RNAi activity and binding kinetics and some of 
these interactions cannot be predicted by the Nearest-neighbor model alone 
(Wee et al., 2012; Wee, 2013). 
Objective 
The underlying mechanism of small regulatory RNAs begins and ends with two 
simple reaction steps: (1) association/finding its target (2) dissociation after 
finding its target — this is either releasing cleaved products (RNAi) or 
dissociating after acting as a scaffold for regulatory silencing factors (miRNA). 
Some of these steps have been measured in ensemble in vitro kinetic studies or 
inferred by structural predictions. The goal of this thesis is to understand the 
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initial and terminal reaction steps of AGO-RISC, the effector complex in small 
RNA regulation, by direct and quantitative measurement. These measurements 
utilize a powerful technique that takes measurements of individual molecules in 
a population rather than the measured average of many molecules in a 
population. Direct measurement using single-molecule TIRF microscopy 
coupled to co-localization analysis allows us to measure the interaction of RNA 
and protein simultaneously. This work highlights the remarkable ability of 
proteins to discriminate true substrates over mimics and illustrates how efficient 
enzymes favor substrates over products. This thesis uncovers how the 
biophysical properties of one macromolecule (small regulatory RNA) can be 
influenced or changed when bound to another macromolecule (protein, 
Argonaute). My work shows how components of the small RNA pathway have 
evolved to suit their regulatory functions in the cell and also highlight a potential 
insight into how other nucleic acid guided endonucleases parallel Argonaute 
proteins. 
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CHAPTER II: Rapid and specific purification of 
Argonaute-small RNA complexes from crude cell 
lysates 
 
 
 
Disclaimer 
This work is the joint effort among the authors: Carlos Fabián Flores-Jasso 
(CFF-J), William E. Salomon (WES), and Phillip D. Zamore (PDZ). CFF-J 
performed experiments related to fly RISC and the initial optimization of the 
purification technique. WES established a mammalian S100 extract that was 
robust at recapitulating RNAi and optimized the conditions for mouse RISC 
purification. WES performed experiments, analyses, and prepared figures 
related to mouse AGO2-RISC. CFF-J and PDZ wrote the manuscript. All authors 
provided critical review of the data and manuscript. This chapter includes 
several pieces of unpublished data and some discussion related to the 
mammalian S100 extract optimization and the purification of mouse AGO2-
RISC.  
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SUMMARY 
Small interfering RNAs (siRNAs) direct Argonaute proteins, the core components 
of the RNA-induced silencing complex (RISC), to cleave complementary target 
RNAs. Here, we describe a method to purify active RISC containing a single, 
unique small RNA guide sequence. We begin by capturing RISC using a 
complementary 2′-O-methyl oligonucleotide tethered to beads. Unlike other 
methods that capture RISC but do not allow its recovery, our strategy purifies 
active, soluble RISC in good yield. The method takes advantage of the finding 
that RISC partially paired to a target through its siRNA guide dissociates >300 
times faster than a fully paired siRNA in RISC. We use this strategy to purify fly 
Ago1- and Ago2-RISC, as well as mouse AGO2-RISC. The method can 
discriminate among RISCs programmed with different guide strands, making it 
possible to deplete and recover specific RISC populations. Endogenous 
microRNA:Argonaute complexes can also be purified from cell lysates. Our 
method scales readily and takes less than a day to complete. 
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INTRODUCTION 
Small interfering RNAs (siRNAs) and microRNAs (miRNAs) mediate the post-
transcriptional repression of complementary target RNAs (Bartel, 2009; Ghildiyal 
and Zamore, 2009). siRNAs typically guide the cleavage of extensively 
complementary RNAs (Hammond et al., 2000; Zamore et al., 2000; Elbashir et 
al., 2001a; Elbashir et al., 2001b), a phenomenon called RNA interference 
(RNAi). In contrast, most animal miRNAs target partially complementary RNAs, 
triggering their destruction (Baek et al., 2008; Selbach et al., 2008; Ingolia et al., 
2009; Guo et al., 2010) and, in some cases, repressing their translation into 
protein (Hendrickson et al., 2009; Bazzini et al., 2012). Both siRNAs and miRNAs 
assemble with Argonaute proteins to form the RNA-induced silencing complex 
(RISC). Assembly of siRNA or miRNA/miRNA* duplexes into RISC is facilitated 
by proteins that orient the siRNA, such as the Dicer-2/R2D2 heterodimer in 
insects, and by proteins thought to allow conformational rearrangement of 
Argonaute, such as HSP90 and Hsc70 chaperones (Tahbaz et al., 2001; Iki et 
al., 2010; Iwasaki et al., 2010; Johnston et al., 2010; Miyoshi et al., 2010; Olivieri 
et al., 2012; Preall et al., 2012; Xiol et al., 2012). 
In Drosophila melanogaster, miRNAs and siRNAs are sorted between 
Argonaute1 (Ago1) and Argonaute2 (Ago2) according to their duplex structure 
and the identity of their first nucleotide (Forstemann et al., 2007; Tomari et al., 
2007; Czech et al., 2008; Ghildiyal et al., 2008; Okamura et al., 2008b; Seitz et 
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al., 2011). The extensively double-stranded structure of siRNA sends them into 
Ago2, while the presence of specific mismatches within the miRNA/miRNA* 
duplex directs miRNAs into Ago1. In mammals, whose four Argonaute proteins 
are more closely related to fly Ago1 than to fly Ago2 (Tolia and Joshua-Tor, 
2007), no sorting mechanism has thus far been detected, and miRNAs and 
siRNAs assemble into AGO1, AGO2, AGO3, and AGO4. In mice and humans, 
only AGO2 can catalyze target cleavage (Liu et al., 2004; Meister et al., 2004b). 
Chemically modified, complementary oligonucleotides that bind siRNAs 
and miRNAs block their activity in vitro and in vivo (Hutvagner et al., 2004; 
Meister et al., 2004a; Krutzfeldt et al., 2005; Leaman et al., 2005; Elmen et al., 
2008; Lanford et al., 2010; Obad et al., 2011). The most widely used anti-miRNA 
oligonucleotides employ 2′-O-methyl ribose modifications to block degradation 
of the oligonucleotide. Such 2′-O-methyl anti-miRNA oligonucleotides not only 
inhibit miRNA function in cultured cell lines, cell lysates, and Caenorhabditis 
elegans (Hutvagner et al., 2004; Zheng et al., 2010), but also can be used to 
capture Argonaute complexes programmed with a specific small RNA sequence 
(Hutvagner et al., 2004). Unfortunately, RISC captured using fully 
complementary 2′-O-methyl oligonucleotides tethered to beads cannot be 
recovered under native conditions, precluding its further study. 
Despite great advances in understanding the miRNA and siRNA 
pathways, the biochemical details of how Argonaute proteins function remains 
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incomplete. A key limitation in the study of Argonaute protein function is the lack 
of methods to purify RISC complexes assembled through natural pathways and 
that contain a single, unique guide sequence. Purification of RISC using 
antibodies against endogenous or epitope-tagged Argonautes allows the 
selection of specific Argonaute proteins, but these contain a complex mixture of 
siRNA and miRNA guides (Hutvagner and Zamore, 2002; Mourelatos et al., 
2002; Liu et al., 2004; Meister et al., 2004a; Ikeda et al., 2006; Beitzinger et al., 
2007; Azuma-Mukai et al., 2008). RISC has also been purified using a guide 
strand with a 3′ biotin joined to the siRNA through a UV-sensitive linker, which 
was cleaved by photolysis (Martinez et al., 2002; Martinez and Tuschl, 2004; 
Ameres et al., 2007) and using tethered siRNAs from which proteins were 
recovered with denaturing buffers (Gerbasi et al., 2010). However, photolysis is 
inefficient, and recovery by denaturation, of course, fails to preserve RISC 
activity. Both approaches can only be used to isolate experimentally 
programmed RISC, whereas our method permits purification of endogenous 
complexes from cell and tissue extracts. 
Recombinant eukaryotic Argonaute proteins have been produced in 
bacteria, and in insect, yeast, human, and lepidopteran cells (Rivas et al., 2005; 
MacRae et al., 2008; Ye et al., 2011; Elkayam et al., 2012; Nakanishi et al., 2012; 
Schirle and MacRae, 2012). Recombinant Argonaute proteins can be partially 
inactive (Rivas et al., 2005) and often contain endogenous RNAs (Nakanishi et 
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al., 2012; Schirle and MacRae, 2012). Furthermore, recombinant Argonaute 
proteins must be loaded with single-stranded RNA, a pathway not thought to 
exist in vivo, and lack associated proteins that may modify Argonaute function. 
Here, we describe a method to purify active Argonaute complexes 
(RISCs) containing a single, unique small RNA guide. Like previous techniques, 
our method begins by capturing RISC using a complementary 2′-O-methyl 
oligonucleotide tethered to paramagnetic beads (the capture oligo). The strategy 
takes advantage of the finding that fly Ago2-RISC dissociates from a target RNA 
>300 times more rapidly when its guide strand is partially paired than when it is 
fully paired to a target (Wee et al., 2012). We can therefore elute purified, active, 
soluble RISC from the capture oligo in good yield in native conditions. We use 
this strategy to purify Drosophila Ago2-RISC bearing an siRNA and Ago1-RISC 
loaded with a miRNA, as well as an siRNA assembled into mouse AGO2 in 
lysates from immortalized embryonic fibroblasts. Finally, we show that active 
RISC can be selectively purified from a population of RISCs containing different 
guide strands. This method scales readily and takes no more than a single day 
to complete. 
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RESULTS 
miRNA-like pairing allows efficient capture and release of RISC 
We incubated an siRNA duplex in Drosophila embryo lysate to assemble the 
guide strand into Ago2-RISC. We captured the RISC containing the siRNA guide 
using a 31 nt 2′-O-methyl oligonucleotide tethered via a 5′ biotin to 
streptavidin-paramagnetic beads. RISC, captured on the oligo, was then 
washed in buffer containing 2 M potassium acetate and eluted with a competitor 
DNA oligonucleotide fully complementary to the capture oligo in buffer 
containing 1 M potassium acetate. Figure 2.1 illustrates the method. Three types 
of capture oligos were tested: an oligo fully complementary to the siRNA guide; 
an oligo complementary only to the seed of the siRNA (positions 2–8); and an 
oligo complementary to the seed and four nucleotides in the 3′ supplementary 
region of the siRNA. The amount of capture oligo used (5 µM) was greater than 
the concentration of 2′-O-methyl oligonucleotide (1–2 µM) that fully blocks 
target cleavage directed by this siRNA in Drosophila embryo lysate (Figure S2.1). 
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Figure 2.1: Strategy to purify active RISC  
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To monitor the efficiency of binding and recovery of siRNA-programmed 
RISC for each of the three types of capture oligos, we assayed cleavage of a 
5′ 32P-radiolabeled target RNA (Figure 2.2). In parallel, we followed a 
5′ 32P-radiolabeled guide siRNA through the purification procedure (Table 2.1). 
The fully complementary capture oligo, the capture oligo with seed plus 
3′ supplementary pairing, and the capture oligo pairing only with the seed, all 
effectively depleted the programmed RISC from the lysate: we detected less 
than 2% of the original RISC cleaving activity in the supernatant of an assembly 
reaction incubated with any of the capture oligos tethered to paramagnetic 
beads or in the subsequent, pooled washes (100 mM and 2 M potassium 
acetate). For the fully complementary capture oligo, addition of a competitor 
oligonucleotide (the competitor) complementary to the capture oligo failed to 
release any detectable target-cleaving RISC activity (Table 2.1). In contrast, a 
competitor efficiently released active RISC from the capture oligo 
complementary to only the seed plus the 3′ supplementary region or the seed 
alone. We note that high salt (1 M potassium acetate) was essential: at lower 
salt concentrations, addition of a competitor complementary to the capture oligo 
failed to release any detectable target-cleaving RISC activity (Figure 2.2) or 
32P-radiolabeled guide siRNA (Table 2.1, compare “low salt + competitor” to 
“eluate”). 
  
  
59 
 
  
  
60 
Figure 2.2: Active RISC can be eluted from a capture oligo partially 
complementary to the small RNA guide  
let-7-programmed Drosophila Ago2-RISC, assembled in in Drosophila embryo 
lysate, was incubated with a capture oligo fully complementary to let-7, to the 
let-7 seed plus 3′ supplementary region, or only to the let-7 seed sequence. The 
RISC assembly reaction (Input), the supernatant after capture (Sup), the washes 
(five with 100 mM and five with 2 M potassium acetate, pooled and 
concentrated to the volume of the original RISC assembly reaction, 100 µl; 
Wash), and the eluate from the capture oligos were incubated with 100 nM 
target RNA for 5 min at 25°C to detect Ago2-RISC activity. Ø, no incubation.
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TABLE 2.1      
Capture oligo 
complementarity 
Active RISC 
assembled 
siRNA in 
supernatant 
Washes Eluate 
(high salt + 
competitor) 
Yield 
Low salt Low salt + competitor High salt 
None 12 ± 1 16 ± 1 0.15 ± 0.01 0.10 ± 0.01 0.83 ± 0.06 0.13 + 0.01 1.1% 
Complete 
complementarity 
to guide strand 
12 ± 1 10 ± 1 0.43 ± 0.01 0.092 ± 0.008 0.10 ± 0.01 0.29 ± 0.03 2.4% 
Guide strand 
seed plus 
3′ supplementary 
12 ± 1 7.4 ± 0.4 0.10 ± 0.02 0.12 ± 0.02 0.10 ± 0.02 9.4 ± 0.1 78% 
Guide strand 
seed only 
12 ± 1 8.1 ± 0.4 0.11 ± 0.01 0.11 ± 0.01 0.097 ± 0.009 9.6 ± 0.6 80% 
Passenger strand 
seed plus 
3′ supplementary 
12 ± 1 21 ± 1 0.22 ± 0.05 0.12 ± 0.07 0.082 ± 0.008 0.082 ± 0.008 0.68% 
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Table 2.1: Yield of fly Ago2-RISC eluted from the capture oligo  
RISC was assembled in Drosophila embryo lysate using 25 nM siRNA duplex. For the supernatant and washes, 
the amount of 5′ 32P-radiolabeled siRNA (pmol) was measured as a surrogate for RISC. Active RISC assembled 
and eluted were measured as described in the Materials and Methods. Data are mean ± S.D., n = 3.The RISC 
eluted by this method contains competitor DNA that is partially complementary to an RNA target fully matching 
the siRNA guide. In practice, the contaminating competitor DNA does not detectably interfere with target 
cleavage. However, the competitor can be readily removed by subsequent ion exchange chromatography (See 
Materials and Methods).
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Purification of Ago1 programmed with a miRNA 
In flies, canonical miRNA/miRNA* duplexes load Ago1 rather than Ago2 
(Forstemann et al., 2007; Tomari et al., 2007). To test whether the method could 
be used to selectively purify Ago1-RISC, we incubated a let-7/let-7* duplex with 
Drosophila embryo lysate, and then purified the let-7-programmed Ago1-RISC 
using the capture oligo complementary to the seed plus the 3′ supplementary 
region.  Although Ago 1-RISC is inherently less catalytically active than Ago2 
(kcat/KM for Ago2 is >60-fold greater than for Ago1) and target cleavage is 
unlikely to play an important role in Ago1-mediated mRNA repression 
(Forstemann et al., 2007), Ago1 can be followed by target cleaving activity 
(Figure 2.3A). Target cleavage assays of let-7-programmed Ago1-RISC detected 
activity in the input and eluate samples (Figure 2.3A). Quantitative mass 
spectrometry (Figure 2.3C) revealed that the eluate was more enriched for Ago1 
(467-fold over background) than for Ago2 (fivefold enrichment). In contrast, RISC 
assembled with a let-7 siRNA (Figures 2.3B, 2.3C and Tables S2.1 and S2.2) 
contained mainly Ago2 (356-fold enrichment over background) rather than Ago1 
(1.6-fold enrichment). Importantly, we used the same capture oligo to purify 
each Argonaute complex, changing only the let-7 duplex used to assemble 
RISC. Flies do not produce let-7 during embryogenesis (Pasquinelli et al., 2000), 
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so all let-7 RISC activity reflects Argonaute programmed in the lysate by the 
let-7 siRNA or miRNA/miRNA* duplex. 
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Figure 2.3: Drosophila Ago1- and Ago2-RISC, as well as mouse AGO2-
RISC, can be purified using a partially complementary capture oligo. 
(A) A let-7/let-7* duplex was loaded into Drosophila Ago1 or (B) a let-7 siRNA 
was loaded into Drosophila Ago2 by incubation in Drosophila embryo lysate and 
purified with a partially complementary capture oligo. The RISC assembly 
reaction (Input), the supernatant after capture (Sup), the first wash, and the 
eluates were incubated with 100 nM let-7 complementary target RNA for 10 min 
(Ago1 and Ago2) and 180 min (Ago1) at 25°C. (C) Tenfold concentrated, purified 
Drosophila Ago1- and Ago2-RISC and control samples were analyzed by 
quantitative mass spectrometry to determine their protein composition. The 
enrichment of each Argonaute protein in the purified RISC was calculated as the 
ratio of let-7-programmed, purified samples to control samples in which the 
small RNA duplex was omitted (background).   
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Purification of mouse AGO2-RISC 
We developed a cell extract system that robustly recapitulates RNAi in vitro that 
is superior to commonly used HeLa cell extracts for mammalian RNAi (Figures 
2.4 and S2.2). The improved cell extract is cytosolic S100 extract from 
immortalized, Ago2–/– mouse embryonic fibroblasts (MEFs; Broderick et al., 
2011; O'Carroll et al., 2007) that stably express about 30-fold more Ago2 mRNA 
than wild-type MEFs and contain ~200-fold more AGO2 in the S100 cytosolic 
extract (Figure 2.4). Our method also effectively purifies mammalian AGO2-
RISC. The S100 was incubated with a let-7 siRNA duplex to program RISC and 
we used the same capture oligo and protocol as for fly RISC, and then tested 
the eluate for target cleaving activity (Figure 2.4D). Again, target cleaving activity 
was detected in the eluate when we used a capture oligo complementary to 
seed plus the 3′ supplementary region or to the seed alone, but not the fully 
complementary capture oligo. 
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Figure 2.4: Establishment of a mammalian in vitro RNAi extract system and 
purification of mouse Ago2 
(A) Representative target cleavage for different S100 cytosolic cell extracts 
programmed with let-7 siRNA after 5 minutes incubation with let-7 target. S100 
extracts and target cleavage assay were performed as described in Material and 
Methods. (B) Quantification of RNAi target cleavage guided by let-7 siRNA 
programmed in mammalian S100 cell extracts. (C) Western blot of AGO2 levels 
in S100 cytosolic extracts. Stoichiometric amounts of total protein (37.5ug) were 
loaded on a 4–20% SDS-polyacrylamide gel with the exception of S100 extract 
from Ago2–/– MEFs over-expressing mouse AGO2 (20ug) in order to prevent 
overexposure of the membrane. The relative amount of Ago2 was calculated by 
normalizing loading to β-tubulin and comparing to wild-type MEF S100 (set at 
1.0). (D) Purification of let-7-programmed mouse AGO2-RISC. let-7 siRNA was 
assembled in S100 cytosolic extract from Ago2–/– MEFs over-expressing mouse 
AGO2 then purified using either fully or partially complementary capture oligos. 
Target cleaving activity was tested using 100 nM target RNA for 5 min at 37°C. 
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Although MEFs express at least three of the four mammalian Argonaute 
proteins (Broderick et al., 2011), quantitative mass spectrometry detected in the 
eluate only mouse AGO2 (Table S2.3), which was 64-fold enriched over the 
background control (Figure S2.2C). Perhaps the endogenous mouse AGO1, 
AGO3, and AGO4 proteins in the S100 are preoccupied with endogenous 
miRNAs and therefore unavailable for loading with exogenous siRNA. 
Separation of a mixture of two RISCs 
As a test of specificity, we asked whether our method can resolve RISCs 
programmed with different siRNAs. We separately assembled let-7 and 
luciferase siRNAs into RISC using fly embryo lysate or mouse S100 cell extract. 
Next, we mixed the assembly reactions and then used a let-7-specific capture 
oligo to purify RISC from one half of the mixture. We used a luciferase-specific 
capture oligo to purify luciferase-siRNA-programmed RISC from the other half. 
Finally, we tested the eluates for their ability to cleave either let-7 or luciferase 
target RNAs. RISC purified using the let-7-specific capture oligo only cleaved 
the let-7 target (Figures 2.5 and 2.6). Conversely, RISC purified using the 
luciferase-specific capture oligo only cleaved the luciferase target. Thus, the 
method can separate a mixture of RISCs programmed with different small RNA 
sequences.  
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Figure 2.5: The purification method separates fly RISCs programmed with 
different siRNA guides. 
(A) Experimental strategy. Red, guide; blue, passenger strand. (B) The activity of 
the samples was measured by incubating them with target RNAs (100 nM) 
complementary to let-7 (186 nt) and luciferase  (506 nt) guide siRNA strands for 
5 min (Input, Sup, Eluate) or 30 min (Eluate) at 25°C. Ø, no incubation. 
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Figure 2.6: The purification method separates mouse RISCs programmed 
with different siRNA guides. 
(A) Experimental strategy. Red, guide; blue, passenger strand. (B) The activity of 
the samples was measured by incubating them with target RNAs (100 nM) 
complementary to let-7 (186 nt) and luciferase  (506 nt) guide siRNA strands for 
5 min (Input, Sup, Eluate) or 30 min (Eluate) at 37°C. Ø, no incubation.  
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Efficient purification with good yield 
Both fully complementary and partially complementary capture oligos depleted 
all (Figures 2.2, 2.3A and 2.3B) or most (Figure 2.4D) detectable RISC activity 
from the lysate, but RISC was recovered efficiently only from the partially 
complementary capture oligo. To estimate the yield for our purification method, 
we measured both the amount of active purified RISC recovered in the eluate by 
pre-steady-state kinetic analysis and the differential loss of the passenger and 
guide strands (Figures S2.4). Nearly all the active RISC assembled was 
recovered from the partially complementary capture oligo: 78% for the capture 
oligo complementary to the seed plus the 3′ supplementary region and 80% for 
the capture oligo complementary to the seed alone (Table 2.1). Overall, the 
specific activity (pmole active RISC/mg protein) of fly Ago2-RISC increased 
790-fold between the assembly reaction and the eluate of the capture oligo 
(Table 2.2). For mouse AGO2-RISC, the specific activity increased 320-fold.
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Table 2.2 
Species 
Starting material Final purified RISC 
Purification 
factor Total protein 
(mg) 
Active RISC 
(pmole) 
Specific activity 
(pmole/mg) 
Total protein 
(mg) 
Active RISC 
(pmole) 
Specific 
activity 
(pmole/mg) 
Fly 28 12 0.43 0.025 8.6 340 790 
Mouse 3.3 2.6 0.78 0.0089 2.3 250 320 
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Table 2.2: Purification of let-7 programmed Ago2-RISC from Drosophila embryo lysate and AGO2-over-
expressing MEF S100
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Purification of endogenously loaded miRNAs 
We tested whether our method can also be used to purify RISC programmed 
with endogenous miRNAs. miR-21 is the most abundant miRNA in MEFs (J.A. 
Broderick and PDZ, unpublished data). We used a capture oligo complementary 
to the miR-21 seed plus 3′ supplementary region to purify miR-21-RISC from 
MEF S100 lysate, and then tested its ability to cleave a fully complementary 
miR-21 target RNA. Active miR-21-programmed RISC was recovered in the 
eluate  (Figure 2.7A). 
miR-286 is one of the most abundant miRNAs in 2–6 h Drosophila 
embryos (Ruby et al., 2007; Chung et al., 2008). We used a capture oligo 
complementary to the miR-286 seed plus 3′ supplementary region to purify 
miR-286-RISC from embryo lysate. Northern hybridization demonstrated that we 
could successfully recover miR-286 in the eluate of the capture oligo (Figure 
2.7B). 
Unlike purification of exogenously programmed RISC from fly embryo or 
mouse cell lysate, the capture oligo did not fully deplete the targeted miRNA 
from the lysate for either of the endogenous miRNAs. The failure to deplete miR-
21- or miR-286-RISC from the lysate cannot be explained by an insufficient 
amount of capture oligo, because a second round of incubation with fresh 
capture oligo failed to deplete the remaining Drosophila miR-286 (Figure 2.7B). 
The simplest explanation is that as much as half of the miR-286 in the embryo 
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lysate is bound to its mRNA targets and is therefore unavailable to bind the 
capture oligo. 
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Figure 2.7: Purification of endogenous miRNA-RISC complexes 
(A) S100 cytosolic extract from Ago2–/– MEFs over-expressing mouse AGO2 was 
concentrated tenfold, and then purified using a capture oligo partially 
complementary to mouse miR-21. Target cleavage assays were performed by 
incubating samples with 100 nM target RNA for 5 min (Input, Sup, Eluate) or 
30 min (Eluate) at 25°C. Ø, no incubation. (B) Drosophila miR-286 was purified 
from embryo lysate using a partially complementary capture oligo. Total RNA 
from each sample was resolved by denaturing electrophoresis, and miR-286 
detected by northern hybridization.  
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DISCUSSION 
We have described a simple method to purify from crude extracts active RISC 
complexes containing a single guide RNA sequence. Additionally, we describe a 
more robust cell extract system for the study of mammalian RNAi by over 
expressing AGO2 in MEF cells. Our procedure preserves the activity of 
target-cleaving Argonaute protein, but should also find use purifying 
Argonaute:small RNA complexes that do not catalyze endonucleolytic cleavage 
of their target RNAs. 
 Drosophila embryo lysate has been used extensively to study the 
biochemical mechanism of RNAi due to its robustness whereas there are fewer 
studies using mammalian cell extracts (Hutvagner and Zamore, 2002; Schwarz 
et al., 2002; Haley et al., 2003). A benefit to the use of cell extracts or lysates is 
that Argonaute proteins are programmed with their natural substrate, a siRNA 
duplex rather than using a single stranded RNA and recombinant protein (Rivas 
et al., 2005; MacRae et al., 2008). Why is embryo lysate more robust than 
mammalian extract system? There may be more Argonaute present in embryo 
lysate, however, a likely scenario is that the mammalian AGO proteins are 
already bound to miRNAs thus with no new AGO being translated in the cell 
extract, the exogenous siRNA cannot associate with AGO and does not form 
RISC. Alternatively, Drosophila reserves the AGO2 protein for viral siRNAs that 
are generated by Dicer upon infection (Wang et al., 2006). In our system, the 
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non-infected embryo lysate contains many unloaded AGO2 that is 
programmable (Haley et al., 2003). We used a MEF cell line that overexpresses 
AGO2 along with normal levels of other AGO proteins (O'Carroll et al., 2007; 
Broderick et al., 2011). This overexpression of AGO2 is at levels that satisfy the 
steady-state level of miRNAs while leaving an appreciable amount unloaded 
AGO that that is competent for siRNA assembly. This allows for the preparation 
of cell extracts that are reasonable in volume and concentration and, can be 
used to generate AGO2-RISC at concentrations that is suitable for in vitro 
biochemical studies.  
Our method offers the advantage of purifying freely diffusing RISC 
complexes that can be used to study small RNA-directed Argonaute enzyme 
kinetics (Wee et al., 2012). Free diffusion is essential for quantitative population 
or single-molecule analysis of target binding by RISC. 
Our method isolates only fully assembled, mature RISC containing a 
single-stranded RNA guide (Table 2.1). Thus, the proteins that co-purify with 
RISC should be only those present at the encounter with target. Our mass 
spectrometry analyses support this view, as we did not find proteins that 
participate in small RNA biogenesis or RISC assembly. We detected no peptides 
from Dicer-1, Dicer-2, R2D2, Loquacious, or C3PO (Jiang et al., 2005; Liu et al., 
2006; Liu et al., 2007; Liu et al., 2009) co-purifying with Drosophila Ago1- or 
Ago2-RISC, nor did we detect Dicer, TRBP, or PACT (Hutvágner et al., 2001; 
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Chendrimada et al., 2005; Haase et al., 2005; Lee et al., 2006) co-purifying with 
mouse AGO2-RISC (Figure S2.3 and Tables S2.1–S2.3). 
Heat shock proteins such as Hsp90 and Hsc70 also function in RISC 
assembly (Iki et al., 2010; Iwasaki et al., 2010; Johnston et al., 2010; Miyoshi et 
al., 2010; Miyoshi et al., 2010). Hsc70-4 was enriched over background for 
Drosophila Ago1-RISC purified by our method (Tables S2.1–S2.3). Hsc70-4 
associates with Argonaute during its assembly into RISC, but Hsc70 and Hsp90 
inhibitors had no detectable affect on target cleavage by Ago2 (Iwasaki et al., 
2010); our data suggest Hsc70-4 may nonetheless play a role for Ago1 in target 
finding, target cleavage, product release, or enzyme regeneration after target 
cleavage. Whereas Ago2 was the most enriched protein in the Ago2 sample, 
other proteins were highly enriched in the Ago1 sample (Table S2.1); ribosomal 
protein L7A was the only protein enriched in both samples. We do not yet know 
if these Argonaute-associated proteins play a role in RISC function. 
Although the siRNAs and miRNAs used here contained no chemical 
modifications, we have used the method to purify RISC programmed with 
fluorescently labeled siRNA guide strands (CFF-J and PDZ, unpublished data). 
We envision that our method will prove useful in the biochemical dissection of 
the RNAi and miRNA pathways and in the identification of proteins that modify 
and extend RISC function. 
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Materials and Methods 
General methods 
Synthetic DNA (IDT, Coralville, IA) and RNA (GE Healthcare Dharmacon, 
Lafayette, CO) oligonucleotides were gel purified before use. RNA 
oligonucleotides were synthesized containing a 5′ phosphate. The strands of the 
let-7 and luciferase siRNA duplexes were annealed in lysis buffer 
(30 mM HEPES-KOH, pH 7.4, 100 mM potassium acetate, 2 mM magnesium 
acetate) using a 1:1.3 molar ratio of guide to passenger. The let-7/let-7* duplex 
was annealed using a 1:5 molar ratio of miRNA to miRNA*. 
Drosophila embryo lysate and MEF S100 cytosolic extract Drosophila 
embryo lysate from 0–8 h embryos and RISC assembly were as described 
(Haley et al., 2003). The protein concentration of the embryo lysate was 
~30 mg/ml. 
S100 extract was generated from SV40 large T-antigen immortalized 
Ago2−/− MEFs that stably over-express mouse Ago2 mRNA (O'Carroll et al., 
2007), SV40 large-T antigen immortalized MEF (Salomon and Zamore, 
unpublished) or HeLa cells (ATCC, Manassas, VA). Cells were grown to 
confluence in 5% CO2 at 37°C in DMEM (Thermo Fisher Scientific – Life 
Technologies, Grand Island, NY) supplemented with 15% fetal bovine serum 
(GE Healthcare Bio-Sciences, PAA Laboratories, Pittsburg, PA) and 50 U/ml 
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penicillin and streptomycin (Thermo Fisher Scientific – Life Technologies). S100 
extract was prepared as described (Dignam et al., 1983) except that the cell 
pellet was washed three times in ice-cold PBS and once in Buffer A (10 mM 
HEPES–KOH, pH 7.9, 10 mM potassium acetate, 1.5 mM magnesium acetate, 
0.5 mM DTT, EDTA-free protease inhibitor cocktail). The supernatant was 
removed, and 0.11 cell pellet volumes of Buffer B (300 mM HEPES-KOH, 
pH 7.9, 1.4 M potassium acetate, 30 mM magnesium acetate, 0.5 mM DTT, 
EDTA-free protease inhibitor cocktail) was added, followed by centrifugation at 
100,000 × g at 4°C for 20 min. Ice-cold 80% (w/v) glycerol was then added to 
achieve a 13% (w/v) final glycerol concentration, followed by gentle inversion to 
mix. S100 was aliquoted, frozen in liquid nitrogen, and stored at −80°C. S100 
protein concentration was ~3–4 mg/ml. 
Capture oligonucleotides and siRNAs 
Streptavidin paramagnetic beads (100 µl; Dynabeads MyOne Streptavidin T1 
10 mg/ml, Thermo Fisher Scientific – Life Technologies) were washed and 
incubated with 5′ biotinylated, 2′-O-methyl capture oligonucleotides (500 pmol) 
according to the manufacturer’s instructions, then re-suspended in 100 µl of 
lysis buffer containing 2 mM dithiothreitol (DTT) and kept on ice for RISC 
purification. Capture oligonucleotides (entirely 2′-O-methyl ribose) were: 
5′-biotin-UCU UCA CUA UAC AAC CUA CUA CCU CAA CCU U-3′ (fully 
complementary to let-7), 5′-biotin-UCU UCC UGC GAC AAU AGC CUA CCU 
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CAA CCU U-3′ (seed plus 3′ supplementary pairing for let-7); 5′-biotin-UCU 
UCC UGC GCA CCA AGC CUA CCU CAA CCU U-3′ (seed pairing to let-7); 
5′-biotin-UCU GAC GCA CUU GAU UCU UAC GAU UUA UCU A-3′ (seed plus 
3′ supplementary pairing for luciferase siRNA guide); 5′-biotin-GAU GAA CCA 
CUC AGA GAC AUA AGC UAA UCU A-3′ (seed plus 3′ supplementary pairing 
for mmus-miR-21); 5′-biotin-UCU GAC AAC GUU GUG UAA CCU CUA GUC 
CAU CU-3′ (seed plus 3′ supplementary pairing for Drosophila miR-286). siRNA 
sequences were 5′-pCGA GGU AGU AGG UUG UAU AGU-3′ (used as let-7 
siRNA guide in Drosophila embryo lysate) or 5′-pUGA GGU AGU AGG UUG 
UAU AGU-3′ (used as let-7 siRNA guide in MEF lysate); 5′-pUAU ACA ACC 
UAC UAC CUC CUU-3′ (let-7 passenger); 5′-pCAA UCG UAU UUG UCA AUC 
AGA-3′ (luciferase guide); 5′-pUGA UUG ACA AAU ACG AUU UUU-3′ 
(luciferase passenger). miRNA sequences were 5′-pUGA GGU AGU AGG UUG 
UAU AGU-3′ (let-7); 5′-pUAU ACA AUG UGC UAG CUU UCU-3′ (let-7*). 
RISC purification 
The buffer from the washed capture oligo paramagnetic beads (500 pmole 
capture oligo on 1 mg beads) was removed and replaced with 100 µl RISC 
assembly reaction, then incubated with gentle rotation at room temperature for 
30 min. The supernatant was removed, and the beads were washed five times 
with lysis buffer containing 2 mM DTT and 0.01% (v/v) Triton X-100, followed by 
five washes with lysis buffer containing 2 M potassium acetate, DTT, and Triton 
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X-100. RISC was eluted by re-suspending the beads in 100 µl of lysis buffer 
containing 1 M potassium acetate, DTT, Triton X-100, and 1 nmol (10 µM f.c) 
competitor oligo and incubating with gentle rotation for 120 min at room 
temperature. Competitor sequences were 5′-AAG GTT GAG GTA GTA GGT TGT 
ATA GTG AAG A-3′ (for the capture oligo fully complementary to let-7); 5′-AAG 
GTT GAG GTA GGC TAT TGT CGC AGG AAG A-3′ (for the capture oligo with 
seed plus 3′ supplementary pairing to let-7); 5′-AAG GTT GAG GTA GGC TTG 
GTG CGC AGG AAG A-3′ (for seed pairing to let-7); 5′-TAG ATA AAT CGT AAG 
AAT CAA GTG CGT CAG A-3′ (for seed plus 3′ supplementary to luciferase). 
5′-AGA TGG ACT AGA GGT TAC ACA ACG TTG TCA GA-3′, (for seed plus 3′ 
supplementary pairing to Drosophila miR-286); 5′-UAG ATT AGC UTA UGT CTC 
TGA GUG GTT CAT C-3′, (for seed plus 3′ supplementary pairing to mouse 
miR-21). Finally, all samples were dialyzed at 4°C against three changes (2 h 
each) of a 2,000-fold excess of lysis buffer containing 2 mM DTT. 
For quantitative analysis of yield (Table 2.1), guide strands were 
5′ 32P-radiolabeled. 
Ion exchange chromatography on Mono S 5/50 GL (GE Healthcare) was 
used to remove competitor DNA. The column was equilibrated in lysis buffer 
containing 2 mM DTT. After loading, the column was washed with five column 
volumes lysis buffer containing 2 mM DTT. RISC was eluted with lysis buffer 
containing 2 mM DTT and 500 mM potassium acetate. The competitor DNA 
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eluted in the wash. When necessary, samples were concentrated by centrifugal 
ultrafiltration (10 kDa cutoff; EMD Millipore, Billerica, MA). 
RISC activity and concentration 
Target cleavage assays were as described (Haley et al., 2003). Target RNAs 
were transcribed with T7 RNA polymerase from templates generated by PCR of 
pGL2 plasmid (Promega, Madison, WI) using these primers: 5′-GCG TAA TAC 
GAC TCA CTA TAG GGT CAC ATC TCA TCT ACC TCC-3′ (let‑7a forward); 
5′-CCC ATT TAG GTG ACA CTA TAG ATT TAC ATC GCG TTG AGT GTA GAA 
CGG TTG TAT AAA AGG TTG AGG TAG TAG GTT GTA TAG TAT CCA GAG 
GAA TTC ATT ATC AGT G-3′ (let‑7a reverse); 5′-GAT GCG TAA TAC GAC TCA 
CTA TAG GGT TCC GCA TAG AAC TGC CTG CGT CA-3′ (luciferase forward); 
5′-TCC AGA TCC ACA ACC TTC GCT TCA-3′ (luciferase reverse); 5′-GCG TAA 
TAC GAC TCA CTA TAG GGG TCC TTT GAT CGT GAC AAA ACA AT-3′ (mouse 
miR-21 forward); 5′-CCC ATT TAG GTG ACA CTA TAG ATT TAC ATC TAG TTG 
AGG TGC GGA ACT GTG TAT AAA AGG TTA GCT TAT CAG ACT GAT GTT 
GAA TCC AGA GGA ATT CAT TAT CAG TG-3′ (mouse miR-21 reverse). 
In Figure S2.4, reaction products were resolved by denaturing polyacrylamide 
gel electrophoresis, and the amount of cleaved target was quantified using an 
FLA-9000 phosphorimager (GE Healthcare) and ImageGauge software (Fuji Life 
Sciences, Tokyo). IC50 values were obtained by fitting (Igor Pro 6.22, 
WaveMetrics, Oswego, OR) the data to the Hill equation assuming non-
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cooperative behavior. Pre-steady-state kinetic data were fit in Igor Pro to the 
burst-and-steady-state equation, 
 
where F(t) is target cleaved with time, E is the enzyme concentration, and a and 
b are rate constants according to the following scheme,  
 
The concentration of RISC assembled in Drosophila embryo lysate (Figure S2.4) 
was estimated by measuring the loss of 5′ 32P-radiolabeled passenger and 
guide strands. Control reactions, in which the lysate was pre-incubated with 
1 mM (f.c.) N-ethylmaleimide (NEM) at 4°C for 10 min to prevent RISC assembly 
(Nykanen et al., 2001), demonstrated that differential loss of passenger and 
guide strands required RISC assembly. Unreacted NEM was quenched with 
1.2 mM (f.c.) DTT. Reaction products were resolved by denaturing 20% 
polyacrylamide gel electrophoresis and detected as described. The rate of 
siRNA decay was determined separately for each replicate, and the significance 
determined using Student’s two-sample, t-test (GraphPad Prism 5, GraphPad 
Software). 
F(t) = E × a
2
a + b( )2
1− e−(a+b)t( ) + E × aba + b( ) t
E + S a⎯→⎯ ES b⎯→⎯ E + P
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Western Blotting 
S100 cell extract was diluted in lysis buffer containing 1M DTT to 2.5 mg·ml total 
protein concentration. The diluted S100 extract was mixed 1:1 in 2× Laemmli 
sample buffer (120 mM Tris-HCl, pH 6.8, 10% (w/v) SDS, 20% v/v glycerol, 
0.02% (w/v) bromophenol blue, 100 mM fresh DTT) and boiled at 95°C for 5 
minutes. Samples were separated by 4-20% HEPES-SDS-PAGE and transferred 
at 4°C in Tris-glycine buffer to nitrocellulose membrane overnight at 30 V. The 
membrane was blocked in fluorescent western blot blocking buffer (Rockland, 
Limerick, PA) diluted 1:1 in TBS-T buffer for 1 h and incubated overnight at 4°C 
with primary antibody diluted in fluorescent western blot blocking buffer 
(Rockland) diluted 1:1 in TBS-T. Rabbit anti-human and mouse Ago2 antibody 
(Cell Signaling Technologies, Danvers, MA) (Li et al., 2010) was diluted 1:1,000 
and mouse anti-β-tubulin antibody (Sigma, St. Louis, MO) was diluted 1:3,000. 
After three 5 min washes in TBST the membranes were incubated for 1 h at 
room temperature in the dark with secondary goat anti-rabbit 800CW IRDye-
conjugated antibody (Li-Cor, Lincoln, NE) and secondary goat anti-mouse 
680RD IRDye-conjugated antibody (Li-Cor), both diluted 1:10,000. After three, 
15 min washes in TBST, the membrane was placed on an Odyssey Imager 
where 785 nm and 685 nm lasers excited the secondary antibody. Images were 
quantified using Image Studio (Li-Cor).  
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Northern hybridization 
Total RNA (5 µg), isolated from 2–6 h fly embryo lysates using Trizol (Thermo 
Fisher Scientific – Life Technologies) according to manufacturer’s instructions, 
was resolved on a 0.4 mm thick, 15% denaturing polyacrylamide sequencing 
gel. After electrophoresis, the gels were blotted at 20 V for 1 h to a Hybond-NX 
membrane (GE Healthcare) in 0.5× TBE (Tris-Borate-EDTA) buffer by semi-dry 
transfer (Trans-Blot SD, Bio-Rad, Hercules, CA). The RNA was cross-linked to 
the membrane with freshly prepared 140 mM l-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide (Sigma) in 130 mM 1-methylimidazole (Sigma), pH 8, for 1 h at 
60°C. The DNA oligonucleotide probe, Drosophila miR-286 
5′-AGCACGAGTGTTCGGTCTAGTCA-3′ (25 pmol), was 5′-radiolabeled with T4 
polynucleotide kinase (New England Biolabs, Ipswich, MA) and γ-32P-ATP (450 
μCi per reaction, specific activity ~6000 Ci/mmol; Perkin Elmer, Waltham, MA). 
After labeling, unincorporated nucleotides were removed (Sephadex G-25 spin 
column, GE Healthcare), and the probes were added to the Church buffer 
(Church, 1984) and hybridized overnight at 37°C. Membranes were washed 
three times for 20 min in 0.01× SSC containing 0.1% SDS (w/v) at 37°C and 
exposed to storage phosphor screens (GE Healthcare). 
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Mass spectrometry 
For mass spectrometry, RISC was purified from a 2 ml assembly reaction and 
then concentrated tenfold. Proteins were separated from low molecular weight 
contaminants by a brief period of SDS polyacrylamide gel electrophoresis, then 
a single gel slice containing all protein was excised, eluted and digested with 
trypsin. For comparison, control reactions in which the small RNA duplex was 
omitted were included (Figures 2.3C and S2.3, background and minus siRNA 
controls). 
Tryptic peptides were dissolved in 0.1% (v/v) trifluoroacetic acid, loaded 
onto a fused silica trap column (2 cm × 100 µm C18), and then fractionated on a 
fused silica column (25 cm × 75 µm C18) developed with a linear gradient from 
100% solvent A (0.1% formic acid, 5% acetonitrile in water) to 35% solvent B 
(0.1% formic acid in water) at a flow rate of 300 nl min-1 over 90 min using a 
nano LC: EASY system (Thermo Scientific – Proxeon) directly coupled to an LTQ 
Orbitrap Velos mass spectrometer (Thermo Scientific). Data-dependent 
acquisitions from MS scans (350–2000 m/z) in the Orbitrap at resolution, 
r = 60,000 were followed by ten MS/MS scans acquired in the LTQ ion trap 
instrument. 
Raw data files were processed with Mascot Distiller (Matrix Science, 
Boston) or Extract-MSn (Thermo Scientific) to generate peak lists and then 
searched against the Drosophila melanogaster (NCBInr) or Mus musculus 
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(UniProtKB/Swiss-Prot) index using Mascot Search engine 2.3.02 (Matrix 
Science) with 10 ppm parent mass and 0.5 Da fragment mass tolerances. Amino 
acid modifications considered were acetyl (for the amino-terminus of the 
protein), pyroglutamic acid (for amino-terminal glutamine), propionamide and 
carbamidomethylation modification of cysteine, and oxidation of methionine. 
Label-free quantification using extracted ion chromatograms (XIC) was 
performed using both the replicate and average methods in the Mascot Distiller 
quantitation software (Matrix Science). Mascot searches were also loaded into 
Scaffold3 software (Proteome Software, Portland, OR) for further comparative 
analyses and filtering. 
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Figure S2.1: Determining the concentration of fully and partially 
complementary 2′-O-methyl oligonucleotides required to inhibit RISC 
activity. 
let-7 duplex siRNA (guide strand, red; passenger strand, blue) was assembled 
into Ago2-RISC in Drosophila embryo lysate. Then, 2′-O-methyl 
oligonucleotides (black) fully complementary to let-7 (A), complementary to the 
let-7 seed plus the 3′ supplementary region (B), to the let-7 seed alone (C), or 
not complementary to let-7 (D) were added and incubated at 25°C for 30 min. 
Finally, 32P-radiolabeled target RNA was added (50 nM f.c.), incubated for 5 min, 
and target cleavage measured. Data are mean ± S.D., n = 3.
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Figure S2.2: Comparison of HeLa cell and Ago2 overexpressing MEF cell S100 cytosolic extracts for RNAi 
activity 
Drosophila embryo lysate was programmed with 25 nM luciferase siRNA at 25°C while HeLa and MEF S100 cell 
extracts were programmed with or without (buffer) 25 nM luciferase siRNA at 37°C. Target cleavage assay was 
carried out using 100 nM capped 32P-labeled luciferase RNA target. Samples were resolved on a urea-denaturing 
polyacrylamide gel and the gel was dried and exposed as described in the Material and Methods. 
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Figure S2.3: Silver-stained 4–20% acrylamide gel loaded with 50 fmol 
affinity purified let-7–programmed fly or mouse Ago2-RISC 
(A) Proteins whose identities were established by mass spectrometry are 
labeled. Asterisks denote proteins that were not enriched compared to control 
and are therefore likely to be contaminants. (B) Silver stained 4–20% SDS-PAG 
comparing 1M and 2M potassium acetate washes in RISC purification. 
MEF cells overexpression AGO2 were incubated with or without let-7 siRNA 
prior to purification. The observed bands for with or without siRNA programming 
are similar with the exception of AGO2. (D) Mass spectrometry comparison of 
AGO2 enrichment over no siRNA control. AGO2 was enriched 30-fold for 
1M potassium acetate wash and 64-fold for the 2M potassium acetate wash. 
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Figure S2.4: Measuring RISC concentration 
(A) The target cleaving activity of purified fly and mouse AGO2-RISC was 
measured by pre-steady state kinetics using 100 nM 5′ 32P-radiolabeled target 
RNA. For fly RISC, the reaction was incubated at 10°C; for mouse RISC, the 
reaction was incubated at 23°C. Total enzyme concentration was determined by 
fitting the data to the burst-and-steady-state equation (see Methods). 
(B) Drosophila embryo lysates were incubated with let‑7a siRNA duplex (25 nM 
f.c.), 5′ 32P-radiolabeled on the guide or passenger strand. RISC assembly 
reactions mock-treated with N-ethylmaleimide (NEM): dithiothreitol (DTT) was 
added before the NEM. The differential decay of the guide and passenger 
strands (12 pmole; p = 0.0001) indicates the amount of RISC assembled. In the 
control reactions, RISC assembly was blocked by treating with NEM. Unreacted 
NEM was subsequently quenched with DTT. Data are mean ± S.D., n = 3. 
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Table S2.1: Proteins enriched in purified fly Ago1-RISC compared to 
the control 
Mass 
(kDa) 
  Ago1   
control Protein 
17603 3595 CG3800, isoform A 
27875 1339 Ribosomal protein L8, isoform A 
30713 1086 Ribosomal protein L7A, isoform D 
71087 917 Heat shock protein cognate 4, isoform A 
24258 851 Ribosomal protein L10Ab, isoform A 
41004 639 Hrp48.1 
29718 590 Ribosomal protein L6, isoform B 
24020 589 Ribosomal protein L19 
71051 549 CG7185 
106150 467 Argonaute1, isoform B 
69882 425 Poly(A)-binding protein, isoform A 
63368 386 RE72930p 
62091 310 IGF-II mRNA-binding protein, isoform A 
25765 283 GM01970p 
69298 277 Trailer hitch 
12227 252 Ribosomal protein L30, isoform C 
102887 229 CG8108, isoform B 
40624 217 Mushroom-body expressed, isoform A 
25010 207 Rrp40 
74898 190 Rasputin, isoform B 
50208 188 RE71384p 
34616 185 Fibrillarin 
46274 183 Rrp45 
26933 153 RE67757p 
103528 132 CG18811 
18127 131 CG8928 
102854 130 Rrp6 
36219 119 Hrp40.2 
15893 111 Ribosomal protein L27 
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112140 101 SD10981p 
23058 93 Ribosomal protein S6, isoform B 
29534 92 Ribosomal protein L7 
37150 78 Replication factor C subunit 4 
78000 61 Protein on ecdysone puffs, isoform B 
25700 52 Ribosomal protein S5b 
85029 40 Belle 
116767 33 CG16940, isoform A 
33589 28 GM02257p 
32366 24 Rrp42 
118850 14 Lethal (2) 35Df 
75773 6 Fmr1, isoform C 
24310 6 Ribosomal protein L15, isoform A 
95704 5 Argonaute2 
136765 4 Argonaute2, isoform B 
105665 3 CG14476, isoform B 
296201 3 Nucleoporin 358 
57007 2 DNop5 protein 
98496 2 Aubergine, isoform A 
72190 2 Heat shock protein cognate 72 
50760 1 Phosphoprotein phosphatase 2A 55 kDa regulatory subunit 
41797 1 Actin 
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Table S2.2: Proteins enriched in purified fly Ago2-RISC compared to the 
control 
Mass 
(kDa) 
Ago2 
control Protein 
95704 420 Argonaute 2 
136765 291 Argonaute 2, isoform B 
30713 229 Ribosomal protein L7A, isoform D 
296201 138 Nucleoporin 358 
98496 118 Aubergine, isoform A 
32366 45 Rrp42 
97788 25 Bicaudal C, isoform A 
33589 4 GM02257p 
112140 3 SD10981p 
103528 3 CG18811 
24020 3 Ribosomal protein L19 
74898 3 Rasputin, isoform B 
88155 3 CG10077, isoform A 
48682 2 Yolk protein 1 
62091 2 IGF-II mRNA-binding protein, isoform A 
63368 2 RE72930p 
69882 2 Poly(A)-binding protein, isoform A 
30209 2 Stubarista, isoform A 
41004 2 Hrp48.1 
29718 2 Ribosomal protein L6, isoform B 
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106150 1 Argonaute1, isoform B 
100356 1 CG10777 
27875 1 Ribosomal protein L8, isoform A 
17603 1 CG3800, isoform A 
46274 1 Rrp45target cleaving 
40624 1 Mushroom-body expressed, isoform A 
118850 1 Lethal (2) 35Df 
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Table S2.3: Proteins enriched in purified mouse AGO2-RISC compared to 
the control 
Mass 
(kDa) 
AGO2 
Control Protein 
97 64 Argonaute2  
50 1 Tubulin β-5 chain  
72 1 78 kDa Glucose-regulated protein  
50 1 Tubulin beta-2C chain  
71 1 Heat shock cognate 71 
77 1 Far upstream element-binding protein 2  
109 1 Exosome complex exonuclease RRP44  
70 <1 Splicing factor 1  
103 1 RNA-binding protein 12  
69 <1 Far upstream element-binding protein 1  
70 1 Heat shock 70 kDa protein 1A  
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Chapter III: Single-Molecule Imaging Reveals that 
Argonaute Re-shapes the Binding Properties of 
Its Nucleic Acid Guides  
 
 
Disclaimer  
This work is the joint effort among the authors: William E. Salomon (WES), 
Samson M. Jolly (SMJ), Melissa J. Moore (MJM), Phillip D. Zamore (PDZ), and 
Victor Serebrov (VS). SMJ prepared and optimized small DNA assembly of 
Thermus thermophilus Argonaute. VS performed single-molecule microscopy, 
wrote custom Matlab scripts for analysis, and assisted with data analysis. WES 
prepared all reagents (with the exception of Thermus thermophilus AGO), 
performed all in vitro analyses, single-molecule analyses, and prepared all of the 
figures. WES and PDZ wrote the manuscript. All authors contributed to critical 
review of data and manuscript. Addition of unpublished and supporting data has 
been included in this chapter. 
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SUMMARY 
Argonaute proteins repress gene expression and defend against foreign nucleic 
acids using short RNAs or DNAs to specify the correct target RNA or DNA 
sequence. We have developed single-molecule methods to analyze target 
binding and cleavage mediated by the Argonaute:guide complex, RISC. We find 
that both eukaryotic and prokaryotic Argonaute proteins reshape the 
fundamental properties of RNA:RNA, RNA:DNA, and DNA:DNA hybridization: 
a small RNA or DNA bound to Argonaute as a guide no longer follows the 
well-established rules by which oligonucleotides find, bind, and dissociate from 
complementary nucleic acid sequences. Moreover, mouse AGO2-RISC can 
distinguish between a miRNA-like target, to which it binds tightly, and the 
products of target cleavage, which it releases more quickly. By re-writing the 
rules for nucleic acid hybridization, Argonautes allow oligonucleotides to serve 
as specificity determinants with thermodynamic and kinetic properties more 
typical of RNA-binding proteins than of RNA or DNA. 
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INTRODUCTION 
Small silencing RNAs such as microRNAs (miRNAs) and small interfering RNAs 
(siRNAs) direct Argonaute proteins to repress cellular mRNAs and silence 
foreign RNAs including viral mRNAs and RNA genomes. Argonaute proteins 
typically acquire their guide RNAs as 19–26 bp duplexes produced by dedicated 
processing and loading pathways (Hutvagner and Simard, 2008; Kawamata and 
Tomari, 2010). The final steps in production of a functional Argonaute-small RNA 
complex require expulsion of the passenger strand from the small RNA duplex 
to generate RISC (RNA-induced silencing complex)—an Argonaute protein 
bound to a single-stranded guide RNA (Matranga et al., 2005; Rand et al., 2005; 
Leuschner et al., 2006; Kwak and Tomari, 2012). 
Argonaute proteins share a modular structure comprising the PAZ, Mid, 
and PIWI domains (Song et al., 2004). The Mid domain binds the 5′ phosphate 
of the guide RNA, anchoring it to the protein (Wang et al., 2008b). The Mid 
domain can also recognize the first base (g1) of a guide RNA. Mid domains that 
prefer a uridine at this position explain why miRNAs typically begin with U 
(Frank et al., 2010; Cora et al., 2014). One consequence of the Mid-domain:g1U 
interaction is that the g1 position of a miRNA, siRNA, or piRNA is unavailable for 
base pairing (Ma et al., 2005; Parker et al., 2005; Wang et al., 2014). The PAZ 
domain binds the 3′ end of the guide. PAZ domains play critical roles in loading 
Argonaute proteins with miRNA and siRNA duplexes during RISC assembly, and 
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have been proposed to compete for binding with target RNAs that can base-pair 
with the 3′ terminal nucleotides of the guide (Song et al., 2003; Lingel et al., 
2004b; Ma et al., 2004; Tomari and Zamore, 2005). The PIWI domain, a 
structural homolog of the DNA-guided RNA endonuclease RNase H, contains 
the catalytic site, which positions a pair of magnesium ions near the scissile 
phosphate (Liu et al., 2004; Martinez and Tuschl, 2004; Schwarz et al., 2004; 
Wang et al., 2008b; Wang et al., 2009; Schirle et al., 2014). Some animal 
Argonaute proteins contain an additional N-terminal domain that prevents base 
pairing of the target to the guide beyond position guide position g16 
(Kwak and Tomari, 2012; Faehnle et al., 2013; Hauptmann et al., 2013). 
In animals, miRNAs and siRNAs typically silence gene expression by 
distinct mechanisms. Mammalian and fly miRNAs bind their targets via the seed 
sequence, a domain comprising guide nucleotides g2–g8 (Lewis et al., 2003; 
Rajewsky and Socci, 2004; Krek et al., 2005; Lewis et al., 2005; Lim et al., 2005). 
miRNA-directed Argonaute binding provides a platform that can recruit proteins 
that trigger exonucleolytic RNA degradation or inhibit translational initiation or 
elongation (Huntzinger and Izaurralde, 2011). Argonaute pre-positions these 
seven nucleotides so that they appear to be present in an RNA A-form helix, 
with its characteristically stacked bases, despite only one RNA strand being 
present in RISC (Ma et al., 2004; Parker et al., 2005; Wang et al., 2008a; 
Parker et al., 2009; Elkayam et al., 2012; Nakanishi et al., 2012; Wee et al., 
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2012). By organizing the seed nucleotides into a conformation favorable for 
base-pairing (Ma et al., 2004; Parker et al., 2005; Wang et al., 2008a; Elkayam et 
al., 2012; Nakanishi et al., 2012), Argonaute pre-pays the entropic penalty 
inherent in binding complementary RNAs (Parker et al., 2009). Consequently, the 
binding specificity of RISC derives mainly from the seed sequence. In fact, 
mouse AGO2-RISC has nearly the same affinity for a seed-matched target as it 
does for a fully complementary target (Wee et al., 2012). 
siRNAs generally have more extensive complementarity to their target 
RNAs than miRNAs. To act as endonucleases, Argonaute proteins must retain 
the key catalytic amino acids that organize the active site—a property of 
mammalian AGO2 but not AGO1 or AGO4 (AGO3 retains the catalytic residues 
but nonetheless cannot cleave RNA (Faehnle et al., 2013; Hauptmann et al., 
2013)). Efficient endonucleolytic cleavage of a target requires that the guide 
base pair at least 5–8 nucleotides beyond the seed; this additional ‘zippering’ of 
the guide:target helix provides little additional binding energy, but allows the 
enzyme to attain a catalytically competent conformation (Haley and Zamore, 
2004; Ameres et al., 2007) that places the scissile phosphate near a magnesium 
ion in the active site (Wang et al., 2008a; Wang et al., 2009) . Complementarity 
between g2–g16 and t2–t16 allows Argonaute to cleave the target 
phosphodiester bond between nucleotides t10 and t11 (Elbashir et al., 2001a; 
Elbashir et al., 2001b; Rivas et al., 2005). 
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In the absence of protein, the fundamental properties of ~21 nt RNA 
oligomers make them poor guides for directing gene regulation. Single-
stranded, 5′ monophosphorylated RNA is readily degraded by endo- and 
exonucleases and can form intra- and intermolecular structures that inhibit 
target binding. At physiological temperature, pH, and ionic strength, 21 nt RNA 
oligomers bind with little specificity, because sub-sequences >12 nt hybridize 
stably to complementary sites in the transcriptome and because this high affinity 
binding accommodates insertions, deletions, and mismatches (Herschlag, 
1991). Moreover, the rate of RNA and DNA hybridization is limited by the rate of 
successful collisions that convert to stable binding events (Ross and Sturtevant, 
1960; Ross and Sturtevant, 1962; Nygaard and Hall, 1964; Wetmur and 
Davidson, 1968). This slow on-rate (kon) means that the search for 
complementary targets is the rate-determining step for base pairing between 
21 nt guides and their complementary targets. Once formed, 21 bp RNA:RNA 
duplexes are nearly irreversible in physiological conditions: a fully base-paired 
double-stranded RNA composed of let‑7a and its complement is predicted to 
have a KD = 6.3 × 10−7 nM, implying a koff = 5.7 × 10−9 s−1 (𝜏 = ~5.6 years). In 
contrast, an 8 bp duplex formed with just the let‑7a seed sequence is unstable: 
the predicted KD  = 56 µM implies a koff = 52 s−1 (𝜏 = ~20 msec). 
We sought to understand how Argonaute proteins overcome the inherent 
limitations posed by short oligonucleotide guides. Here, we show that 
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Argonaute proteins reshape the fundamental properties of RNA:RNA, RNA:DNA, 
and DNA:DNA hybridization. We find that once bound to Argonaute, a small 
RNA or DNA guide no longer follows the well-established rules for finding, 
binding, and dissociating from complementary nucleic acid sequences. By 
re-writing the rules, Argonautes allow oligonucleotides to serve as specificity 
determinants with thermodynamic and kinetic properties more typical of 
RNA-binding proteins than of nucleic acids. 
RESULTS 
Measurement of RNAi using single-molecule spectroscopy 
To measure how Argonaute proteins alter the properties of oligonucleotides, we 
used Co-localization Single-Molecule Spectroscopy (CoSMoS), an 
implementation of multi-color, total internal reflection fluorescence (TIRF) 
microscopy that achieves high signal-to-noise ratios by exciting only those 
fluorescent molecules immediately above the slide surface (Friedman et al., 
2006). To adapt CoSMoS to study RISC, a fluorescently labeled target RNA was 
attached to a glass surface via a biotin-streptavidin-biotin-PEG 3,400 linkage 
and then incubated with purified RISC assembled in vitro to contain a 
fluorescent guide strand (Figure 3.1A). The strategy relies on two novel reagents 
developed for these studies: (1) a target RNA designed to allow the 
unambiguous differentiation between target cleavage and photobleaching; and 
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(2) RISC assembled via the cellular Argonaute-loading pathway using an siRNA 
duplex containing a fluorescently labeled guide strand and then purified to 
remove unassembled siRNA and cleaved passenger strands (Flores-Jasso et al., 
2013). 
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Figure 3.1: Single-Molecule Analysis of Nucleic Acid-Guided Argonaute 
Proteins 
(A) Strategy to measure RNA- or DNA-guided Argonaute interactions with RNA 
or DNA targets. (B) Photobleaching of a target labeled with a single Alexa647 
dye is indistinguishable from target cleavage. In contrast, the stepwise 
photobleaching of a target with 17 Alexa647 dyes is readily distinguished from 
target cleavage. (C) Michaelis-Menten analysis of target cleavage for a standard 
RNA guide and a 3′ Alexa555-labeled RNA guide. Mean ± S.D. (n = 3). (D) A 
trace of an individual molecule of target RNA undergoing RNAi. 
Blue: 5′ -tethered, 3′ (Alexa647 × 17)-labeled RNA target, fully complementary 
to let‑7a; red: mouse AGO2-RISC programmed with 3′ Alexa555-labled let‑7a 
RNA guide. Colored bars above trace summarize the species observed. This 
color code is used in the rastergrams. (E) Color-coded rastergram 
representation of let‑7a-guided AGO2 binding and cleaving a fully 
complementary RNA target. The rastergram presents 426 individual RNA target 
molecules, each in a single row. 
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Photobleaching of fluorescent molecules is a technical challenge that 
plagues many single-molecule experiments, especially when high time 
resolution is required or when a molecule of interest must be continuously 
excited with laser light for an extended time. To overcome photobleaching and 
to distinguish photobleaching from target cleavage, we constructed a 141 nt 
RNA target containing 17 Alexa647 dyes within a 148 nt DNA 3′ extension. The 
multiply labeled target provided two related advantages. First, its extreme 
brightness allowed the use of decreased laser power, thereby decreasing the 
rate at which individual dyes photobleached. This allowed long observation 
times (30 min continuous illumination capturing 10,000 frames at 100 ms per 
frame; Figure 3.1B and Materials and Methods). Second, the presence of 
multiple Alexa647 dyes yielded a characteristic stepwise photobleaching pattern 
that was readily distinguishable from the all-or-none fluorescence change 
caused by target cleavage and 3′ product release. Figure 3.1B compares 
two molecules undergoing photobleaching: the target labeled with a single 
3′ Alexa647 dye undergoes binary signal loss indistinguishable from target 
cleavage, whereas the target bearing 17 Alexa647 dyes gradually loses 
fluorescence in many discrete steps. 
Mouse AGO2 was loaded with an RNA guide in cytoplasmic extract from 
Ago2−/− mouse embryonic fibroblasts overexpressing AGO2 under the control of 
the murine stem cell virus promoter (O'Carroll et al., 2007). Loading was 
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accomplished using a double-stranded siRNA carrying a 3′ Alexa555 dye on the 
guide strand; programmed RISC was then sequence-affinity purified (Flores-
Jasso et al., 2013). To test whether dye addition altered the properties of 
AGO2-RISC, we compared the KM and kcat of AGO2 programmed with an 
unmodified guide corresponding to the sequence of let‑7a, with AGO2 
programmed with the 3′ Alexa555-labeled guide (Figures 3.1C and S3.1A). The 
KM for let‑7a-loaded RISC (1.7 ± 0.1 nM) was nearly identical to that containing 
3′ Alexa555-labeled let‑7a (1.2 ± 0.2 nM). Moreover, these KM values agree well 
with previous values for human AGO2-RISC (Martinez and Tuschl, 2004; Rivas 
et al., 2005; Ameres et al., 2007). Similarly, kcat for RISC containing the 
3′ Alexa555-labeled let‑7a guide (6.6 ± 0.4 × 10−2 sec−1) was similar to the kcat of 
RISC programmed with let‑7a without the dye (7.8 ± 0.2 × 10−2 sec−1). 
RISC Changes the Rate-Determining Step for Nucleic Acid Hybridization 
Argonaute proteins have been proposed to increase the rate of nucleic acid 
hybridization by pre-organizing the nucleotides of the seed sequence into a 
stacked conformation that makes productive collisions with target more likely. 
The association rate constant, kon, for mammalian AGO2 has been inferred from 
KD and koff values measured in ensemble binding experiments (Wee et al., 2012) 
or estimated by fitting pre-steady state ensemble data to a three-phase 
exponential model in which the fastest phase was assumed to correspond to kon 
(Deerberg et al., 2013). 
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To measure kon directly, we simultaneously recorded the fluorescence of 
individual target RNAs attached to the slide and individual molecules of mouse 
AGO2-RISC containing fluorescent guide strand (Figure 3.1D and Materials and 
Methods). For each target RNA molecule, RISC arrival time was taken to be the 
first detectable co-localization of RISC fluorescence and target RNA 
fluorescence. Our standard conditions detected the arrival of RISC molecules 
that remained co-localized with a target ≥200 msec (one frame at 5 frames∙s−1; 
Materials and Methods). Figure 3.1D provides an example of Alexa555-labeled 
RISC arriving at an Alexa647-labeled target: when RISC arrives at ~40 s, the 
Alexa 555 fluorescence co-localizing with the Alexa647 target increases in a 
single step; it remains high until both Alexa555 (RISC) and Alexa647 (target) 
fluorescence drop to baseline at ~60 s, signifying target cleavage and 
simultaneous departure of RISC and the 3′ cleavage product. Figure 3.1E 
displays 426 individual single-molecule traces, ordered by time of target 
cleavage, as a ‘rastergram.’ Rastergrams summarize the arrivals, departures, 
and target cleavage events for many individual target molecules. 
To understand how AGO2 changes the rate at which an oligonucleotide 
arrives at a target, we used CoSMoS to compare the kon of single-stranded 
let‑7a RNA and let‑7a-programmed AGO2-RISC (Figure 3.2). After their arrival at 
the target, let‑7a alone and let‑7a bound to AGO2 follow different paths. 
Formation of a 21 bp RNA:RNA duplex is essentially irreversible under 
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physiological conditions, so observation of let‑7a ended when its Alexa555 label 
photobleached. Subsequently, no new, fluorescent RISC was detected binding 
to the target. The target, labeled with 17 Alexa647 dyes, continued to be 
detectable, gradually losing fluorescence via discrete photobleaching events 
(Figure 3.2A). In contrast, binding of let‑7a RISC ended with target cleavage; 
Alexa555 and Alexa647 fluorescence were lost simultaneously. 
On-rates for RISC (kon) or let‑7a alone were determined by fitting the 
cumulative distribution of arrivals to a single exponential, corrected for non-
specific background binding to the slide (Figure S3.1B and Materials and 
Methods). The on-rate of let‑7a RNA alone binding to a fully complementary 
target (9.1 ± 1.7 × 106 M−1∙s−1; Figures 3.2A and S3.2) was considerably slower 
than the rate of macromolecular diffusion. The sequence of let‑7a comprises 
only three (A, G, and U) of the four nucleotides. The on-rate for let‑7a alone 
measured by CoSMoS agrees well with previous single-molecule estimates of 
kon for short oligonucleotides lacking G or C (Zhang et al., 2014). In comparison, 
kon for let‑7a-programmed mouse AGO2-RISC binding to the fully 
complementary target RNA (3.9 ± 0.5 × 108 M−1∙s−1) was ~43-fold faster than kon 
for let‑7a alone (Figures 3.2A and S3.2–S3.3). Moreover, the rate at which 
AGO2-RISC finds its target approaches the limit of macromolecular diffusion at 
37°C: ~6.4 × 109 M−1∙s−1 under our standard conditions, which include 20% 
glycerol (Segur and Oberstar, 1951; Berg and von Hippel, 1985). Thus, as 
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proposed previously (Wee et al., 2012; Deerberg et al., 2013; Jung et al., 2013), 
Argonaute accelerates productive arrival of its guide at a complementary target 
sequence. 
While these data indicate that AGO2 improves kon by ~43-fold for binding 
of let‑7a to a fully complementary target sequence, the unusual sequence 
composition of let‑7a might understate the general enhancement in target 
finding. To test this, we determined kon for a miRNA containing all four 
nucleotides, miR‑21, either alone or bound to mouse AGO2 (Figures 3.2 and 
S3.2–S3.3). As expected from its greater sequence complexity, miR‑21 RNA 
alone bound its complementary RNA target ~17 times more slowly (kon, miR‑21 
alone = 5.3 ± 0.2 × 105 M−1∙s−1) than let‑7a alone. Mouse AGO2 accelerated 
miR‑21 binding ~250-fold (kon miR‑21 AGO2-RISC = 1.3 ± 0.1 × 108 M−1∙s−1). 
Thus, accelerating oligonucleotide target finding to close to the rate of diffusion 
is a general property of AGO2-RISC. 
Is this acceleration of target finding a general property of other Argonaute 
proteins or unique to mouse AGO2? To answer this, we measured kon to a fully 
complementary sequence for TtAgo, the DNA-guided Argonaute protein (Swarts 
et al., 2014a) from the eubacterium Thermus thermophilus. T. thermophilus 
grows at 62–75°C (Cava et al., 2009), and TtAgo does not efficiently cleave 
either RNA or DNA at 37°C (Figure S3.4A). Control experiments established that 
the addition of an Alexa555 dye to the 3ʹ′ end of the DNA guide does not alter 
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the ensemble binding properties of TtAgo (Figure S3.4B). In vivo, TtAgo binds 16 
nt DNA guides (SMJ and PDZ, unpublished), so we loaded TtAgo at 75°C with a 
single-stranded DNA comprising the first 16 nt of let‑7a, and then studied its 
binding at 37°C using CoSMoS. On its own, the 16 nt “let‑7a” guide bound a 
complementary RNA target ~140 times more slowly (kon = 4.6 ± 0.1 × 105 M−1∙s−1) 
than the same DNA guide bound to TtAgo (kon = 6.2 ± 0.1 × 107 M−1∙s−1; 
Figures 3.2 and S3.4C). 
Why is the kon for Thermus thermophilus Argonaute ~6 times slower than 
that of mouse AGO2? We suspect that at 37°C TtAgo spends less time in a 
binding-competent conformation, consistent with its greater target cleavage 
activity at 75°C (Figure S3.4A). We conclude that both mouse AGO2 and TtAgo 
alter the rate-determining step for nucleic acid hybridization (kon), ensuring that 
the speed at which Argonaute finds its complementary target RNA or DNA is 
limited by the rate of macromolecular diffusion. 
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Figure 3.2: Compared to Nucleic Acid Alone, Argonaute Accelerates Guide 
Binding to Target 
(A) Comparison of target binding rates (kon) by 21 nt RNA-guided mouse AGO2- 
and 16 nt DNA-guided TtAgo versus the RNA or DNA guide strands alone. 
Cumulative binding fraction plots are accompanied by the fluorescence intensity 
trace for a representative individual molecule. Red arrowheads: photobleaching 
of the Alexa555 guide; blue arrowheads: stepwise photobleaching of a single 
Alexa647 group; scissors: Argonaute-catalyzed target cleavage; blue F: Förster 
resonance energy transfer from the Alexa555 guide to the Alexa647 target 
bearing 17 dye moieties. (B) Comparison of kon values for mouse AGO2-let‑7a 
and TtAgo-let‑7a. For let‑7a and miR‑21 RNA targets, mouse AGO2 and RNA 
alone values are reported as mean ± S.D. (n = 3), with >1,000 individual 
molecules collected. All other values were measured using several hundred 
individual molecules, and error of fit is reported. kon values were corrected for 
the rate of non-specific binding to the slide surface. 
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Argonaute Accelerates the Rate of Target Finding by Creating the Seed 
Sequence 
The three structural domains of Argonaute proteins divide their guide RNAs into 
discrete functional domains. To determine which domain contributes most to 
the Argonaute-dependent enhancement of target binding, we measured kon 
using three different target RNAs: (1) a target complementary just to the seed 
sequence (g2–g8); (2) a target complementary to both the seed and the region of 
3ʹ′ supplementary pairing (g13–g16); and (3) a target with complete 
complementarity to the guide (g2–g21; Figures 3.2B and S3.2–S3.3). For each 
target RNA, we determined kon for both the guide alone and the guide loaded 
into mouse AGO2 (Figures 3.2 and S3.2–S3.3). We also measured kon for 
let‑7a-RISC binding to an RNA having ≤ 6 nt complementary to any region of the 
let‑7a guide sequence and ≤ 4 nt complementary to the let‑7a seed sequence. 
For this essentially non-complementary control RNA, we were unable to detect 
any binding interactions above non-specific background binding to the slide 
(Figure S3.5A). 
Structural comparisons of eubacterial and human AGO2 show that an 
N-terminal Argonaute domain prevents pairing beyond g16 in animal 
Argonautes; and computational analyses of piRNAs in flies, silk moths, and mice 
suggest that target cleavage does not require complementarity beyond target 
position t16 (Wang et al., 2009; Kwak and Tomari, 2012; Wee et al., 2012; 
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Faehnle et al., 2013; Hauptmann et al., 2013; Wang et al., 2014). Thus even 
targets with complete complementarity to the guide strand are unlikely to pair 
past g16 when the guide is bound to Argonaute. 
In the absence of protein, nucleic acid hybridization is favored by greater 
complementarity, presumably because the larger number of potential base pairs 
provides more opportunities for nucleation, the rate-determining step for 
productive binding (Egli and Saenger, 1988). Consistent with this principle, kon 
for let‑7a RNA alone increased approximately 2-fold, from 4.6 ± 1.6 × 106 M−1 s−1 
for the target with complementarity only to the seed sequence (g1–g8) or 
5.1 ± 1.8 × 106 M−1 s−1 for the target with seed and 3′ supplementary pairing (g1–
g8 plus g13–g16) to 9.1 ± 0.1 × 106 M−1 s−1 for the fully complementary target 
(g1–g21) (Figures 3.2B and S3.2). Yet when loaded in AGO2-RISC, let‑7a bound 
all three targets with very similar, near diffusion-limited on-rates, ranging from 
2.4 ± 0.1 × 108 M−1∙s−1 to 3.9 ± 0.5 × 108 M−1∙s−1; (Figures 3.2B and S3.2). 
Additionally, there was little to no difference in kon when the total length of the 
target changed (Figure S3.6); let‑7a AGO2-RISC had similar kon values when 
comparing a the longer 141 nt RNA + 148 nt DNA target to 28 nt RNA targets 
that perfectly paired (2.3 ± 0.1 × 108 M−1∙s−1) or paired only to the seed 
nucleotides (1.5 ± 0.1 × 108 M−1∙s−1). In contrast, the apparent rate of RISC 
finding an RNA target fully complementary to let‑7a except for the seed 
nucleotides (3.6 ± 0.2 × 107 M−1∙s−1) was ~10-fold slower (Figures 3.2B and 
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S3.5B). We observed similar kon effects for miR‑21 RISC, whose kon was ~20-fold 
faster than miR‑21 RNA alone when binding a target with complementarity only 
to the seed (1.1 ± 0.1× 107 M−1∙s−1) or to both the seed and four, 3ʹ′ 
supplementary bases (1.7 ± 0.1 × 107 M−1∙s−1; Figure S3.2). We conclude that the 
seed sequence created by mouse AGO2 accounts for most of the enhancement 
in the rate of target finding. 
To further test this idea, we measured kon for a series of six target RNAs 
bearing a dinucleotide mismatch in their seed-complementary sequence 
(Figures 3.3A, S3.3 and S3.5B). We performed these experiments at 10 
frames∙s−1, a time resolution likely to be sufficient to detect the first arrival of 
RISC, because kon values did not change at higher time resolutions (25 
frames∙s−1; data not shown). Compared to a seed-matched target, dinucleotide 
mismatches at guide positions g2g3, g3g4, g4g5, or g5g6 reduced kon 6.3- to 
10-fold. Mismatches with positions g6g7 or g7g8 reduced kon just 1.3-fold, 
compared to a target complementary to the 7 nt seed sequence. These data 
further support the view that Argonautes accelerate target finding by pre-
organizing the seed and that acceleration is diminished when the seed pairing is 
disrupted at positions g2–g5.  
TtAgo also required seed complementarity to accelerate the rate of target 
finding: the rate for TtAgo, guided by a 16 nt DNA, to find a target DNA 
complementary to the seed (kon = 7.1 ± 0.1 × 107 M−1∙s−1) or both the seed and 
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four, 3ʹ′ supplementary nucleotides (kon = 4.8 ± 0.1 × 107 M−1∙s−1), was essentially 
the same as when the entire guide was complementary to the target 
(kon = 6.4 ± 0.1 × 107 M−1∙s−1; Figures 3.2 and S3.2, Table 3.1). 
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Figure 3.3: Mismatches Highlight the Role of the Seed Sequence in Target 
Binding 
Comparison of the kinetic properties of let‑7a-guided mouse AGO2-RISC with 
different targets. Values were derived from data collected from several hundred 
individual RNA target molecules; error of fit is reported. All kon and koff values 
were corrected for the rate of non-specific binding to the slide surface. koff and 
KD values for nucleic acid in the absence of protein were predicted from the 
measured kon and ∆G37˚C of binding calculated by nearest neighbor analysis 
(Reuter and Mathews, 2010; Turner and Mathews, 2010). koff was not determined 
for the fully complementary target because it was cleaved under our 
experimental conditions. 
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Table 3.1 
21 nt let‑7a RNA loaded in mouse AGO2 
 RNA Target 
Extent of 
complementarity 
 
kon (M−1∙s−1) 
 
koff (s−1) 
 
KD (nM) 
Complete 3.9 ± 0.5 × 108 << PB << PB 
Seed only 2.4 ± 0.1 × 108 0.0036 ± 0.0003 0.015 ± 0.002 
Seed + 3ʹ′ 
Supplementary 2.8 ± 0.5 × 10
8 0.0030 ± 0.0004 0.011 ± 0.002 
 DNA Target 
Complete 1.0 ± 0.1 × 109 << PB << PB 
Seed only 7.8 ± 0.2 × 108 0.41 ± 0.09 0.53 ± 0.07 
Seed + 3ʹ′ 
Supplementary 6.4 ± 0.2 × 10
8 0.57 ± 0.02 0.9 ± 0.1 
    
16 nt let‑7a-derived DNA guide loaded in TtAgo 
 RNA Target 
Extent of 
complementarity 
 
kon (M−1∙s−1) 
 
koff (s−1) 
 
KD (nM) 
Complete 6.2 ± 0.1 × 107 << PB << PB 
Seed only 2.0 ± 0.1 × 107 0.35 ± 0.03 17 ± 2 
Seed + 3ʹ′ 
Supplementary 5.8 ± 0.1 × 10
6 0.51 ± 0.06 88 ± 12 
 DNA Target 
Complete 6.4 ± 0.1 × 107 << PB << PB 
Seed only 7.1 ± 0.1 × 107 1.0 ± 0.1 15 ± 2 
Seed + 3ʹ′ 
Supplementary 4.8 ± 0.1 × 10
7 0.86 ± 0.08 18 ± 2 
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Table 3.1: Kinetic values for RISC with RNA or DNA Targets 
Properties of Argonaute-guide complexes binding to RNA or DNA targets with 
different extents of complementarity to the guide strand. << PB, not determined 
because koff was much slower than the rate of photobleaching. 
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The rate of a diffusion-limited bimolecular reaction depends on the 
viscosity of the solution, because diffusion proceeds more slowly at higher 
viscosity (Berg and von Hippel, 1985). To test whether target finding by AGO2 
similarly depends on viscosity, we measured kon for let‑7a-RISC without or with 
20%—our standard conditions—or with 50% (w/v) glycerol (Figure 3.5). As 
predicted for a diffusion-limited process, the kon for a fully complementary let‑7a 
target increased from 3.9 ± 0.5 × 108 M−1∙s−1 in 20% glycerol to 
6.4 ± 0.1 × 108 M−1∙s−1 when glycerol was omitted. When the glycerol 
concentration was increased to 50%, increasing the viscosity of the reaction, kon 
decreased to 1.7 ± 0.1 × 108 M−1∙s−1. 
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Figure 3.4: RISC target finding is a diffusion-limited reaction 
Cumulative binding curves for mouse let‑7a AGO2-RISC to perfect targets in 
buffer containing 0, 20, or 50% (f.c.) glycerol. kon represents the analysis of 521 
targets for 0% glycerol, 1,264 targets for 20% glycerol, and 491 targets for 
50% glycerol.  
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Seed Mismatches Cause Rapid Dissociation of Mouse AGO2 RISC 
Ensemble experiments at 25°C show that mouse AGO2-RISC departs slowly 
from seed-matched targets (Wee et al., 2012), a time-scale too long for direct 
observation by fluorescence of individual RISC molecules, because 
photobleaching of the guide RNA dye generally occurs before a departure is 
observed (the rate of Alexa555 photobleaching under our standard condition 
was ~0.06 s−1, τ ~ 17 s; Materials and Methods). As an alternative strategy to 
measure koff for mouse AGO2-RISC at 37°C, a more physiologically appropriate 
temperature, we measured the apparent koff over a range of laser exposure (i.e., 
by changing the frame length) and extrapolated to no laser exposure (the 
y-intercept) to obtain koff: 0.0036 ± 0.0003 s−1, 𝜏 ~280 s (Figure S3.5C). Because 
the photobleaching rate was much slower than the dissociation rate for less 
complementary targets, koff was readily measured by standard methods for the 
six targets containing a dinucleotide mismatch within the let‑7a seed-match 
(Figures 3.3B, S3.3, and S3.7). Compared to the seed-matched target, RISC 
dissociated from these seed-mismatched targets from 70 to 3,200 times faster. 
As we observed for kon, individual positions within the seed 
contributed differentially to anchoring AGO2-RISC on the target RNA, with base 
pairs at g2–g6 contributing more than base pairs at g7 or g8. Even a single 
nucleotide mismatch to g8, converting a 7 nt seed to a 6 nt seed, increased koff 
by 24-fold (Figures 3.3B and S3.3). Thus, RISC discriminates between seed-
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matched and seed-mismatched targets both during its initial search and after it 
has bound; it finds seed-mismatched targets more slowly and remains bound to 
them for less time than fully seed-complementary targets. 
Seed Pairing Explains Mouse AGO2 Binding to miRNA-Like Targets 
The effect of target:guide mismatches within the seed sequence cannot be 
accurately predicted from nearest-neighbor thermodynamic rules (Xia et al., 
1998). For example, a dinucleotide mismatch at the end of a 7 nt seed-match is 
predicted to increase ΔG for RISC:target binding by 1.7 (g2g3:t2t3 mismatch) to 
1.9 kcal∙mol−1 (g7g8 mismatch), compared to a fully complementary seed match 
target site (g2–g8; Figure S3.7). In reality the effect is much larger: a g2g3 
dinucleotide mismatch (i.e., only g4–g8 paired) reduced the stability of the 
RISC:target complex by 6.1 ± 0.1 kcal∙mol−1, while a g7g8 mismatch (g2–g6 
paired) reduced the stability of RISC binding by 2.7 ± 0.1 kcal∙mol−1 (Figure 
S3.7). Similarly, a g3g4 mismatch, which is predicted to decrease binding 
stability by 3.8 kcal∙mol−1, reduced it by 5.9 ± 0.1 kcal∙mol−1. 
Additional base pairs with the 3′ half of the guide (3′ supplementary 
pairing) are associated with high probability miRNA-binding sites (Grimson et al., 
2007). The addition of four 3ʹ′ supplementary base pairs is predicted to change 
the ΔG37°C of a fully base paired let‑7a seed by −3.7 kcal∙mol−1, yet our 
experiments failed to detect a substantial change in binding stability for let‑7a 
bound to its target by seven seed base pairs or by seven seed plus four 
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additional 3′ supplemental base pairs (ΔΔG37°C = −0.20 ± 0.2 kcal∙mol−1). In 
contrast, dissociation of AGO2 guided by miR‑21, which has a more AU-rich 
seed than let-7, was slowed >7-fold by adding 3′ supplementary base pairing 
(Figure S3.5D). Increasing the base-pairing strength of the seed by replacing 
three seed-match adenosines with 2,6 diaminopurine nucleotides decreased koff 
4-fold and increased RISC affinity by –0.83 kcal∙mol−1, far less than the 
predicted –3 kcal∙mol−1 (Figure S3.5D ;Gryaznov and Schultz, 1994; Freier and 
Altmann, 1997). 
AGO2 Discriminates between RNA and DNA targets 
Mouse AGO2, like all known animal Argonautes, has only been reported to 
function by binding RNA targets. In contrast, TtAgo can cleave both RNA and 
DNA targets, although only DNA targets have been identified in vivo (Wang et 
al., 2008a; Wang et al., 2008b; Wang et al., 2009; Swarts et al., 2014a). How do 
animal Argonaute proteins discriminate between RNA and DNA? We compared 
the binding of mouse AGO2 to RNA targets with binding to the same sequences 
composed of DNA (Figures 3.2B and S3.2). As we observed for RNA, AGO2 
accelerated the search for a complementary binding site on DNA. In fact, kon for 
a seed-matched (g2–g8), seed-matched plus supplementary pairing (g2–g8, 
g13–g16), or a completely complementary (g2–g16) DNA target was ~2.3 to 3.3 
times faster than the on-rate for the corresponding RNA target (Table 3.1). 
However, mouse AGO2-RISC did not remain stably bound to the DNA, 
  
140 
dissociating, on average, just ~2.4 s (koff = 0.41 ± 0.09 s−1) after binding a seed-
matched DNA target. In contrast, AGO2-RISC remained bound to an otherwise 
identical RNA target for an average of ~280 s (koff = 0.0036 ± 0.0003 s−1; Table 
3.1 and Figures S3.3 and S3.5C). We observed a similar difference in koff for 
DNA and RNA targets with both seed and 3′ supplementary complementarity. 
The >110-fold faster dissociation of AGO2-RISC from DNA compared to RNA 
supports the view that even when acting in the nucleus, eukaryotic RISCs bind 
nascent transcripts, not single-stranded DNA (Buhler et al., 2006; Sabin et al., 
2013). 
In contrast to mammalian Argonautes, bacterial Argonautes are thought 
to preferentially bind and cleave foreign DNA, such as horizontally transferred 
plasmids (Olovnikov et al., 2013; Swarts et al., 2014a). Consistent with this 
function, TtAgo showed no substantive preference for binding RNA over DNA 
targets (Figures 3.2B, S3.2, and Table 3.1). TtAgo found its binding sites in RNA 
and DNA at similar rates (e.g., seed-matched target kon = 2.0 ± 0.1 × 107 M−1∙s−1 
for RNA versus 7.1 ± 0.1 × 107 M−1∙s−1 for DNA; Figures 3.2B and S3.2), and, 
once bound, departed from RNA and DNA at similar rates (koff = 0.35 ± 0.03 s−1 
for RNA versus 1.0 ± 0.1 s−1 for DNA; Figure S3.4C and Table 3.1). 
A Kinetic Framework for Mammalian RNAi 
For a 5ʹ′-tethered target, target cleavage by RISC leaves the 5ʹ′ cleavage product 
tethered to the slide surface, allowing detection of RISC that remains bound via 
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guide nucleotides g11–g21. When let‑7a guided mouse AGO2, target cleavage 
and release of the 5′ cleavage product from RISC were simultaneous within the 
time resolution of our experiments (e.g., Figure 3.1D). This suggests that 5′ 
product release is faster than RISC dissociation from the 3′ cleavage product, 
which contains the seed-complementary sequence. 
To measure 3′ cleavage product release, we synthesized a let‑7a-
complementary target with biotin on its 3ʹ′ end and 17 Alexa647 dyes at its 
5ʹ′ end (Materials and Methods and Table S3.1). The 3ʹ′-tethered target allowed 
us to detect four distinct reaction species: (1) target alone, (2) RISC bound to the 
target, (3) RISC bound to the 3′ cleavage product, and (4) the 3′ product after 
RISC dissociation (Figure 3.5A). Our experiments with 5′-tethered target add 
information about RISC bound to 5′ cleavage product and the 5′ product alone, 
completing the set of all observable species in the RNAi reaction. Figure 3.5B 
presents rastergrams that summarize the results for hundreds of RNA target 
molecules where the reaction states of AGO2-RISC and target were observed 
for the entire duration of the experiment. 
As expected, kon for 3′- and 5′-tethered targets (3.7 ± 0.1 × 108 M−1∙s−1 
and 3.9 ± 0.5 × 108 M−1∙s−1, respectively) was nearly identical to let‑7a-AGO2-
RISC binding rates (Figures 3.2B and S3.2). However, the order and rates of 
dissociation differed considerably for the 5ʹ′ and 3ʹ′ cleavage products 
(Figure 3.5B). The first product to be released was nearly always the 5′ product, 
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after which AGO2-RISC slowly dissociated from the 3′ product. After 
AGO2-RISC departed, we frequently observed RISC rebinding to the 
3′ cleavage product (Figure 3.5B). The 3ʹ′ product is complementary to the seed 
sequence; thus, let‑7a AGO2-RISC maintains high affinity for a seed-match even 
after target cleavage, highlighting the essential role of the seed in RISC binding. 
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Figure 3.5: let‑7a Binds Tightly to the Seed-Matching, 3′ Product of Target 
Cleavage 
(A) A trace of an individual molecule of a 3′-tethered target fully complementary 
to let‑7a. The trace shows that mouse let‑7a-RISC bound the target (magenta 
bar), cleaved the target, and then remained bound to the 3′ product (red bar). 
Finally, RISC departed or the guide’s Alexa555 photobleached. The 3′ cleavage 
product containing the seed remains on the slide surface, allowing a new 
molecule of RISC to bind. (B) Rastergrams comparing 5′-tethered (426 individual 
molecules) and 3′-tethered (452 individual molecules) RNA targets fully 
complementary to let‑7a. 
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To quantitatively assess the product release mechanism, we performed 
global fitting (Figure 3.6A) of a unified reaction scheme that accounts for all 
observed intermediates and products (Figure 3.6B). A global fit is possible for 
our kinetic data because the loss or production of different reaction species 
(e.g., 5ʹ′- and 3ʹ′-products) share one or more kinetic steps in the mechanism. By 
fitting multiple data sets simultaneously to the same kinetic mechanism, the rate 
constants for shared steps become global parameters constrained to be the 
same for all data sets. Our proposed reaction mechanism includes branched 
pathways for product release: one branch corresponds to the 5′ product being 
released first and the 3′ product released subsequently (Figure 3.5B, k5′ 1st 
followed by k3′ 2nd), while in the other, the order of product release is reversed 
(Figure 3.5B, k3′ 1st followed by k5′ 2nd). Both branches arrive at the same final 
state: two free products and free AGO2-RISC.  
To account for the sigmoidal kinetics of product release (Figure 3.6A) we 
included an additional kinetic step. Because both branches of the mechanism 
share this step, its rate constant (k) was treated as global parameter for fitting. 
The rate constant (k) for the additional step likely corresponds to the rate of the 
slowest step in the target cleavage reaction—e.g., the conformational change in 
Argonaute that brings the catalytic Mg2+ near the scissile phosphate (Wang et 
al., 2009; Sheng et al., 2014). The global fit based on four experimentally 
measured product release curves obtained using 5ʹ′- and 3ʹ′-tethered targets 
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(Figures S3.8A and S3.8B) defined three of the five rate constants (k, k5′ 1st and 
k3′ 1st). The rate constants (k3′ 2nd and k5′ 2nd) for release of the 3ʹ′ or 5ʹ′ products 
following release of the other product were determined directly from the 
distributions of waiting times beginning with the departure of the first cleavage 
product and ending with the departure of the second (Figures S3.8A and S3.8B), 
after subtracting the photobleaching rate (Materials and Methods). 
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Figure 3.6: AGO2-Catalyzed Cleavage and Product Release 
(A) Global fit analysis (Materials and Methods) of 5′- and 3′-tethered targets for AGO2 guided by let‑7a or miR‑21. 
(B) The detailed kinetic scheme used for global fitting. Rate constants are color-coded according to (A). 
Percentages in parentheses report the proportion of product molecules released first. 
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Seed Pairing Determines the Rate of Slicing and the Order of Product 
Release 
To determine whether the features of cleavage and product release observed for 
let‑7a RISC depend on the guide RNA identity and base-pairing stability with the 
target, we performed experiments paralleling those shown in Figure 3.5B but 
with 5′- and 3′-tethered targets fully complementary to miR‑21 miRNA and 
AGO2-RISC loaded with miR‑21. We also made a 5ʹ′-tethered let‑7a target that 
contained mismatches with the let‑7a seed at positions g4 and g5 (Figures S3.3 
and S5C). We then carried out global fitting of the kinetic scheme in Figures 
3.6B and S3.8A to these data to determine slicing and product release rates, as 
well as the order of product release. 
Slicing rate depended on guide strand identity: let‑7a has the slowest 
slicing rate we measured (k = 0.15 s−1), while miR‑21 AGO2-RISC cleaves its 
target twice as fast (k = 0.31 s−1). The let‑7a has the strongest seed pairing with 
ΔG = −15.6 kcal∙mol−1. The miR‑21 seed is significantly weaker: ΔG = −13.3 
kcal∙mol−1. The let‑7a target with seed mismatches that weaken the seed base 
pairing by about 5 kcal∙mol−1 (ΔG= −10.1 kcal∙mol−1) is cleaved faster than the 
fully complementary let‑7a target (k = 0.20 s−1), but still slower than miR‑21. This 
trend appears to inversely correlate with the stability of seed pairing to the 
target, albeit not precisely, indicating that there may be additional determinants 
of the cleavage rate (Figure S3.8C). Interestingly, miR‑21 AGO2-RISC failed to 
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cleave or even detectably bind the miR‑21 target that contains g4g5 
mismatches (data not shown), indicating that weakening seed base pairing 
below a certain threshold prevents target recognition and cleavage. 
The stability of seed pairing with respect to the stability of base pairs in 
the 3′-part of the guide strand determines the order of product release, as 
clearly evidenced by the proportion of the reaction directed through one of the 
two product release branches (Figure 3.5B, values in parentheses). For let‑7a, 
whose seed pairing (g2–g8; ΔG= −15.6 kcal∙mol−1) is predicted to be more stable 
than the pairing of the 3′-half of the guide with the 5′ product (g11–g16; 
ΔG = −10.8 kcal∙mol−1), the 5′ product was released before the seed-matching 
3′ cleavage product for 92% of molecules. 
For let‑7a, release of the 3′ cleavage product from RISC limits the rate of 
enzyme turnover, kcat. Is 3′ product release generally rate-determining for RISC 
turnover? To test this, we analyzed two additional miRNA:target combinations: 
miR‑21 paired to a fully complementary target and let‑7a paired to a target 
bearing two mismatches to the let‑7 seed. Unlike let‑7a, miR‑21 has a smaller 
predicted difference in the stabilities of target pairing to the seed and 3′-half 
(ΔGg2–g8 = −13.3 kcal∙mol−1 versus ΔGg11–g16 = −11.1 kcal∙mol−1). For miR‑21, only 
57% of the 5′ product was released first. For let‑7a paired to a target 
mismatched to guide positions g4g5, the 5′ product is predicted to pair with 
let‑7a more stably than the partially seed-matching 3′ product 
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(ΔGg2-g8 = −10.1 kcal∙mol−1 versus ΔGg11–g16 = −10.8 kcal∙mol−1). For this 
guide:target pair, only 26% of the 5′ product was released before the 3′ 
cleavage product. We conclude that the course of product release—5′ first or 3′ 
first—does not follow a strict order but rather reflects the sequences of the 
guide and target. 
Product release rates followed the base pair stability trends. For the 3′ 
product, the release rate of let‑7a paired to a fully complementary target (0.06 
s−1) was tenfold slower than for let‑7a paired to the g4g5:t4t5 mismatched target 
(0.6 s−1), reflecting their different predicted free energies of base pairing between 
the seed sequence and the 3′ product (−15.6 kcal∙mol−1 versus −10.1 
kcal∙mol−1). For the 5′ product, the release rates were more similar: 0.7 s−1 for 
let‑7a, 0.5 s−1 for miR‑21, and 0.2 s−1 for let‑7a with the seed-mismatched target. 
The free energies of pairing for all three 5′ products were roughly −11 kcal∙mol−1. 
Release of the First Product Promotes Release of the Second 
Formally, there are two rates for the release of each cleavage product: a rate for 
when the product departs first and a rate for when the same product departs 
second, the other product having already dissociated. For example, k5′ 1st is the 
rate for 5′ product release in the presence of bound 3′ product, while k5′ 2nd is the 
rate for 5′ product release after the 3′ product has already left. Our data suggest 
that release of the first product promotes release of the second product (Figure 
3.6). For example, the rates of the 5′ and 3′ products of miR‑21 were both ~4-
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fold faster when they were released second rather than first. Similarly, release of 
the 5′ product of cleavage of the let‑7a seed-mismatched target was 
0.21 ± 0.01 s−1 when released first, but 1.3 ± 0.1 s−1 when released second. A 
notable exception was the seed-matched 3′ product of let‑7a target, by far the 
most stably bound product we examined. This 3′ cleavage product dissociated 
at ~0.05 s−1 regardless of the presence of the 5′ product. 
We can imagine two mechanisms by which the departure of one product 
can accelerate dissociation of the other. Stacking interactions between the 
terminal bases of the products may mutually stabilize their binding. Supporting 
this view, the 5′ product of miR‑21 leaves ~4-fold faster when it departs after 
the 3′ product (and vice versa)—an ~0.9 kcal∙mol−1 difference in stability. This 
difference in ΔG is within the range of the contributions of dangling nucleotides 
to RNA helix stability (Xia et al., 2001). Alternatively, departure of one of the two 
products may facilitate a conformational change that destabilizes the second 
product. Such a conformational change might correspond to the return of the 
endonuclease active site to the conformation present prior to zippering of the 
guide:target helix 3′ to the seed sequence (Wang et al., 2009; Elkayam et al., 
2012; Schirle and MacRae, 2012; Faehnle et al., 2013). 
Strong Seed Pairing Slows RISC Turnover 
The rates for target cleavage and product release allow calculation of the overall 
turnover rate: kcat = k ∙ k5′ 1st ∙ k3′ 2nd/(k ∙ k5′ 1st + k ∙ k3′ 2nd + k5′ 1st ∙ k3′ 2nd) when the 
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5′ product is released first, and kcat = k · k3′ 1st · k5′ 2nd/(k ∙ k3′ 1st + k ∙ k5′ 2nd + k3′ 1st∙ k5′ 
2nd) when the 3′ product is released first. The two pathways result in similar kcat 
values. For let‑7a, the calculated kcat value, 0.036 ± 0.002 s−1, agrees well with 
kcat determined by traditional, ensemble initial velocity analysis 
(0.066 ± 0.004 s−1; Figure 3.1C). The calculated turnover rate was about fourfold 
faster for both miR‑21 (0.16 ± 0.1 s−1) and let‑7a with the g4g5 seed-mismatched 
target (0.13 ± 0.1 s−1). The slower kcat for let‑7a reflects the stronger seed pairing 
to its fully complementary target (ΔG= −15.6 kcal∙mol−1, k3′ 1st = 0.06 s−1, k3′ 2nd = 
0.05 s−1). This slow 3′ product release step for let‑7a limits the overall turnover 
rate. Both miR‑21, with its weaker pairing strength in its seed, and let‑7a paired 
to the target whose seed pairing was intentionally weakened with 
g4g5 mismatches, direct faster cleavage than let‑7a with a fully complementary 
target, because their product release rates are comparable to or faster than k, 
the apparent RISC cleavage rate (Figure 3.6B). Thus, guide RNAs, including 
siRNAs, with more stable base pairing between their seed and their target are 
predicted to cleave fewer targets per unit time than targets whose rate of 3′ 
product release is not rate-determining. 
The autoantigen protein La has been proposed to facilitate multiple-
turnover target cleavage by human AGO2 RISC (Liu et al., 2011). Thus, La 
protein might accelerate release of the cleaved target from RISC, so that 
product release is no longer rate-determining in vivo (Figure 3.7A). To test this 
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idea, we measured the rate of multiple-turnover target cleavage by let‑7a-AGO2 
RISC in the absence or presence of an equimolar (1 nM) or excess (50 or 
500 nM) amount of La protein (Figure 3.7B). We were unable to detect any 
difference in the rate of target cleavage among the four reaction conditions. We 
conclude that, in cells, La protein is unlikely to overcome the rate-limiting step of 
product release for let‑7a-AGO2 RISC. 
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Figure 3.7: Measurement of the RNA binding protein La on multiple 
turnover activity 
(A) Dissociation constant determination for purified La determined by gel-shift 
analysis (Materials and Methods). (B) RISC target cleavage under conditions of 
target excess. Target cleavage was performed at 23˚C and 37˚C (Materials and 
Methods). 
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AGO2 Distinguishes between miRNA-Like Binding Sites and Cleavage 
Products 
Although quantitatively different from the energetics of nucleic acid 
hybridization, the free energy of base pairing between the seed sequence and 
its target influences the rates of all steps in the RNAi reaction, including binding 
and dissociation of RISC, cleavage of the target, and release of the cleaved 
products. However, one aspect of RISC function emerges from our studies that 
is not predicted by the stability of guide-target base pairing: AGO2 appears to 
discriminate between a miRNA-like binding site, which typically pairs only with 
nucleotides g2–g8, and binding to the seed-matched, 3′ product of target 
cleavage, which pairs with nucleotides g2–g10 (Figure 3.8). 
We measured the koff for a full-length target RNA bound to let‑7a-guided 
AGO2-RISC for a target complementary only to the let‑7a seed (g2–g8) and for 
targets with one (g9:t9) or two (g9g10:t9t10) additional base pairs beyond the 
seed, as would be found in the 3′ product after target cleavage. The standard 
rules for nucleic acid hybridization predict that the addition of one or two 
additional base pairs beyond the seed should decrease ΔG, slowing dissociation 
of RISC (Figure 3.8). Counterintuitively, these additional base pairs increased the 
dissociation rate ~4-fold: koff was 0.014 ± 0.001 s−1 when g2–g9 paired with the 
target and 0.015 ± 0.001 s−1 (τ ~66 s) when g2–g10 paired, but 0.0036 s−1 
(τ ~280 s) when only g2–g8 were paired. In vivo, AGO2 has little opportunity to 
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bind targets with complementarity from t2–t10, but this pairing scheme is 
typically found in the 3′ cleavage product generated by the RNAi pathway. RISC 
departed >3-fold faster from the 3′ product generated by target cleavage 
(koff = 0.05 ± 0.01 s−1) than from the full-length target complementary to g2–g10, 
and ~14-fold faster than from the full-length, seed-matched (t2–t8) target. When 
the 3′ cleavage product was subsequently bound by other RISC molecules, they 
depart at essentially the same rate as the RISC that first catalyzed cleavage, 
koff = 0.044 ± 0.001 s−1 (τ ~23 s; Figure 3.8B). 
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Figure 3.8: Argonaute can Distinguish between miRNA Targets and Cleaved 
Products 
(A) Effects of additional complementarity and 3′ target length on RISC binding 
and dissociation. koff was measured directly, correcting for photobleaching, 
except for the seed-matched, full-length target, whose dissociation was slower 
than the rate of photobleaching and was therefore measured by varying laser 
exposure time and extrapolating to no illumination. ∆∆G37˚C was calculated from 
KD (= koff / kon); theoretical ∆∆G37˚C was predicted using nearest-neighbor analysis 
to estimate ∆G. (B) Experimentally measured koff, corrected for photobleaching, 
for let‑7a-guided mouse AGO2-RISC dissociating from the 3′ product of a 
previously cleaved, 3′-tethered, fully complementary target RNA. 
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One potential explanation for the accelerated departure of RISC from a 3′ 
cleavage product compared to a seed-matched target is that the seed-matched 
target extends far beyond position t10, providing greater opportunities for non-
sequence specific interactions between AGO2 and its target. To test this idea, 
we designed a series of 5′ monophosphorylated, 30 nt RNAs that end at either 
position t8, t9, or t10 so as to mimic a 3ʹ′ cleavage product (Figure 3.8A). 
Compared to the full-length target complementary to guide positions g2–g10 
(koff = 0.014 ± 0.001 s−1), the 3′ cleavage product mimic dissociated faster 
(koff = 0.026 ± 0.001 s−1; Figure 3.8), further supporting the idea that AGO2 
makes sequence-independent contacts with its RNA targets (Ameres et al., 
2007). RISC also departed approximately eight times faster from a seed-
matched (t2–t8, koff = 0.028 ± 0.001 s−1) mimic of the 3′ cleavage product than 
from the seed-matched, full-length target. 
Nonetheless, such contacts do not explain why RISC departed faster 
when paired with t2–t10 than with only t2–t8 of a full-length target. If 
non-sequence-specific protein-RNA interactions do not explain the faster 
departure from the 3′ cleavage product than for a seed matched target, how 
does g9g10:t9t10 pairing alter the properties of RISC so that it binds more 
weakly to an RNA with nine potential base pairs than to an RNA with which it 
makes only seven? Extending base pairing beyond position g8 of the seed likely 
requires an energetically unfavorable conformational rearrangement in RISC. 
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The structure of human AGO2 with a guide RNA complementary to nucleotides 
t2–t9 of short target RNA suggests that pairing beyond t8 requires opening the 
central cleft of AGO2 (Schirle et al., 2014). Such a presumably disfavorable 
change in conformation would explain why base pairing beyond guide position 
g8 is atypical for miRNA-target interactions. These properties of AGO2 were not 
anticipated from thermodynamic predictions for the strength of nucleic acid 
base pairing (Figures 3.8 and S3.8). 
DISCUSSION 
Our data demonstrate directly that Argonaute proteins from both bacteria and 
mammals accelerate the rate at which their guide strands find complementary 
targets. Argonautes can accelerate on-rates as much as 250 times, and both 
TtAgo, which is DNA-guided, and mouse AGO2, which is RNA-guided, can 
enhance target finding for both DNA and RNA targets. The acceleration of target 
binding by AGO2 requires seed complementarity with its target, consistent with 
pre-organization of the seed sequence by Argonautes playing a major role in this 
phenomenon. However, seed nucleotides do not contribute equally to target 
binding: g2–g5:t2–t5 base pairs contribute more to the initial binding of RISC to 
target RNA than g6–g8:t6–t8 base pairs, which function mainly to slow 
dissociation of RISC from its target after a successful encounter. Remarkably, 
the existence of seed sequence subdomains with distinct functions in target 
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binding was first predicted from the structure of human AGO2-RISC bound to a 
seed-matched target RNA (Schirle et al., 2014). 
Because target binding is a bimolecular process, the rate at which RISC 
finds its targets in vivo depends on the concentrations of both target sites and 
Argonaute-bound guide. In light of recent reports that in vivo target site 
concentration is quite high and exceeds that of miRNA-guided RISC (Denzler et 
al., 2014), the rate of target finding is unlikely to limit the speed at which miRNAs 
destabilize their target mRNAs. Furthermore, the rates of target binding in our 
single-molecule experiments approach the speed of macromolecular diffusion, 
suggesting that additional proteins such as poly(A) binding protein (PABP) 
cannot promote association of RISC with seed-complementary targets, as has 
been previously suggested (Moretti et al., 2012). Of course, our studies were 
conducted with purified components outside of the cell, and future experiments 
measuring the diffusion and rate of target binding of bacterial and mammalian 
RISCs in living cells will be required to test these ideas. 
In addition to accelerating hybridization of guides to targets, Argonaute 
proteins alter how quickly target sequences dissociate from RISC. For mouse 
AGO2, koff can be as slow as 0.003 s−1. That is, at 37°C, more than 5 minutes is 
required for an average RISC to depart from a typical miRNA-binding site. In 
fact, many miRNA-guided Argonautes are predicted to bind their target sites 
with greater affinity than most known RNA-binding proteins. Consequently, 
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RISC likely serves to stabilize the binding of other proteins, such as GW182 or 
mRNA-degrading nucleases, to the targets of miRNAs. The high binding affinity 
of RISC derives mainly from its slow dissociation rate, which is far slower than 
would be expected for seven base pairs between RNA strands: the KD of a guide 
RNA in RISC bound to a seed-match target is ~4 million times tighter and 
dissociates ~14,000 times slower than for RNA alone. 
Many of these properties spring from the unique configuration of guide 
nucleotides g2–g8 within Argonaute proteins, which pre-organize them into the 
seed sequence. Our data show that the sequence of the seed, whose existence 
was detected by insight or computation before the first structure of an 
Argonaute-bound guide was available (Lai and Posakony, 1998; Lai, 2002; Lewis 
et al., 2003), influences the rate of dissociation, with RISC dissociating from its 
seed-matched target far more slowly when guided by let‑7a than by miR‑21. 
Moreover, mismatches in the seed increase the dissociation of RISC from its 
otherwise fully complementary seed-matched target more than what would be 
predicted from the thermodynamics of base pairing (Figure S3.7). For example, 
a g2g3:t2t3 mismatch increased koff ~3,000-fold, an increase in free energy 
~6 kcal∙mol−1; for RNAs hybridizing in the absence of protein, the predicted 
change was just ~1 kcal∙mol−1. Together, our data suggest that Argonautes do 
more than simply pre-organize the seed—which would pre-pay the entropic cost 
of hybridization to a similar extent for all seed sequences (Figure 3.9). Argonaute 
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proteins must also provide an environment in which the free energy of each non-
seed base pair is decreased, but the rank order of base pairing strength 
predicted by nearest-neighbor analysis remains essentially unchanged. Guide 
positions g9 and g10 are a notable exception to this idea. t9 and t10 target 
complementarity to the guide provide no increase in binding affinity, and, when 
not at the 5′ end of the target RNA (a cleavage product), actively destabilize 
RISC binding. Thus, miRNA prediction algorithms that penalize or at least give 
no credit for pairing at nucleotides t9 and t10 are more likely to identify 
biologically important mRNA targets. 
Intriguingly, mismatches at the 5ʹ′ end of the seed have the greatest effect 
on koff (Figure 3.3), even when these mismatches are not predicted to have the 
greatest effect on base pairing stability (Figure S3.7). These data suggest that 
even within the seed sequence, Argonaute assigns greater value to mismatches 
before guide position g5 than from g5–g8. In fact, the structure of AGO2, loaded 
with a guide and bound to a seed matched target, suggests that pairing beyond 
g5:t5 requires a conformational rearrangement in the protein 
(Schirle et al., 2014). Such a rearrangement could account for the reduced 
contribution of bases g5–g8 to binding affinity. 
Although most miRNA-binding sites match the seed sequence, some 
sites use centered pairing, ≥11 nt of contiguous complementarity to the guide 
typically starting at position t4 (Shin et al., 2010). While target mismatches with 
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the 5′ end of the seed normally prevent stable miRNA binding, extensive 
complementarity to the center and 3′ end of a miRNA may provide 
compensatory binding energy. Supporting this idea, let‑7a-RISC binding to a 
seed-matched target containing a g4g5:t4t5 mismatch was rescued by 
additional base pairs 3′ to the seed (Figures 3.3 and S3.5). Regulation of the 
Glutathione S-transferase Mu 3 (GSTM3) mRNA by miR‑21, which pairs with 
nucleotides t5–t16 provides an example of a centered site (Shin et al., 2010). We 
speculate that the faster than typical off-rate of the miR‑21 seed (Figures 3.3 
and S3.5) facilitated the evolution of this type of site. Because centered sites 
extend well into the 3′ region of the guide, centered pairing may offset the 
destabilizing effects of g9g10:t9t10 complementarity pairing conformation. 
Alternatively, the absence of g2–g5:t2–t5 seed pairing may alleviate the 
conformational strain associated with g2–g10:t2–t10 complementarity. 
The extent of complementarity between guide and target determines 
whether RISC simply binds or binds and cleaves. In animals, miRNAs typically 
guide binding, whereas siRNAs usually direct target cleavage. Our data suggest 
that mammalian AGO2 can discriminate between seed-matched “miRNA 
targets,” to which RISC remains tightly bound, and “siRNA targets,” with which 
it pairs more extensively. After target cleavage, release of the two cleavage 
products follows no strict order, and AGO2 creates an environment in which 
dissociation of either of the cleavage products accelerates departure of the 
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other product. Thus, release of either cleavage product can be rate-determining, 
but is nevertheless faster than would be predicted from the extent of base 
pairing with the guide. For the 3′ product, its faster than expected release can 
be explained, in part, by the loss of non-sequence specific protein-RNA 
contacts after the 5′ product leaves. 
TtAgo also senses the type of target to which it is bound. In vivo, TtAgo 
catalyzes cleavage of foreign DNA with extensive complementarity to its 16 nt 
DNA guide (Swarts et al., 2014a). Consistent with this idea, TtAgo dissociated 
slowly from a fully complementary target DNA, but quickly from a target that 
was only partially complementary (τ ≤ 1 s at 37°C; Table 3.1). Unlike mouse 
AGO2, which appears to have evolved to bind stably only to RNA, TtAgo readily 
binds and cleaves both DNA and RNA. In contrast, mouse AGO2 finds 
complementary sites in DNA more rapidly than RNA but fails to bind stably to 
DNA (τ ≤ 2 s ; Table 3.1). 
Our efforts to apply single-molecule methods to study the fundamental 
properties of bacterial and mammalian Argonaute proteins demonstrate the 
utility of this approach. Unlike classical ensemble approaches for measuring the 
kinetics of RNA binding and cleavage by RISC, single-molecule studies allow 
direct and continuous observation of rapid events for both the target and guide. 
We anticipate that future studies will extend this approach to other Argonaute 
proteins, including the animal-specific PIWI clade, which defends the germline 
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against transposons, and plant Argonautes, which mediate both mRNA 
cleavage (Llave et al., 2002; Tang et al., 2003) and repression of mRNA 
translation (Brodersen et al., 2008; Iwakawa and Tomari, 2013), as well as to 
more complex sets of proteins that collaborate with Argonautes to carryout the 
repression of gene expression. 
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Figure 3.9: A Kinetic Model for Mouse AGO2-RISC Function 
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Materials and Methods 
Preparation of siRNAs and RNA Targets 
Synthetic RNAs for passenger and guide strands (GE Healthcare Dharmacon, 
Lafayette, CO; Sigma-Aldrich Corp, St. Louis, MO) were deprotected and gel 
purified (Table S3.2). Guide RNAs and targets bearing a 3′ amine modification or 
3′ product mimic targets containing an internal 2′-amino uridine were reacted 
with Alexa Fluor 555 or Alexa Fluor 647 N-hydroxysuccinimide ester (Life 
Technologies, Thermo Fisher Scientific, Grand Island, NY) in 0.1M sodium 
tetraborate (pH 8.0) overnight at 4˚C and then purified from a denaturing 
20% polyacrylamide gel and eluted overnight from the gel slice into 0.4 M NaCl, 
25 mM EDTA rotating in the dark at room temperature, and then precipitated 
with ethanol. (The Alexa dye caused an ~1 nt increase in apparent mobility.) 
All target RNAs were transcribed using T7 RNA polymerase and DNA templates 
generated by PCR (Table S3.2) from pGL2-Control vector (Promega, Madison, 
WI) and then gel purified (Haley et al., 2003). RNA substrates for kinetic analyses 
were in vitro transcribed with 32P α-UTP (6,000 Ci/mmol; Perkin Elmer, Waltham, 
MA) and then capped with 32P α-GTP (3,000 Ci/mmol; Perkin Elmer) and 
guanylyl transferase as described (Wee et al., 2012). All RNAs were gel purified 
and concentrations were determined by absorbance at 260 nm prior to addition 
of Alexa dye. 
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RNA targets tethered via the 5ʹ′ end were transcribed in the presence of 
5ʹ′-biotin-GMP (TriLink Biotechnologies, San Diego, CA) at a ratio of 4:1 relative 
to GTP, then gel purified. The 3ʹ′ ends of these RNAs were trimmed using a 
“gapmer” antisense oligonucleotide (Table S3.2) and RNaseH (Life 
Technologies). The trimmed RNA was gel purified and concentration was 
determined by absorbance at 260 nm. Alexa Fluor 647 dyes were added to the 
3′ end of the in vitro transcribed, 5ʹ′-biotinylated, RNase H-trimmed RNA by 
template-directed extension using Klenow polymerase fragment. In a typical 
labeling procedure, 50–500 pmol RNA target was annealed to a 1.5–2-fold molar 
excess of DNA template oligonucleotide (Table S3.2) in 10–20 µL 
10 mM HEPES-KOH (pH 7.4), 20 mM NaCl and 0.1 mM EDTA at 70˚C followed 
by slowly cooling to 30˚C over 20 min. Afterwards, the annealed strands (< 25% 
of final reaction volume) were added without further purification to the 
3′ extension reaction, comprising 1× NEB buffer 2 (New England Biolabs, 
Ipswich, MA), 0.5 mM dATP, 0.5 mM dCTP, 0.1 mM or a 2-fold molar excess of 
Alexa Fluor 647-aminohexylacrylamido-dUTP (Life Technologies) over the 
theoretical amount of dUTP required for Klenow extension, whichever was 
greater, and 0.25 U/µL Klenow fragment (3′→5′) exo-minus, New England 
Biolabs) and incubated at 37˚C for 1 h. The reaction was quenched by the 
addition of 500 mM (f.c.) ammonium acetate and 20 mM (f.c.) EDTA. A 10-fold 
molar excess of “Trap” oligonucleotide (Table S3.2) was added to the DNA 
  
173 
template oligonucleotide. The entire reaction was precipitated overnight at 
−20˚C in 3 volumes of ethanol. The labeled target was recovered by 
centrifugation, dried, and dissolved in Gel Loading Buffer II (Life Technologies 
AM8547), incubated at 95˚C for 60 seconds, and gel purified. 
RNA targets tethered by their 3′ ends were in vitro transcribed as 
described above except 5′-biotin-GMP was omitted. After gel purification, the 
5′ triphosphate was converted to a monophosphate using RNA 
5′ polyphosphatase (Epicentre, Madison, WI), and then the 3ʹ′ end was trimmed 
using a gapmer antisense oligonucleotide (Table S3.2) and RNaseH (Life 
Technologies). To label the 5′ end of the target, a DNA extension was 
transcribed in the presence of Alexa Fluor 647-aminohexylacrylamido-dUTP 
using a DNA oligonucleotide template and Klenow polymerase. The labeled 
Alexa647-dUTP DNA was gel purified, and its concentration was determined by 
absorbance at 260 nm. To ligate DNA to the 5′ end of a RNA, we first ligated a 
synthetic DNA/RNA linker to the 3′ end of the gel-purified DNA made by Klenow 
extension using a synthetic DNA splint and T4 DNA ligase (Table S3.2). The 
Alexa 647-containing DNA bearing 30 nt of RNA at its 3′ end was ligated onto 
the 5′ end of the in vitro transcribed, 5′ monophosphorylated target as 
described (Moore and Query, 2000). The 5′ DNA with Alexa647-RNA target was 
gel purified and a 3′ biotin was added by Klenow extension using the template 
oligonucleotide for the synthesis of a short 3′ DNA extension with a single biotin 
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(Table S3.2) as described above, except that the Klenow reaction contained 
0.5 mM dUTP instead of Alexa647-dUTP, and 0.1 mM biotin-dCTP (TriLink 
Biotechnologies) instead of dCTP. 
RISC Purification and Ensemble Kinetics 
S100 extract was generated from SV40 large T-antigen-immortalized Ago2−/− 
MEFs that stably over-express mouse AGO2 (O'Carroll et al., 2007). Cell extract 
was prepared as described (Dignam et al., 1983) except that acetate, not 
chloride, was used as the counter ion (Wee et al., 2012; Flores-Jasso et al., 
2013). To load AGO2-RISC, 25 nM let‑7a or miR‑21 siRNA duplex was 
incubated in S100 extract (50% total reaction volume) for 1.5 h at 37˚C in 
15 mM HEPES-KOH (pH 7.9) 100 mM potassium acetate, 5 mM magnesium 
acetate, 5 mM dithiothreitol, 1 mM ATP, 25 mM creatine phosphate, 30 µg∙mL−1 
creatine kinase. RISC was purified as described (Flores-Jasso et al., 2013) 
except that excess competitor oligo (Table S3.2) was removed by incubating the 
eluate with streptavidin paramagnetic beads (Dynabeads MyOne Streptavidin T1 
10 mg∙mL−1, Life Technologies) for 15 min at 4˚C. 
Briefly, the assembled AGO2-RISC was incubated overnight at 4˚C a 
biotinylated, 2′-O-methyl capture oligo linked to paramagnetic beads 
(Dynabeads MyOne Streptavidin T1). The eluted RISC was concentrated, and 
the potassium acetate concentration adjusted to 100 mM (f.c.) by centrifugal 
ultrafiltration (Amicon Ultra-centrifugal filter, 10K MWCO, EMD Millipore, 
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Billerica, MA). The concentration of active, purified RISC was measured by pre-
steady-state target cleavage assays at 23˚C in the presence of 100 or 200 nM 
32P-radiolabeled target RNA. For Michaelis-Menten kinetics, cleavage assays 
were performed at 25˚C with 0.1 nM purified let‑7a-RISC and 0.1 to 5 nM 
32P-radiolabeled target RNA. For experiments with La protein, cleavage assays 
were performed at 23˚C or 37˚C with 1 nM purified let‑7a-RISC, 200 nM 
32P-radiolabeled target RNA, and 0–500 nM La purified from bovine thymus 
(Arotec Diagnostics, Petone, Wellington, New Zealand). 
La RNA-Binding Assays 
To establish that La was active, the KD of La binding RNA was determined by 
native-gel mobility analysis as described (Teplova et al., 2006) except that 
1.5 nM 32P-radiolabeled, 21 nt RNA oligonucleotide (Table S3.2, Sigma-Aldrich 
Corp) containing three 3ʹ′ terminal uridines was incubated with 0–2 µM purified 
La (Arotec Diagnostics) for 10 min at 37˚C in 50 mM Tris-HCl, pH 7.9, 50 mM 
potassium acetate, 5 mM magnesium acetate, 1 mM dithiothreitol, 10% (w/v) 
glycerol, 0.01% (v/v) Igepal CA-630. Samples were resolved by electrophoresis 
through an 8% native, polyacrylamide gel run at 4˚C for 10 min at 250 V and 
then at 100 V for 1 h. The gel was dried, exposed to an image plate, and then 
scanned and analyzed using a FLA-7000 laser scanner (GE Healthcare 
Bioscience) and MultiGuage 3.0 software (Fujifilm, Tokyo). The KD was 
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determined using Igor Pro 6.36 (WaveMetrics, Lake Oswego, OR) by fitting the 
binding data to 
𝑓 = 𝐸𝑇 + 𝑆𝑇 + 𝐾𝐷 − − 𝐸𝑇 + 𝑆𝑇 + 𝐾𝐷 ∙ − 𝐸𝑇 + 𝑆𝑇 + 𝐾𝐷 − (4 ∙ ( 𝐸𝑇 ∙ 𝑆𝑇 )2 ∙ 𝑆𝑇  
 
where f is fraction target bound, [ET] is total enzyme concentration, [ST] is total 
RNA target concentration, and KD is the apparent equilibrium dissociation 
constant. 
Thermus thermophilus Argonaute Expression, Assembly, and Purification 
Expression and purification of TtAgo was as described (Wang et al., 2008b) 
except for the final chromatography step. Briefly, TtAgo was amplified from 
genomic DNA and cloned into pET SUMO (Life Technologies). Expression in E. 
coli BL21-DE3 was induced with 0.2 mM isopropyl-β-D-thiogalactoside at 37˚C 
for 20 h. Cells were lysed with a micro-fluidizer (Microfluidics, Westwood, MA) 
and TtAgo isolated by HisTrap HP (GE Healthcare) chromatography. The amino-
terminal six-histidine tag was cleaved from TtAgo using SUMO-protease (Life 
Technologies), and then the protein was further purified by HiTrap SP HP (GE 
Healthcare) chromatography. Finally, purified TtAgo was dialyzed into storage 
buffer (18 mM HEPES-KOH, pH 7.4, 100 mM potassium acetate, 
3 mM magnesium acetate, 0.1 mM EDTA, 0.01% (w/v) Igepal CA-630, 
5 mM dithiothreitol, 20% (w/v) glycerol). RISC was assembled by incubating 
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3 µM 16 nt, synthetic, single-stranded DNA oligonucleotide corresponding to the 
first 16 nt of let‑7a with or without a 3ʹ′ Alexa555 dye with 1 µM TtAgo for 30 min 
at 75˚C in a reaction comprising storage buffer containing 0.01% (w/v; f.c.) 
Igepal CA-630 and 8% (w/v; f.c.) glycerol. Unassembled DNA guide was 
removed by passing the reaction through a Q Sepharose Fast Flow (GE 
Healthcare) spin column. Protein concentration was measured by Bradford 
assay. The concentration of active TtAgo was determined by stoichiometric 
binding as described (Wee et al., 2012). 
Microscope Slide Preparation 
Because the traditional polyethylene glycol (PEG) coating (Joo and Ha, 2012) 
resulted in high non-specific binding of RISC to the slide, we developed an 
alternative strategy using poly-L-lysine-graft-PEG copolymer (PLL-g-PEG) and 
heparin. PLL-g-PEG copolymer was prepared by dissolving 13 mg of 
poly-L-lysine (Sigma P7890) in 260 µL 0.1 M sodium bicarbonate to yield a 
~50 mg∙mL−1 solution. The solution was transferred to a vial containing 
2 mg biotin-PEG-succinimidyl valerate MW 3,400 (Laysan Bio, Arab, AL) and 
vortexed to dissolve. This solution was then transferred to a vial containing 
80 mg mPEG-succinimidyl valerate MW 2,000 (Laysan Bio) and vortexed to 
dissolve. The mixture was incubated at room temperature for 4 h with slow 
agitation, dialyzed against 2 L phosphate buffered saline buffer 
(10 mM disodium phosphate, 1.8 mM monopotassium phosphate, 
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137 mM sodium chloride, 2.7 mM potassium chloride, pH 7.4) for 12–16 h at 
4˚C, and then against 2 L deionized water for 12 h at 4˚C using a 6–8 kDa MW 
cutoff membrane (Gerard Biotech, Oxford, OH). The solution (≤ 200 µL) was 
aliquoted into pre-weighed 1.5 mL microcentrifuge tubes. Aliquots were frozen 
in dry ice for 10 min, then dried in a SpeedVac rotary evaporator without heat for 
≥ 2 h or until completely dry. Each tube was weighed again to determine the 
mass of dried PLL-g-PEG, which was then stored at −20˚C. 
Microscope slides (Gold Seal 24 × 60 mm, No. 1.5, Cat. #3423), and 
coverslips (Gold Seal 25 × 25 mm, No. 1, Cat. #3307) were cleaned by 
sonicating for 30 min in NanoStrip (KMG Chemicals, Houston, TX), followed by 
washing with at least 10 changes of deionized water. Clean slides and 
coverslips were stored in deionized water. 
Slides and coverslips were dried with a stream of nitrogen. Using a 
plastic syringe tipped with a 200 µL pipette tip and filled with high vacuum 
grease (Dow Corning, Midland, MI), six ~1 mm diameter beads of vacuum 
grease were applied to the slide to create five parallel flow cells. The coverslip 
was placed on top of the slide and gently pressed down to ensure a good seal 
between the glass and vacuum grease and generate a ~0.3 mm gap between 
the slide and coverslip. Each flow cell volume was ~30 µL. Flow cells were filled 
with 2 mg∙mL−1 PLL-g-PEG in 10 mM HEPES-KOH, pH 7.4, and incubated at 
room temperature for ≥1 h. Fresh slides were prepared for each day of imaging. 
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A syringe pump (KD Scientific, Holliston, MA) run in the withdrawal mode at 
0.15 mL∙min−1 was used to apply suction to the flow cell outlet to perform 
washes and flow in reagents. Immediately before each experiment, a flow cell 
was filled with 10 µg∙mL−1 streptavidin (New England Biolabs), incubated for 
2 min and washed three times with 60 µL LSE buffer (30 mM HEPES-KOH (pH 
7.9), 120 mM potassium acetate, 3.5 mM magnesium acetate, 
20% (w/v) glycerol, 1 mM dithiothreitol), and then incubated with 60 µL LSE 
buffer supplemented with 50 µg∙mL−1 heparin (Sigma H4784) for 2 min before 
tethering target molecules to the slide surface. 
Single-Molecule Microscopy 
Imaging was performed on an IX81-ZDC2 zero-drift inverted microscope 
equipped with a cell^TIRF motorized multicolor TIRF illuminator with 491, 561, 
and 640 nm 100 W lasers and a 100×, 1.49 numerical aperture UAPON 
100×OTIRF objective (Olympus, Tokyo, Japan). A digitally-controlled objective 
heater (Bioscience Tools, San Diego, CA) maintained objective temperature at 
37˚C. Temperature on the slide surface was independently monitored by a small 
gauge thermocouple (Type E, 0.25 mm O.D., Omega Engineering Inc., Sutton, 
MA) inserted between the slide and coverslip. Images were recorded with two 
EM-CCD cameras (ImagEM, Hamamatsu Photonics, Hamamatsu, Japan). A 
dichroic image splitter (DC2, Photometrics, Tucson, AZ) was used to separate 
fluorescent emissions from spectrally distinct fluorescent dyes. All illumination 
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and acquisition parameters were controlled with Metamorph software (Molecular 
Devices, Sunnyvale, CA). The TIRF imaging system was isolated from floor 
vibrations with a Micro-g laboratory table (Technical Manufacturing Corporation, 
Peabody, MA). 
The enzymatic oxygen scavenging system comprised 5 mM 
protocatechuic acid (PCA, Aldrich 37580 ) and 1 U∙mL−1 Pseudomonas sp. 
protocatechuate 3,4-Dioxygenase (PCD, Sigma P8279; Crawford et al., 2008; 
Aitken et al., 2008). PCA was purified before use by two rounds of 
recrystallization from water. Triplet quenchers, trolox (Aldrich 238813), 
propyl gallate (Sigma P3130), and 4-nitrobenzyl alcohol (Aldrich N12821) were 
each added to 1 mM f.c. (Dave et al., 2009). Target molecules were tethered to 
the surface at a density of ~0.1 molecule/µm2, ensuring that most molecules 
were individual, well isolated spots and minimizing clusters. 
After a flow cell was treated with streptavidin and heparin, it was filled 
with ~50 pM target in LSE supplemented with 50 µg∙mL−1 heparin, oxygen 
scavenging system and triplet quenchers. Target deposition was monitored by 
taking a series of images; once the desired density was achieved, the flow cell 
was washed twice with 50 µL LSE supplemented with oxygen scavenging 
system and triplet quenchers. To image RISC binding, continuous acquisition of 
frames was started simultaneously with flowing in RISC solution in LSE buffer 
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supplemented with oxygen scavenging system and triplet quenchers. Typically 
2,000–4,000 frames were collected at 2–10 frames∙s−1. 
Image Analysis 
Image analysis was performed in MATLAB using custom scripts and the 
MATLAB co-localization analysis package (Friedman and Gelles, 2015). Images 
were recorded as uncompressed TIFF files and later merged into stacked TIFF 
files. Lateral drift of the surface was determined for each frame using target 
molecules as fiducial markers. Locations of target molecules were picked in the 
first frame acquired by a fast bandpass filter-based search algorithm (Crocker 
and Grier, 1996). Chosen target locations were visually examined, and locations 
not corresponding to individual target molecules removed. Then, the positions 
of target molecules were determined with higher accuracy by 2D Gaussian 
fitting. The positions of targets were then mapped onto the RISC channel as 
previously described (Friedman et al., 2013). Maps for this procedure were 
created using images of fluorescent streptavidin-labeled microspheres that were 
tethered to the biotinylated slide surface and that emit in both the target and 
RISC channels (40 nm diameter; Life Technologies F-8780). Coordinates of 
target locations in each frame in both the target and RISC channel were 
corrected for lateral drift. Detection of fluorescent spots and co-localization 
analysis in all frames was carried out as described (Friedman et al., 2013), with 
the criterion for target and RISC spot co-localization being within < 1 camera 
  
182 
pixel (160 nm) of the location of each other. This analysis yielded time intervals 
for RISC binding events to each target molecule. The same analysis was carried 
out for “dark” locations on the slide surface that did not contain target 
molecules; these served as a control for non-specific binding of RISC to the 
slide surface. Typically, 400–700 target molecule locations and an equal number 
of “dark” locations were analyzed. 
Correction for Non-Specific Events 
In TIRF-based, single-molecule co-localization experiments, one of the 
interacting molecules must be tethered to a slide surface for its stable 
association with a freely diffusing interaction partner to be visualized as the 
co-localization of their spectrally distinct fluorescent emissions. Despite efforts 
to minimize non-specific binding by coating the slide surface with hydrophilic 
polymers (e.g., polyethylene glycol), a background of non-specific binding is 
always present, and may be high depending on the nature and concentration of 
fluorescent molecules. Both on-rate and off-rate measurements are affected by 
non-specific binding and need to be corrected for the non-specific background. 
In addition, off-rate measurements need to be corrected for photobleaching, 
because RISC departure is indistinguishable from photobleaching. 
On-Rate Correction for Non-Specific Arrivals 
To subtract non-specific arrivals from observed arrivals (a mixture of specific 
and non-specific arrivals), the specific arrivals may be represented in statistical 
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terms as the intersection of two events for a given time bin (e.g., each acquired 
frame): A, a specific arrival occurs, and B, a non-specific arrival has never 
occurred in any of the prior time bins. Probability of event A for time interval 
between t and (t+ Δt), PA(t< T< (t+ Δt)), is given by f!(t) ∙ Δt , where f!(t) is the 
probability density function (PDF), and Δt is a small time interval. For a single 
exponential process, f!(t) = 𝑘! · exp(−𝑘! · t), where k! is the rate constant for 
specific arrivals. The probability of the event B, PB(T > t), is given by the survival 
function S!"(t) = 1− F!"(t), where F!"(t) is the cumulative distribution function 
(CDF). Assuming a single exponential process for non-specific arrivals, F!"(t) = 1− exp(−𝑘!" · t). F!"(t), and therefore S!"(t) can be obtained from the 
control experiments where “dark” locations that do not contain target molecules 
are selected, and so all RISC arrivals must be non-specific. 
Conversely, non-specific arrivals can be represented as the intersection 
of events A′ and B′, where A′ is the event where a non-specific arrival occurs in 
the time interval t < T < (t + Δt), and B′ is the event where a specific arrival has 
never occurred in any of the prior intervals. Assuming that non-specific arrivals 
follow exponential distribution, probability of A′ is given by Δt · f!"(t) = Δt · 𝑘!" ·exp(−𝑘!" · t), and probability of B′ is given by S!(t) = exp(−𝑘! · t), where f!" t  
is the PDF for non-specific arrivals, and S!(t) is the survival function for specific 
arrivals, and k
NS
 is the rate constant for non-specific arrivals. 
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Since A and B are independent events, their joint probability is the 
product of their probabilities: 
P(A⋃B) = P(A) · P(B) = Δt · 𝑘! · exp (−k! · t) · exp (−𝑘!" · t))  = Δt · 𝑘! · exp (−(𝑘! + 𝑘!") · t)  
The same is true for A′ and B′, and 
P(A′⋃B′) = P(A′) · P(B′) = Δt · 𝑘!" · exp (−𝑘!" · t) · exp (−𝑘! · t))  = Δt · 𝑘!" · exp (−(𝑘! + 𝑘!") · t)  
In our experiments to measure on-rate, only the first arrival at each target 
location is counted, and this arrival can be either specific, or non-specific. 
Therefore, the probability to count any arrival in a given time interval is the union 
of A⋃B  and A′⋃B′ and is given by 
𝑃!"# = P A⋃B ⋃ A′⋃B′ = P(A) · P(B) + P(A′) · P(B′) = (𝑘! +𝑘!") · Δt · exp(−(𝑘! + 𝑘!") · t)  
Therefore the corresponding PDF for experimental (mixed specific and non-
specific) arrivals is 
f!"#(t) = (k! + 𝑘!") · exp(−(𝑘! + 𝑘!") · t), 
and the CDF is 
F!"# t = 1− exp − 𝑘! + 𝑘!" · t   (1) 
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Thus, the experimentally measured rate is just a sum of specific and non-
specific arrival rates. Therefore the experimental PDF for mixed arrivals can be 
expressed as: 
f!"#(t) = ( 𝑘! + 𝑘!" / 𝑘! ∙ 𝑘!") · f!(t) · f!"(t), 
which turns out not to be a sum but rather a weighted product of specific and 
non-specific PDFs. 
In many cases, we observe that only a fraction of “dark” locations on the 
slide surface that are picked to measure non-specific rates will ever receive non-
specific arrivals, apparently due to non-uniform coating of the slide surface with 
PLL-g-PEG. This fraction (h, for ‘hot’ locations) can be easily determined from 
the amplitude of the cumulative binding curve for non-specific arrivals. Using the 
same reasoning as before, we can show that in this case the experimental CDF 
for mixed arrivals is given by 
F!"#(t) = 1− (1− h) · exp(−𝑘! · t) − h · exp(−(𝑘! + 𝑘!") · t) (2) 
Each on-rate measurement was analyzed by picking two sets of locations:  first, 
specific locations where a target molecule was seen, and second, non-specific 
locations that did not contain target molecules. The waiting times before first 
RISC arrival in all locations were measured and converted into cumulative form 
C(t), where for each waiting time t, arrivals that occurred before t were summed 
to make up the cumulative number of arrivals. For the non-specific arrivals, the 
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rate (k
NS
), and where applicable, the fraction of locations that exhibited non-
specific arrivals (h) was determined from single-exponential fitting: 
C!"(t) = h · N!" · (1− exp(−𝑘!" · t)),  
where N
NS
 is the number of non-specific locations picked for analysis. 
Next, the specific rate for RISC arrivals to the target-specific locations 
was determined by curve fitting using the known values of h and k
NS
: 
C!(t) = N! · F!"#(t),  
where N
S
 is the number of target-specific locations that bind RISC (determined 
from fitting), and F!"#(t) is given by (2). 
Off-Rate Correction for Non-Specific Events 
Some of the observed RISC binding events are false and come from non-
specific binding to the surface fortuitously close enough to the target location to 
be counted as specific binding according to our co-localization criteria. The 
apparent cumulative counts of RISC dissociation events are the sum of counts 
from target-specific RISC events and non-specific events: 
𝐶!"# ! = 𝐶!"#$ 𝑡 + 𝐶!" 𝑡   
where 𝐶!"(𝑡) corresponds to counts for RISC molecules bound non-specifically 
in target locations, and their contribution can be determined using “dark” 
locations. We find that these non-specific events display double-exponential 
kinetics, and: 
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𝐶!" 𝑡 = 𝐴(1− exp (𝑘!"! ∙ 𝑡))+ 𝐵(1− exp (𝑘!"! ∙ 𝑡)), 
where 𝑘!"! and 𝑘!"! are rates for non-specifically bound RISC, and A and B are 
their respective amplitudes. We find that RISC dissociation kinetics corrected for 
non-specific binding follows a single exponential, and the expression for fitting 
experimentally observed cumulative dissociation counts is given by 𝐶!"# 𝑡 = 𝑁!"#$ ∙ (1− exp −𝑘!"#$ ∙ 𝑡 )+ 𝐴(1− exp (𝑘!"! ∙ 𝑡))+ 𝐵(1−exp (𝑘!"! ∙ 𝑡)), 
where 𝑁!"#$ is amplitude for specific RISC events, 𝑘!"#$ is their rate, and the rest 
of parameters are determined from the fitting of data for “dark” locations.
Off-Rate Correction for Photobleaching 
Equation (1), which was used to correct the on-rates for non-specific RISC 
binding, is also applicable to correcting RISC dwell times for photobleaching, 
since binding and photobleaching are independent processes and have 
characteristic exponential rates. Therefore, the observed cumulative rate for the 
apparent dwell times of RISC is given by 
F!"# t = 1− exp − 𝑘!!!"!#$%&'!!"# + 𝑘!"#$ · t , (3) 
where 𝑘!"#$ is the dissociation rate of target-bound RISC, corrected for non-
specific events as described above, and kphotobleaching is the rate of 
photobleaching. The photobleaching rate under our standard imaging conditions 
was determined in two ways. First, because the dwell times of RISC bound to 
the seed-matched target (Figure S3.5C) was of the order of hundreds of 
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seconds, the apparent dwell times were clearly limited by photobleaching. From 
this data, we determined a photobleaching rate of ~0.06 s−1 under our standard 
acquisition conditions. Second, the same analysis was carried out for the target 
that was fully complementary to the guide in RISC using those molecules that 
were bound by RISC but remained uncleaved in the experiments shown in 
Figure 3.5B; RISC molecules bound to these targets were eventually 
photobleached. Both approaches produced the same photobleaching rate. We 
conclude that our photobleaching rate was reproducible between experiments, 
and that 𝑘!!!"!#$%&'!!"# ≈ 0.06 s−1. Experiments performed to obtain koff for RISC 
bound to 3′ product mimics, seed + t9, and seed + t9t10 targets were 
performed under low time-resolution conditions (1.5 frames∙s−1) where our 
photobleaching rate was determined to be ~0.005 s−1. To obtain the corrected 
dissociation rate for RISC, the known photobleaching rate was subtracted from 
the observed dissociation rate for RISC.
Nearest Neighbor Analysis 
∆G37˚C = −RT ln(1/KD), where R = 1.987 cal∙K−1∙mol−1 and T = 310.15 K. 
Theoretical ∆G37˚C was calculated from nearest neighbor values using 
RNAstructure 5.6 (Reuter and Mathews, 2010; Turner and Mathews, 2010). 
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Figure S3.1: Controls and Concentration Determination for mouse AGO2 
(A) Pre-steady state kinetics was used to estimate the active concentration of 
let‑7a-RISC. The substrate concentration used for unlabeled RISC was 200 nM 
(n = 3). For both RISC preparation 1 (n = 5) and preparation 2 (n = 3), 100 nM 
substrate was used in the assay. Values are mean ± S.D.; the equation used to 
fit each curve is shown below the table. (B) Image representing the selection 
(blue squares around molecules) of the RNA targets used to analyze RISC 
activity. These selections are referred to as areas of interest (AOIs).  
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Figure S3.2: Argonaute Binds to Its Target Faster than Guide Strand Alone  
Binding curves for mouse AGO2 or TtAgo compared to guide strand alone. Solid 
markers: the cumulative number of molecules binding for the first time to a 
single RNA or DNA target. Open markers: the cumulative number of molecules 
binding to regions of slide surface that did not contain an RNA or DNA target. 
The curve in red shows the rate of binding after correcting for non-specific 
binding. 
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Figure S3.3: Rastergrams for Mouse AGO2 to RNA or DNA Targets 
Rastergram summary of traces of individual targets molecules for different 
guide:target pairings for mouse AGO2. A representative rastergram is shown for 
each of the experiments performed with canonical let‑7a RNA targets and 
miR‑21 perfect RNA target. 
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Figure S3.4: Activity, Concentration determination, and Rastergrams for 
Thermus thermophilus Argonaute for DNA and RNA targets 
(A) Target cleavage by of TtAgo at 37˚C, 55˚C, and 75˚C. A 5ʹ′ 32P-radiolabeled 
synthetic DNA or an in vitro transcribed RNA was incubated with purified 
let‑7a-guided TtAgo-RISC. TtAgo cleavage activity after 1 h at 37˚C was 
~2 nM for either RNA or DNA, which is less than a single turnover (~ 35 nM 
let‑7a-TtAgo was used). A digital over-exposure is shown below the linear 
exposure of the gel. (B) Stoichiometric target DNA binding analysis of TtAgo 
RISC guided with a 16 nt DNA corresponding to the first 16 nt of let‑7a. 
(C) Rastergram summary of traces of individual target molecules for different 
guide:target pairings for Thermus thermophilus Argonaute bound to a 16-nt DNA 
guide. 
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Figure S3.5: Mouse AGO2-RISC Binding to and Departing from Partially 
Paired or Seed-Mismatched Targets 
(A) At left, rastergrams for let‑7a-guided RISC binding to a non-complementary 
target (magenta on blue, with target) or the slide surface (red on white, with no 
target). At right, cumulative binding of let‑7a-guided RISC to a 
non-complementary target. Curve in black is the fit to the cumulative distribution 
after subtracting non-specific binding. No binding was detected for an RNA 
target without complementarity to the let‑7a guide strand. (B) Cumulative 
binding curves for targets with disrupted pairing to let‑7a mouse RISC. 
Seed-matched targets bearing dinucleotide mismatches to the seed (red), target 
pairing t11-t21 (orange represents mouse AGO2-RISC and teal represents RNA 
alone), perfectly paired target with dinucleotide mismatch to g4g5 (green). 
(C) Determination of koff for let‑7a-RISC for seed-matched and seed-matched 
plus 3ʹ′ supplementary pairing targets. koff for both targets was slower than the 
rate of photobleaching (k = 0.06 s−1, τ ~17 s) in our standard acquisition 
conditions. To determine koff for let‑7a-RISC, the amount of laser exposure was 
varied by changing the frame rate. The y-intercept for apparent koff versus laser 
exposure was taken to be koff. (D) Measuring koff for miR‑21-RISC for seed-
matched target, seed-matched target containing three 2,6 diaminopurine 
nucleotides (Dap) in place of adenosines, and seed-matched plus four 
3ʹ′ complementary nucleotides targets. Predicted ΔΔG was determined by 
nearest neighbor analysis. koff was corrected for the rate of photobleaching. 
Measured ΔΔG was calculated from the experimentally determined 
on- and off-rates: ΔΔG = ΔG − ΔGseed-match = RTln(KD / KD
seed-match) where 
KD = koff / kon. 
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Figure S3.6: Comparison of Target length and kon for let‑7a AGO2-RISC. 
The kon for let‑7a AGO2-RISC was measured under standard conditions at 37°C. 
The 28 nt RNA targets contained a single Alexa647 dye at the 3′ end and were 
attached to the slide via biotin streptavidin (Table S3.1). Target cleavage was not 
measured because the perfect target contained 2′-O-methyl at t10 and t11 and 
contained a phosphorothioate linkage between t10 and t11. 
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Figure S3.7: Target Mismatches to the Seed Decrease AGO2-RISC kon and 
Increase koff 
Comparison of let‑7a-guided AGO2-RISC binding to targets with dinucleotide 
mismatches to the seed sequence. The nucleotides present in the seed 
mismatched positions are indicated for each value. Error bars represent the 
propagated error determined from the comparison of seed mismatch over 
complete seed only pairing (black bar). Relative ΔΔG37˚C was predicted by 
nearest neighbor analysis (Materials and Methods). 
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Figure S3.8: Seed Base-Pairing Stability Determines Product Release 
(A) Schematic of RNAi and the two product release steps. (B) Cumulative 
product release of 5ʹ′ or 3ʹ′ cleavage products after RNAi. (C) Schematic of RNAi 
reaction model. To account for additional steps that may explain k rate the 
addition of a conformation step that represents the two-state model (Tomari and 
Zamore, 2005) and chemistry step for endonucleolytic cleavage is expressed in 
the schematic while representing the two different branches of product release. 
“E” represents AGO2-RISC, when E is red it is in the first state, ready for target 
binding and when E is magenta it is in the second state conformation or 
cleavage competent conformation. “S” represents the substrate, uncleaved 
target and “P” represents cleavage products (subscript denotes 5′ or 3′). The k 
rate measured by global fit analysis is k = k1 (conformation change) + k2 
(chemistry). The rate of returning to the first state, RISC in target finding mode is 
represented by k3. Note: that the reverse reaction of cleavage, ligation, is 
unreported/unknown with Argonaute proteins, this is denoted by k−2 and the thin 
arrow.
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Table S3.1: RNAs and DNAs used in this study.
Synthetic guide strand 
description 
Sequence 
Passenger, guide, DNA guide, seed, 
m indicates 2′-O-methyl ribose; p indicates 5′ monophosphate Bio, 
Biotin-6-carbon spacer; *, phosphorothioate 
Passenger strand for unlabeled let-7a RISC pUAU ACA ACC UAC UAC CUC CUU 
Guide strand for unlabeled let-7a RISC pUGA GGU AGU AGG UUG UAU AGU 
Passenger strand for Alexa let-7a RISC mUAU ACA ACC UAC UAC CUG CUU 
Guide strand for Alexa let-7a RISC pUGA GGU AGU AGG UUG UAU AGU-NH2 
DNA guide strand with first 16 nt of let-7a pTGA GGT AGT AGG TTG T 
DNA guide strand with first 16 nt of let-7a for 
Alexa labeling pTGA GGT AGT AGG TTG T-NH2 
Passenger strand for Alexa miR-21 RISC mACA UCA GUC UGA UAA GCA UUU 
Guide strand for Alexa miR-21 RISC pUAG CUU AUC AGA CUG AUG UUG-NH2 
28 nt let‑7a perfect RNA target Bio-GAU ACU AUA CAA CmC*mU ACU ACC UCA ACC U-NH2 
28 nt let‑7a seed only target Bio-GAA AAA AAA AAA AAA UCU ACC UCU AAA U-NH2 
Synthetic guide strand 
description 
Sequence 
RNA, DNA; m, 2′-O-methyl; p, 5′ phosphate; 
Bio, Biotin-6-carbon spacer; RISC-binding site; 
2′-N-U, Uridine with 2′ amine; Dap, 2,6 diaminopurine 
Capture Oligo to affinity purify let-7a RISC Bio-mAmUmA mGmAmC mUmGmC mGmAmC mAmAmU mAmGmC mCmUmA mCmCmU mCmCmG mAmAmC mG 
DNA competitor to elute let-7a RISC CGT TCG GAG GTA GGC TAT TGT CGC AGT CTA T-Bio 
Capture Oligo to affinity purify miR-21 RISC Bio-mGmAmU mGmAmA mCmCmA mCmUmC mAmGmA mGmAmC mAmUmA mAmGmC mUmAmA mUmCmU mA 
DNA competitor to elute miR-21 RISC TAG ATT AGC TTA TGT CTC TGA GTG GTT CAT C-Bio 
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Forward primer to generate templates for T7 
transcription of let-7a target RNAs GCG TAA TAC GAC TCA CTA TAG GGT TTT AAT GAA TAC GAT TT 
Reverse primer to generate template for T7 
transcription of fully complementary let-7a 
target 
CCC ATT TAG GTG ACA CTA TAG ATT TAT ACC TAG TTA AAC AGC GGA ACT 
GTG TAT AAA AGG TTG AGG TAG TAG GTT GTA TAG TAT CCA GAG GAA TTC 
ATT ATC AGT G 
Reverse primer to generate template for T7 
transcription of seed-matched let-7a target 
CCC ATT TAG GTG ACA CTA TAG ATT TAT ACC TAG TTA AAC AGC GGA ACT 
GTG TAT AAA AGG TTG AGG TAG ATC CAA CAT ATC AAT CCA GAG GAA TTC 
ATT ATC AGT G 
Reverse primer to generate template 
for T7 transcription of target with seed match 
plus 3′ supplementary pairing to let-7a 
CCC ATT TAG GTG ACA CTA TAG ATT TAT ACC TAG TTA AAC AGC GGA ACT 
GTG TAT AAA AGG TTG AGG TAG ATC CTT GTT ATC AAT CCA GAG GAA TTC 
ATT ATC AGT G 
Reverse primer to generate template for T7 
transcription of t2t3 seed-mismatched let-7a 
target 
CCC ATT TAG GTG ACA CTA TAG ATT TAT ACC TAG TTA AAC AGC GGA ACT 
GTG TAT AAA AGG TTC TGG TAG ATC CAA CAT ATC AAT CCA GAG GAA TTC 
ATT ATC AGT G 
Reverse primer to generate template for T7 
transcription of t3t4 seed-mismatched let-7a 
target 
CCC ATT TAG GTG ACA CTA TAG ATT TAT ACC TAG TTA AAC AGC GGA ACT 
GTG TAT AAA AGG TTG TCG TAG ATC CAA CAT ATC AAT CCA GAG GAA TTC 
ATT ATC AGT G 
Reverse primer to generate template for T7 
transcription of t4t5 seed-mismatched let-7a 
target 
CCC ATT TAG GTG ACA CTA TAG ATT TAT ACC TAG TTA AAC AGC GGA ACT 
GTG TAT AAA AGG TTG ATT TAG ATC CAA CAT ATC AAT CCA GAG GAA TTC 
ATT ATC AGT G 
Reverse primer to generate template for T7 
transcription of t5t6 seed-mismatched let-7a 
target 
CCC ATT TAG GTG ACA CTA TAG ATT TAT ACC TAG TTA AAC AGC GGA ACT 
GTG TAT AAA AGG TTG AGC AAG ATC CAA CAT ATC AAT CCA GAG GAA TTC 
ATT ATC AGT G 
Reverse primer to generate template for T7 
transcription of t6t7 seed-mismatched let-7a 
target 
CCC ATT TAG GTG ACA CTA TAG ATT TAT ACC TAG TTA AAC AGC GGA ACT 
GTG TAT AAA AGG TTG AGG ATG ATC CAA CAT ATC AAT CCA GAG GAA TTC 
ATT ATC AGT G 
Reverse primer to generate template for T7 
transcription of t7t8 seed-mismatched let-7a 
target 
CCC ATT TAG GTG ACA CTA TAG ATT TAT ACC TAG TTA AAC AGC GGA ACT 
GTG TAT AAA AGG TTG AGG TTC ATC CAA CAT ATC AAT CCA GAG GAA TTC 
ATT ATC AGT G 
  
208 
Reverse primer to generate template for T7 
transcription of t8 seed-mismatched let-7a 
target 
CCC ATT TAG GTG ACA CTA TAG ATT TAT ACC TAG TTA AAC AGC GGA ACT 
GTG TAT AAA AGG TTG AGG TAC ATC CAA CAT ATC AAT CCA GAG GAA TTC 
ATT ATC AGT G 
Reverse primer to generate template for T7 
transcription of seed + t9 let-7a target 
CCC ATT TAG GTG ACA CTA TAG ATT TAT ACC TAG TTA AAC AGC GGA ACT 
GTG TAT AAA AGG TTG AGG TAG TTC CAA CAT ATC AAT CCA GAG GAA TTC 
ATT ATC AGT G 
Reverse primer to generate template for T7 
transcription of seed + t9t10 let-7a target 
CCC ATT TAG GTG ACA CTA TAG ATT TAT ACC TAG TTA AAC AGC GGA ACT 
GTG TAT AAA AGG TTG AGG TAG TAC CAA CAT ATC AAT CCA GAG GAA TTC 
ATT ATC AGT G 
let-7a 3′ product mimic with  
seed matched paring to target pCUA CCU CAA CCU UUU AUA CAC AGU UU(2'-N-U) CCG-Bio 
let-7a 3′ product mimic with  
seed matched +t9 pairing to target pACU ACC UCA ACC UUU UAU ACA CAG UU(2'-N-U) CCG-Bio 
let-7a 3′ product mimic with  
seed matched +t9t10 paring to target pUAC UAC CUC AAC CUU UUA UAC ACA GU(2'-N-U) CCG-Bio 
Reverse primer to generate template 
for T7 transcription 
of fully complementary let7a target 
except for a t4t5 seed-mismatch 
CCC ATT TAG GTG ACA CTA TAG ATT TAT ACC TAG TTA AAC AGC GGA ACT 
GTG TAT AAA AGG TTG ATT TAG TAG GTT GTA TAG TAT CCA GAG GAA TTC 
ATT ATC AGT G 
Reverse primer to generate template 
for T7 transcription of 
non-complementary target 
CCC ATT TAG GTG ACA CTA TAG ATT TAT ACC TAG TTA AAC AGC GGA ACT 
GTG TAT AAA AGG TTT AGC TAT AAT GAA ATG CCT TAT CCA GAG GAA TTC 
ATT ATC AGT G 
Reverse primer to generate template for T7 
transcription of target complementary to 3′ 
half of let-7a 
CCC ATT TAG GTG ACA CTA TAG ATT TAT ACC TAG TTA AAC AGC GGA ACT 
GTG TAT AAA AGG TTT TTT TTT TTG GTT GTA TAG TAT CCA GAG GAA TTC 
ATT ATC AGT G 
5′-biotin-labeled, fully complementary 
let-7a DNA target 
Bio-GGG TTT TAA TGA ATA CGA TTT TGT ACC AGA GTC CTT TGA TCG TGA 
CAA AAC AAT TGC ACT GAT AAT GAA TTG GTC TGG ATA CTA TAC AAC CTA 
CTA CCT CAA CCT TTT ATA CAC AGT TCC GCT GTT TAA CTA GAT GT 
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5′-biotin-labeled, seed-matched 
let-7a DNA target 
Bio-GGG TTT TAA TGA ATA CGA TTT TGT ACC AG AGT CCT TTG ATC GTG 
ACA AAA CAA TTG CAC TGA TAA TGA ATT CCT CTG GAT TGA TAT GTT GGA 
TCT ACC TCA ACC TTT TAT ACA CAG TTC CGC TGT TTA ACT AGA TGT 
DNA target with 5′-biotin 
and seed-match plus 
3′ supplementary pairing to let-7a 
Bio-GGG TTT TAA TGA ATA CGA TTT TGT ACC AGA GTC CTT TGA TCG TGA 
CAA AAC AAT TGC ACT GAT AAT GAA TTC CTC TGG ATT GAT AAC AAG GAT 
CTA CCT CAA CCT TTT ATA CAC AGT TCC GCT GTT TAA CTA GAT GT 
Synthetic DNA-RNA for attaching 
Alexa DNA piece to 5′ end of IVT targets pTGT CAC CTA GAT CGA UGA AUU CCU CUG GAU CAC ACA CAA AAA AAA 
Splint for DNA-RNA ligation TAT TCA TTA AAA CCC TTT TTT TTG TGT GTG  
Splint for ligation of Alexa647 DNA to 5′ end of 
RNA target (3′ bound target) CTA GGT GAC AGT GGT TGG GT 
Forward primer for miR-21 perfect target GCG TAA TAC GAC TCA CTA TAG GGG TCC TTT GAT CGT GAC AAA ACA AT 
Reverse primer for miR-21 perfect target 
CCC ATT TAG GTG ACA CTA TAG ATT TAC ATC TAG TTG AGG TGC GGA ACT 
GTG TAT AAA AGG TTA GCT TAT CAG ACT GAT GTT GAA TCC AGA GGA ATT 
CAT TAT CAG TG 
miR-21 seed only target Bio-GAU AAA AAA AAA AAA AAU AAG CUA ACC U.NH2 
miR-21 seed only containing 
2,6 Diaminopurine target Bio-GAU AAA AAA AAA AAA ADapU DapDapG CUA ACC U.NH2 
miR-21 seed + 
3′ supplementary target Bio-GAU AAA AAU CAG AAA AAU AAG CUA ACC U.NH2 
RNA oligo for La binding P.CGC GGC GCC UAC UAC CUC UUU  
Gapmer to direct 3′ end trimming 
with RNase H mCmAmC mUmAmU mAmGA TTT mAmCmA mUmCmU mAmG 
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Substrates 
Sequence 
RNA, DNA; BioG, 5′-Biotin-G; Bio, Biotin-6-carbon spacer;  
U, Alexa Fluor 647 deoxyuridine; target site/pairing to RISC 
2′-N-U, Uridine with 2′ amine; Dap, 2,6 diaminopurine p, 5′ phosphate 
Klenow polymerase template 
to synthesize 3′ DNA extension 
containing 17 Alexa Fluor 647 dyes 
ATT GTT GTT ATT GTT GTT ATT GTT GTT ATT GTT GTT ATT GTT GTT ATT 
GTT GTT ATT GTT GTT ATT GTT GTT ATT GTT GTT ATT GTT GTT ATT GTT 
GTT ATT GTT GTT ATT GTT GTT ATT GTT GTT ATT GTT GTT ATT GTT GTT 
ATT TAT TTA CAT CTA GTT GAG GTG CGG AAC TG 
Trap oligonucleotide 
for the preceding template 
(fully complementary) 
CAG TTC CGC ACC TCA ACT AGA TGT AAA TAA ATA ACA ACA ATA ACA ACA 
ATA ACA ACA ATA ACA ACA ATA ACA ACA ATA ACA ACA ATA ACA ACA ATA 
ACA ACA ATA ACA ACA ATA ACA ACA ATA ACA ACA ATA ACA ACA ATA ACA 
ACA ATA ACA ACA ATA ACA ACA ATA ACA ACA AT 
Klenow polymerase template for the synthesis 
of a short 3′ DNA extension with a single biotin GTT TAT TTA CAT CTA GTT GAG GTG CGG AAC TG 
Klenow polymerase template for the synthesis 
of single-stranded DNA extension 
containing 17 Alexa Fluor 647 dyes 
ATT GTT GTT ATT GTT GTT ATT GTT GTT ATT GTT GTT ATT GTT GTT ATT 
GTT GTT ATT GTT GTT ATT GTT GTT ATT GTT GTT ATT GTT GTT ATT GTT 
GTT ATT GTT GTT ATT GTT GTT ATT GTT GTT ATT GTT GTT ATT GTT GTT 
AGG GTT TTA ATG AAT ACG ATT TTG TAC CAG AGT CC 
DNA primer for the preceding template GGA CTC TGG TAC AAA ATC GTA TTC ATT AAA ACC C 
Trap oligonucleotide for the preceding 
template (fully complementary) 
GGA CTC TGG TAC AAA ATC GTA TTC ATT AAA ACC CTA ACA ACA ATA ACA 
ACA ATA ACA ACA ATA ACA ACA ATA ACA ACA ATA ACA ACA ATA ACA ACA 
ATA ACA ACA ATA ACA ACA ATA ACA ACA ATA ACA ACA ATA ACA ACA ATA 
ACA ACA ATA ACA ACA ATA ACA ACA ATA ACA ACA AT 
5′-tethered, target with complete 
complementarity to a let-7a and a 3′ DNA 
extension containing 17 Alexa Fluor 647 dyes  
Bio-GGG UUU UAA UGA AUA CGA UUU UGU ACC AGA GUC CUU UGA UCG UGA 
CAA AAC AAU UGC ACU GAU AAU GAA UUC CUC UGG AUA CUA UAC AAC CUA 
CUA CCU CAA CCU UUU AUA CAC AGU UCC GCU GUU UAA CUA GAU GUA AAU 
AAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA 
UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA 
CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA 
CAA U 
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5′-tethered, target with a let-7a seed-match 
and a 3′ DNA extension containing 17 Alexa 
Fluor 647 dyes 
BioG-GGU UUU AAU GAA UAC GAU UUU GUA CCA GAG UCC UUU GAU CGU GAC 
AAA ACA AUU GCA CUG AUA AUG AAU UCC UCU GGA UUG AUA UGU UGG AUC 
UAC CUC AAC CUU UUA UAC ACA GUU CCG CUG UUU AAC UAG GUA UAA AUA 
AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU 
AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC 
AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC 
AAU 
5′-tethered, target with a let-7a seed-match 
plus 3′ supplementary pairing and a 3′ DNA 
extension containing 17 Alexa Fluor 647 dyes 
BioG-GGU UUU AAU GAA UAC GAU UUU GUA CCA GAG UCC UUU GAU CGU GAC 
AAA ACA AUU GCA CUG AUA AUG AAU UCC UCU GGA UUG AUA ACA AGG AUC 
UAC CUC AAC CUU UUA UAC ACA GUU CCG CUG UUU AAC UAG AUG UAA AUA 
AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU 
AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC 
AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC 
AAU 
5′-tethered, non-complementary target with 3′ 
DNA extension containing 17 Alexa Fluor 647 
dyes 
BioG-GGU UUU AAU GAA UAC GAU UUU GUA CCA GAG UCC UUU GAU CGU GAC 
AAA ACA AUU GCA CUG AUA AUG AAU UCC UCU GGA UAA GGC AUU UCA UUA 
UAG CUA AAC CUU UUA UAC ACA GUU CCG CUG UUU AAC UAG GUA UAA AUA 
AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU 
AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC 
AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC 
AAU  
5′-tethered target with a let-7a seed-match but 
for a t2t3:g2g3 mismatch and a 3′ DNA 
extension containing 17 Alexa Fluor 647 dyes 
BioG-GGU UUU AAU GAA UAC GAU UUU GUA CCA GAG UCC UUU GAU CGU GAC 
AAA ACA AUU GCA CUG AUA AUG AAU UCC UCU GGA UUG AUA UGU UGG AUC 
UAC CGA AAC CUU UUA UAC ACA GUU CCG CUG UUU AAC UAG GUA UAA AUA 
AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU 
AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC 
AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC 
AAU 
5′-tethered target with a let-7a seed-match but 
for a t3t4:g3g4 mismatch and a 3′ DNA 
extension containing 17 Alexa Fluor 647 dyes 
BioG-GGU UUU AAU GAA UAC GAU UUU GUA CCA GAG UCC UUU GAU CGU GAC 
AAA ACA AUU GCA CUG AUA AUG AAU UCC UCU GGA UUG AUA UGU UGG AUC 
UAC AGC AAC CUU UUA UAC ACA GUU CCG CUG UUU AAC UAG GUA UAA AUA 
AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU 
AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC 
AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC 
AAU  
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5′-tethered target with a let-7a seed-match but 
for a t4t4:g4g5 mismatch and a 3′ DNA 
extension containing 17 Alexa Fluor 647 dyes 
BioG-GGU UUU AAU GAA UAC GAU UUU GUA CCA GAG UCC UUU GAU CGU GAC 
AAA ACA AUU GCA CUG AUA AUG AAU UCC UCU GGA UUG AUA UGU UGG AUC 
UAA AUC AAC CUU UUA UAC ACA GUU CCG CUG UUU AAC UAG GUA UAA AUA 
AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU 
AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC 
AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC 
AAU  
5′-tethered target with a let-7a seed-match but 
for a t5t6:g5g6 mismatch and a 3′ DNA 
extension containing 17 Alexa Fluor 647 dyes 
BioG-GGU UUU AAU GAA UAC GAU UUU GUA CCA GAG UCC UUU GAU CGU GAC 
AAA ACA AUU GCA CUG AUA AUG AAU UCC UCU GGA UUG AUA UGU UGG AUC 
UUG CUC AAC CUU UUA UAC ACA GUU CCG CUG UUU AAC UAG GUA UAA AUA 
AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU 
AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC 
AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC 
AAU  
5′-tethered target 
with a let-7a seed-match 
but for a t6t7:g6g7 mismatch 
and a 3′ DNA extension 
containing 17 Alexa Fluor 647 dyes 
BioG-GGU UUU AAU GAA UAC GAU UUU GUA CCA GAG UCC UUU GAU CGU GAC 
AAA ACA AUU GCA CUG AUA AUG AAU UCC UCU GGA UUG AUA UGU UGG AUC 
AUC CUC AAC CUU UUA UAC ACA GUU CCG CUG UUU AAC UAG GUA UAA AUA 
AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU 
AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC 
AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC 
AAU  
5′-tethered, target 
containing a seed-match to let-7a 
but for a t7t8:g7g8 mismatch 
and a 3′ DNA extension 
containing 17 Alexa Fluor 647 dyes 
BioG-GGU UUU AAU GAA UAC GAU UUU GUA CCA GAG UCC UUU GAU CGU GAC 
AAA ACA AUU GCA CUG AUA AUG AAU UCC UCU GGA UUG AUA UGU UGG AUG 
UAC CUC AAC CUU UUA UAC ACA GUU CCG CUG UUU AAC UAG GUA UAA AUA 
AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU 
AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC 
AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC 
AAU 
5′-tethered, target containing a seed-match to 
let-7a but for a t8:g8 mismatch and a 3′ DNA 
extension containing 17 Alexa Fluor 647 dyes 
BioG-GGU UUU AAU GAA UAC GAU UUU GUA CCA GAG UCC UUU GAU CGU GAC 
AAA ACA AUU GCA CUG AUA AUG AAU UCC UCU GGA UUG AUA UGU UGG AUG 
UAC CUC AAC CUU UUA UAC ACA GUU CCG CUG UUU AAC UAG GUA UAA AUA 
AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU 
AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC 
AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC 
AAU 
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5′-tethered, target with a let-7a seed-match 
+t9 and a 3′ DNA extension containing 17 
Alexa Fluor 647 dyes 
BioG-GGU UUU AAU GAA UAC GAU UUU GUA CCA GAG UCC UUU GAU CGU GAC 
AAA ACA AUU GCA CUG AUA AUG AAU UCC UCU GGA UUG AUA UGU UGG AAC 
UAC CUC AAC CUU UUA UAC ACA GUU CCG CUG UUU AAC UAG GUA UAA AUA 
AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU 
AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC 
AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC 
AAU 
5′-tethered, target with a let-7a seed-match 
+t9t10 and a 3′ DNA extension containing 17 
Alexa Fluor 647 dyes 
BioG-GGU UUU AAU GAA UAC GAU UUU GUA CCA GAG UCC UUU GAU CGU GAC 
AAA ACA AUU GCA CUG AUA AUG AAU UCC UCU GGA UUG AUA UGU UGG UAC 
UAC CUC AAC CUU UUA UAC ACA GUU CCG CUG UUU AAC UAG GUA UAA AUA 
AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU 
AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC 
AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC 
AAU 
let-7a 3′ product mimic with  
seed matched paring to target pCUA CCU CAA CCU UUU AUA CAC AGU UU(2'-N-Alexa647-U) CCG-Bio 
let-7a 3′ product mimic with  
seed matched +t9 pairing to target pACU ACC UCA ACC UUU UAU ACA CAG UU(2'-N- Alexa647-U) CCG-Bio 
let-7a 3′ product mimic with  
seed matched +t9t10 paring to target pUAC UAC CUC AAC CUU UUA UAC ACA GU(2'-N-Alexa647-U) CCG-Bio 
5′-tethered, target with a complete 
complementarity to let-7a except for a 
dinucleotide mismatch to the let-7a seed 
and a 3′ DNA extension containing 17 Alexa 
Fluor 647 dyes 
Bio-GGG UUU UAA UGA AUA CGA UUU UGU ACC AGA GUC CUU UGA UCG UGA 
CAA AAC AAU UGC ACU GAU AAU GAA UUC CUC UGG AUA CUA UAC AAC CUA 
CUA AAU CAA CCU UUU AUA CAC AGU UCC GCU GUU UAA CUA GGU AUA AAU 
AAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA 
UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA 
CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA 
CAA U 
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5′-tethered, target with complementarity to the 
3′ half of let-7a 
and a 3′ DNA extension 
containing 17 Alexa Fluor 647 dyes 
BioG-GGU UUU AAU GAA UAC GAU UUU GUA CCA GAG UCC UUU GAU CGU GAC 
AAA ACA AUU GCA CUG AUA AUG AAU UCC UCU GGA UAC UAU ACA ACC AAA 
AAA AAA AAC CUU UUA UAC ACA GUU CCG CUG UUU AAC UAG AUG UAA AUA 
AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU 
AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC 
AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC 
AAU 
5′-tethered, DNA target with complete 
complementarity to let-7a and a 3′ DNA 
extension containing 17 Alexa Fluor 647 dyes 
Bio-GGG TTT TAA TGA ATA CGA TTT TGT ACC AGA GTC CTT TGA TCG TGA 
CAA AAC AAT TGC ACT GAT AAT GAA TTG GTC TGG ATA CTA TAC AAC CTA 
CTA CCT CAA CCT TTT ATA CAC AGT TCC GCT GTT TAA CTA GAT GTA AAU 
AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC 
AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC 
AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU 
5′-tethered, DNA target with let-7a seed-
match and a 3′ DNA extension containing 17 
Alexa Fluor 647 dyes 
Bio-GGG TTT TAA TGA ATA CGA TTT TGT ACC AGA GTC CTT TGA TCG TGA 
CAA AAC AAT TGC ACT GAT AAT GAA TTC CTC TGG ATT GAT ATG TTG GAT 
CTA CCT CAA CCT TTT ATA CAC AGT TCC GCT GTT TAA CTA GAT GTA AAU 
AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC 
AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC 
AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU 
5′-tethered, DNA target with let-7a seed-
match plus 3′ supplementary pairing and a 3′ 
DNA extension containing 17 Alexa Fluor 647 
dyes 
Bio-GGG TTT TAA TGA ATA CGA TTT TGT ACC AGA GTC CTT TGA TCG TGA 
CAA AAC AAT TGC ACT GAT AAT GAA TTC CTC TGG ATT GAT AAC AAG GAT 
CTA CCT CAA CCT TTT ATA CAC AGT TCC GCT GTT TAA CTA GAT GTA AAU 
AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC 
AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC 
AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU AAC AAC AAU 
Single-stranded DNA containing 17 Alexa 
Fluor 647 dyes used to make 3′-tethered 
targets 
CGT AGA CGC TCT TTT CAG CCA UAA CAA CAA UAA CAA CAA UAA CAA CAA 
UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA 
CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA 
CAA UAA CAA CAA UAA CAA CAA UCC CAC CCC CAA ACC CAA CCA C 
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3′-tethered, fully complementary 
let-7a target containing a 5′ 
single-stranded DNA extension 
containing 17 Alexa Fluor 647 dyes 
(added by ligation) 
CGT AGA CGC TCT TTT CAG CCA UAA CAA CAA UAA CAA CAA UAA CAA CAA 
UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA 
CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA 
CAA UAA CAA CAA UAA CAA CAA UCC CAC CCC CAA ACC CAA CCA CTG TCA 
CCT AGA TCG AUG AAU UCC UCU GGA UCA CAC ACA AAA AAA AGG GUU UUA 
AUG AAU ACG AUU UUG UAC CAG AGU CCU UUG AUC GUG ACA AAA CAA UUG 
CAC UGA UAA UGA AUU CCU CUG GAU ACU AUA CAA CCU ACU ACC UCA ACC 
UUU UAU ACA CAG UUC CGC ACC UCA ACU AGA UGU AAA TAA AC-Bio 
5′-tethered, fully complementary miR-21 target 
containing a 3′ DNA extension containing 17 
Alexa Fluor 647 dyes 
BioG-GGG UCC UUU GAU CGU GAC AAA ACA AUU GCA CUG AUA AUG AAU UCC 
UCU GGA UUC AAC AUC AGU CUG AUA AGC UAA CCU UUU AUA CAC AGU UCC 
GCA CCU CAA CUA GAU GUA AAU AAA UAA CAA CAA UAA CAA CAA UAA CAA 
CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA 
UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA 
CAA CAA UAA CAA CAA UAA CAA CAA U 
miR-21 seed only target Bio-GAU AAA AAA AAA AAA AAU AAG CUA ACC U.NH-Alexa647 
miR-21 seed only containing 
2,6 Diaminopurine target Bio-GAU AAA AAA AAA AAA ADapU DapDapG CUA ACC U.NH-Alexa647 
miR-21 seed + 3′ supplementary target Bio-GAU AAA AAU CAG AAA AAU AAG CUA ACC U.NH-Alexa647 
3′-tethered, fully complementary miR-21 target 
containing 5′-ligated single-stranded DNA 
extension containing 17 Alexa Fluor 647 dyes 
CGT AGA CGC TCT TTT CAG CCA UAA CAA CAA UAA CAA CAA UAA CAA CAA 
UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA 
CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA CAA UAA CAA 
CAA UAA CAA CAA UAA CAA CAA UCC CAC CCC CAA ACC CAA CCA CTG TCA 
CCT AGA TCG AUG AAU UCC UCU GGA UCA CAC ACA AAA AAA AGG GGU CCU 
UUG AUC GUG ACA AAA CAA UUG CAC UGA UAA UGA AUU CCU CUG GAU UCA 
ACA UCA GUC UGA UAA GCU AAC CUU UUA UAC ACA GUU CCG CAC CUC AAC 
UAG AUG UAA AUA AAT AAA C-Bio 
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CHAPTER IV: Perspectives and Future Work 
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Summary 
The Argonaute protein is conserved in all kingdoms of life and it is the core 
effector protein in small regulatory RNA pathways. The study of Argonaute 
enzymology gives us insight into its regulatory roles inside cells but also may tell 
us something about how RNA-guided endonucleases have evolved. The 
Argonaute protein has distinct kinetic features, which it obtains from changing 
the biophysical properties of its bound small RNA guide. These properties 
correlate with the functional role of Argonaute in a given organism or tissue 
types. We sought to understand the initial and terminal steps in small RNA 
regulation in mammals and we have learned how Argonaute proteins have 
specific kinetic features related to their function. This thesis highlights the 
insights we gained with Argonaute and how it can change the biophysical 
properties of nucleic acid. This work is a stimulus to further understand small 
RNA pathways and may reflect a general mechanism of RNA-guided 
endonucleases to which future studies can draw parallels against. 
It’s a duck! No, it’s a plane! No, it is AGO-RISC finding its target! 
In Chapter III, we directly measured the association rate (kon) of mouse 
AGO2-RISC and Thermus thermophilus AGO bound to a small DNA (Figure 3.2 
and Table 3.1). The ability for Argonaute proteins to change the rate of nucleic 
acid hybridization had been previously inferred from structural studies and 
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derived from in vitro ensemble kinetic studies (Ma et al., 2004; Parker et al., 
2005; Wang et al., 2008a; Parker et al., 2009; Elkayam et al., 2012; Nakanishi et 
al., 2012; Wee et al., 2012). Changing the rate of nucleic acid hybridization is a 
fundamental property of the small regulatory RNA pathway since nucleic acid 
hybridization is a slow process and not efficient under physiologic conditions 
(Herschlag, 1991; Herzog and Ameres, 2015). A comparison of the association 
rates (kon) of the small RNA guide alone versus the small RNA guide bound to an 
Argonaute protein shows an acceleration of as much as 250-fold (Figures 3.1 
and 3.2). Both nucleic acid hybridization and RISC target finding use 
three-dimensional diffusion in order to find and bind to their target. Thus, both 
reactions can be influenced by temperature and viscosity; however, nucleic acid 
hybridization is not a diffusion-controlled reaction because of its freely rotating 
nucleotides. As explained in Chapter I and illustrated in Figure 1.6, nucleic acids 
have an entropic penalty associated with hybridization. Rotation of the individual 
nucleotides combined with potential intra- and inter-molecular interactions lead 
to many non-productive collisions and therefore an overall on-rate that is slower 
than diffusion limits. Even though a 21 nt RNA (~7 kDa) is only a fraction of the 
molecular weight of RISC — the 21 nt RNA plus a ~100 kDa protein — the kon 
for RISC is faster (Figure 3.1). This acceleration is attributed to Argonaute 
pre-paying the entropic penalties associated with nucleic acid hybridization by 
pre-organizing a sub-set of the bound small RNA guide to form a pre-helical 
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shape (Ma et al., 2004; Parker et al., 2005; Wang et al., 2008a; Parker et al., 
2009; Elkayam et al., 2012; Nakanishi et al., 2012; Schirle and MacRae, 2012; 
Faehnle et al., 2013). This structural observation has been supported by kinetic 
studies that inferred kon and these values are now confirmed by our direct 
measurements (Figure 3.2 and Table 3.1; Wee et al., 2012; Deerberg et al., 
2013). The protein cradles and anchors this portion of the small RNA guide (g1 
and the seed, g2–g8), Figures 1.4 and 1.5) so that it no longer acts like a nucleic 
acid but more like a RNA-binding domain of a protein. The ‘genius’ of Argonaute 
is that seed is like a modular binding domain that is programmed by the bound 
small RNA. This feature allows Argonaute proteins to have the ability to regulate 
many RNAs and find those targets with nucleotide precision. 
 Another perspective to the small regulatory RNAs that relates to nucleic 
hybridization and entropic penalties is the biogenesis of RISC that typically 
starts from a double-stranded pre-cursor and NOT a single-stranded one. This 
is important for nuclease stability inside the cell, but more importantly, 
double-stranded RNA overcomes potential intra- and inter-molecular 
interactions that single-stranded RNA would make in the cell thus preventing 
RISC formation. The siRNA or miRNA duplex is key to AGO being able to select 
the guide strand or miRNA strand and efficiently assemble it into the protein. 
The revised RISC assembly model proposed by the Tomari lab lends credence 
to this thought since the chaperones keep AGO ‘open for business’ and allow 
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binding of the RNA duplex (Kobayashi and Tomari, 2015). After forming 
pre-RISC, the chaperones are no longer required and Argonaute is able to 
remove one strand to form the RISC with no additional co-factors (Kobayashi 
and Tomari, 2015). This also explains why recombinant Argonaute cannot form 
RISC with a duplex siRNA but rather needs a single-stranded RNA to form RISC 
(Rivas et al., 2005; MacRae et al., 2008). The protein without a small RNA bound 
is either unstable or potentially in a more energetic state that is not conducive 
for binding a RNA duplex (Johnston et al., 2010; Kobayashi and Tomari, 2015). 
Is it possible that the current structural information that is generated by forming 
RISC with a single-stranded guide RNA and recombinant protein misinterpret 
how the guide is positioned in vivo? Future structural studies of affinity purified 
RISC that was assembled in cellular extracts or loaded via chaperone protein 
reconstitution along with recombinant AGO may help us understand if any 
differences exist. Intriguingly, this brings up quandary for small RNA regulation 
since the PIWI clade Argonautes forms RISC via single-stranded RNA. How is 
this possible and/or efficient? How does this pathway overcome the inherent 
problem with assembling single-stranded RNAs? Do RNA-binding proteins exist 
that are associated with the biogenesis machinery and take the place of not 
having a complementary RNA that assists with proper PIWI-RISC formation? 
Future studies to create a biochemical reconstitution extract for piRNAs and 
piRNA biogenesis can hopefully answer this question along with many others. 
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Dwelling on dwell times 
It is remarkable that RISC bound to a seed only target can decrease the 
dissociation rate (koff) by ~14,000-fold when compared to the same target paired 
via seven base pairs of a RNA guide strand alone (Figure 3.3 and Table 3.1). 
Simply put, AGO2-RISC remains bound to a RNA target that only contains 
seven nucleotides of base pairing for nearly 5 minutes at 37°C versus the 
fractions of a second for RNA alone (Figure 3.3). Our results agree well with our 
previous ensemble filter-binding measurements at room temperature (Wee et al., 
2012). Future studies combining TNRC6A (GW182) along with other RNA 
regulatory factors may reveal that this dwell time increases so that 
destabilization and/or translational repression of the RNA target can take place. 
Furthermore, future work in this area will help to address fundamental questions 
related to how miRNA regulate their targets and maybe settle the long-standing 
debate in the field regarding mRNA destabilization and/or translation repression 
as the mode of action. 
While mammalian AGO2 remains bound to seed paired targets for 
minutes, Thermus thermophilus AGO and fly AGO2 only remain bound for only 
seconds (Table 3.1; Wee et al., 2012). The kon for both these Argonaute proteins 
is similar to mammalian AGO2 but why is the mean dwell time so short? Could 
this reflect the evolved functions that each of these Argonautes play inside the 
cell? Argonaute proteins regulate in two manners, either by slicing or by binding 
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to create a scaffold for regulatory factors (Figure 1.1). Thus, we can segregate 
the Argonautes by their function: slicer or non-slicer. Furthermore, there are 
Argonautes that only slice to regulate (e.g., fly AGO2), let’s call them 
‘professional’ slicers and then there slicer Argonautes that can do both binding 
and slicing methods of regulation (e.g., mammalian AGO2), let’s call them 
‘dual-mode’ slicers. In mammals, there is no strict division/sorting of small RNAs 
among the four AGO proteins, since catalytically active or not, each participates 
in the miRNA regulatory pathway (Hutvagner and Simard, 2008). Mammalian 
miRNAs typically do not pair perfectly to their targets; therefore, they never need 
nor can they slice, rather they act as binding scaffolds (Jonas and Izaurralde, 
2015). The one exception is mammalian AGO2 that is a ‘dual-mode’ slicer. 
Primarily, AGO2 binds miRNAs and regulates through a non-slicing pathway but 
it proposed that the retained catalytic activity is required for processing specific 
dicer-independent miRNAs (e.g., mir-451) and plays a role in embryonic 
development (Cheloufi et al., 2010). Meanwhile, ‘professional’ slicers have a 
cellular function to regulate targets with perfect complementarity to their guides. 
This is clear in flies that have small RNA sorting (Ghildiyal et al., 2010); a clear 
example is fly Ago2 which has a role in viral defense (Wang et al., 2006) and it is 
kinetically advantageous for Ago2-RISC not to get ‘distracted’ by targets with 
partial complementarity or seed only pairings that would prevent slicing. On the 
other hand, fly Ago1, the miRNA-specific Argonaute, binds targets with partial 
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complementarity (seed and/or seed + 3′ supplementary pairing) and regulates 
via mRNA destabilization/translation repression. The affinity (KD) to targets for 
‘professional’ slicers versus non-slicers or ‘dual-mode’ slicers have distinctive 
differences. Mammalian AGO2 (a dual-mode slicer) and fly Ago1 (Flores-Jasso 
and Zamore, unpublished) have similar affinities for seed only, seed + 
3′ supplementary, and perfectly paired targets whereas fly AGO2, a professional 
slicer, has a clear preference for perfect targets (Wee et al., 2012). Fly AGO2′s 
affinity for perfect targets is ~4 pM whereas as its KD to seed only paired targets 
is ~200 pM (Wee et al., 2012). Another example of the binding affinity difference 
between ‘professional’ and ‘non-professional’ slicers is seen with TtAgo. There 
are no known miRNAs in Thermus thermophilus but there are small DNAs that 
are hypothesized to have a role in the defense against foreign plasmids (Swarts 
et al., 2014a). The affinity of TtAgo bound with a small DNA to a perfect target is 
~ 10 pM (Jolly and Zamore, unpublished) but similar to fly AGO2, there is a large 
difference to partially paired targets where seed only targets have a KD ~20 nM 
(Table 3.1). The common theme among all of these Argonautes is that the affinity 
to a specific target is congruent with its function. The ‘professional’ slicing 
Argonautes have a greater affinity toward perfect or highly complementary 
targets and Argonautes that primarily regulate without slicing have equivalent 
affinities to any target that contains a miRNA-like pairing or perfect pairing.  
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Seeking out a seed 
Beyond target finding and binding is the remarkable selectivity of Argonautes 
have at distinguishing partial seed pairing versus full seed paring. We performed 
a series of experiments with seed only targets that contained dinucleotide 
mismatches starting from t2 going through end of the seed, t8 (Figure 3.3). 
Nucleic acid hybridization rules would dictate that central mismatches are 
expected to be the most detrimental as they would break the half turn of the 
helix and terminal mismatches would have a less deleterious effect (Figure S3.7). 
Instead, we observed that the seed itself contains sub-domains, the 5′ end 
sub-domain of the seed with more importance for the fast kon and it confers the 
majority of the stabilizing interaction with the target, whereas the 3′ end sub-
domain contributes little to no acceleration for kon but is important for additional 
stability and potentially completes protein conformation changes that create the 
stable RISC-target complex (Figures 3.3, S3.7, and 4.1). 
The 5′ sub-domain of the seed, nucleotides g2–g5, acts like a 
cooperative binding unit, where any mismatch within this sub-domain has the 
same impact on affinity (Figures S3.7 and 4.1). A full seed pairing has a 
KD ~15 pM whereas seed mismatches in the first domain have a KD ~ 250 nM. 
The ~17,000-fold lower affinity for a miRNA target with mismatches in the 
5′ sub-domain illustrates one of the properties of Argonaute to discriminate real 
targets from close matches. The transition point between the 5′ sub-domain 
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correlates nicely with a recent structural study from Schirle and colleagues, the 
structure of human AGO2-RISC bound to a short miRNA target (Schirle et al., 
2014). This structure explained a previous observation that α-helix 7, found in 
the L2 linker between the PAZ and MID domains, would clash and create a kink 
between AGO2-RISC pairing to a target (Figure 1.4, top panel; Schirle and 
MacRae, 2012; Schirle et al., 2014). Comparison of the two structures, target 
bound and unbound, showed that α-helix 7 moves ~4 Å and by doing so 
removes the kink or interruption in the helix (Figure 1.4; Schirle et al., 2014). The 
movement of α-helix 7 and change in protein conformation may represent the 
mechanism by which RISC interrogates and discriminates targets (Schirle et al., 
2014; Swarts et al., 2014b). Complete seed base pairing must start from the 
5′ end to help with proper change in protein conformation to accommodate 
additional base pairs g6–g8. Our kinetic measurements agree well with the 
structural data that a transition point exists in the seed and therefore creates 
sub-domains. Furthermore, our single-molecule work presented in Chapter III 
along work published at the same time from the Joo and MacRae labs come to 
similar conclusions; a subset of the seed is used to interrogate targets 
(Chandradoss et al., 2015; Salomon et al., 2015).  
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Figure 4.1: Revised functional domain map of the small RNA guide. 
Argonaute changes the shape of the small RNA guide when it is in a complex with it. Distinct functional domains 
are created that will change the biophysical properties of the bound small RNA. This map reflects the newly 
discovered sub-domains of the seed while pointing out important features of that were previously described 
(Wee et al., 2012). 
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The 3′ sub-domain of the seed provides more than just additional base 
pair stability between RISC and the target (Figure 4.1). Target mismatches to the 
3′ sub-domain of the seed do correspond to the ΔΔG penalties that are 
predicted by the Nearest-neighbor model BUT, the overall seed pairing stability 
is not just coming from the 5′ end sub-domain. There is interplay of 
Watson-Crick base pairs in a complete seed pairing along with interactions that 
can’t just be assigned to base pairing to the target alone. Another conformation 
change when AGO2 binds a complete seed (g2–g8 paired to t2–t8) is the PAZ 
domain turning (Schirle et al., 2014). The PAZ domain along with α-helix 7 
moves like a rigid body or ‘hinge’ along the other domains and is seen to open 
or widen the N-PAZ channel that may facilitate protein-target interactions 
(Schirle et al., 2014). Future structural studies with longer targets that have seed 
only pairing will help us understand how Argonaute increases its affinity to a 
miRNA site ~17,000 times tighter than nucleic acid pairing alone. 
Argonautes prefer substrates over products 
When RISC is bound to a miRNA target through a full seed pairing it forms a 
fairly stable complex that presumably allows it to regulate the target by acting as 
a scaffold for the destabilization/translation repression machinery. What would 
happen if Argonaute were bound to a target that had pairing past the seed? One 
could reasonably predict it should be more stable. There are a sub-set of miRNA 
targets that have pairing beyond the seed called seed + 3′ supplementary 
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paired targets (pairing t2–t8, t13–t16; Bartel, 2009); Why did these miRNAs not 
evolve to have contiguous base pairs through the central region? Especially 
since many miRNA Argonautes do not contain residues or proper domain 
structure that would allow them to be catalytically active? For example, miR‑21 
has a thermodynamically weaker seed than let‑7a, ΔG= −13.3 versus −15.6, 
respectively. When miR‑21-RISC pairs to a seed + 3′ supplementary target it is 
more stable than when it is on a seed only target whereas for let‑7a there is little 
to no difference between these types of pairing (Figures 3.3B and S3.5D). 
Although, we did not originally set out to answer this question, an important 
insight was discovered when we measured the kinetics of RNAi product release. 
AGO2-RISC has a high affinity to miRNA targets which bear seven nucleotides 
of complementarity, however, counterintuitive to nucleic acid base pairing rules, 
the affinity decreases when RISC is paired one or two additional nucleotides 
past the seed (seed + t9 (8 nt) or seed + t9t10 (9 nt) pairing, Figure 3.8). The 
affinity (KD) goes from 15 pM for a seed only target to 90 pM for the seed plus 
one additional base pair and it is 50 pM for the seed plus two additional base 
pairs. We initiated direct measurement of this type of pairing based on our 
results measuring product release after RNAi where AGO2-RISC left the 3′ 
cleavage product (seed + t9 and t10) ~14 times faster than if it were bound to a 
seed only target. The additional two nucleotides with the cleavage product were 
actually destabilizing instead stabilizing. To further understand the difference 
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and potential influence of having a full-length RNA over a cleavage product or 
‘stump’ led to a panel of different targets (Figure 3.8). Are there RNA-protein 
interactions that help Argonaute recognize a substrate versus product? We 
tested 3 different ‘stumps’ that mimicked cleavage products and varied in base 
pairing (7–9 nt) but the total length (30 nt) did not change. Again, AGO2-RISC 
does not follow the rules of nucleic acid pairing, additional base pairs that 
should increase the mean dwell time (tau, τ), were about the same for 7–9 nt of 
base pairing (Figure 3.8, τ ~30–50 seconds). Re-examination of our previous 
results with the mismatches in the 3′ end seed sub-domain dissociate faster 
than the stumps alone, and those targets were in the context of a full-length 
target. This argues that it is not just about having RNA extending past the point 
of pairing rather it is the amount of pairing that may confer a protein 
conformation that dictates the interactions with the target and it cannot just be 
attributed to Watson-Crick base pairing. Stability is not only about the number 
of base pairs rather the order and position of base pairs. For example, AGO2-
RISC that has no pairing to the 5′ end of the guide (i.e., no seed pairing, t11–t21 
target) has a slow kon (Figure 3.2B) and is close to what is measured for nucleic 
acid alone, 3.6 ± 0.2 × 107 M−1∙s−1 for AGO2-RISC and 7.6 ± 0.9 × 106 M−1∙s−1 for 
the naked guide strand. Furthermore, the mean dwell time for AGO2-RISC 
paired to the t11–t21 target is also similar to nucleic acid alone, τ ~1.3 seconds 
versus τ ~1.7 seconds (predicted) (Figures 3.2B and 3.3B). This idea that RISC 
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stability is a combination of base pair position and target interaction will need 
further kinetic studies to figure out how target length plays a role. Measurements 
of the mean dwell time of AGO2-RISC on different lengths of target that keep a 
constant amount of Watson-Crick base pairs (i.e., seed only pairing with 
different target lengths) could address this question. The experimental setup 
would mimic our measurements with the cleavage product mimics in Figure 3.8 
but systematically extend the RNA at the 5′ end toward the 3′ end of the guide 
strand. Combinations of kinetic studies along with a structural analysis may 
illustrate an elegant interplay of base pairing and non-base pair interactions of 
RISC and the target. 
Seed strength and slicing 
Our analysis of product release and global fitting of the rate of target finding and 
cleavage/product release measured a lag between target binding and product 
release (Figure 3.6) that shows slow step in the RNAi reaction step. What 
molecular events lead to this lag between substrate binding and product release 
(Figure 3.6, k represents measured rate)? We cannot measure when the target is 
cleaved by nucleophilic attack of the scissile phosphate across from g10 and 
g11 of the guide but we can postulate why there is a lag between binding a 
product release (Figure S3.8A, k), assuming the chemistry step is not rate 
limiting (Figure S3.8C, k2). Previous structural studies have revealed that when 
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RISC is unbound to a target it is not in a cleavage competent state since the 
catalytic residues that coordinate the Mg2+ ion are not positioned correctly 
(Wang et al., 2008a; Wang et al., 2008b; Wang et al., 2009; Sheng et al., 2014). 
This means there needs to be a two-step binding process where the target is 
bound then is followed by a conformation change that allows slicing to generate 
the E∙P1∙P2 complex (Figures 3.6B, S3.8A, and S3.8C). The model for having two 
conformation states was originally proposed by Tomari and Zamore; the 
“two-state” model (Tomari and Zamore, 2005). What can influence the rate of 
changing from one state to the other? Does the transition go back and forth as 
the protein negotiates the target to correctly position it for cleavage? We 
measured that stronger seeds like let‑7a have a slower k when compared to 
weaker seeds like miR‑21, 0.15 ± 0.01 s−1 versus 0.31 ± 0.01 s−1, respectively. 
Why is this rate about two times slower for let‑7a when compared to miR‑21? 
Can this be just attributed to seed strength? Our measurements with a target 
only containing seed mismatches at t4t5 shows a slight increase in the rate but 
does not directly address these questions; furthermore the mismatches may 
have their own impact on conformation changes and would not be the best 
approach to answer this question. Recently, a single-molecule FRET study with 
the archaeal Argonaute from Methanocaldococcus jannaschii (MjAgo) shows 
two FRET states and concluded that this would support the ‘two-state’ model 
(Zander et al., 2014). The biology of MjAgo is not well understood but there are 
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no known miRNAs in M. jannaschii and it is a catalytically active Argonaute 
(Makarova et al., 2011; Zander et al., 2014). MjAgo is likely to be a ‘professional’ 
slicer Argonaute where it has a higher affinity for perfect targets over partially 
complementary targets (e.g., seed only pairing), similar to fly AGO2 and TtAGO. 
If the same FRET measurements are made with mammalian AGO2 will there be 
a similar transition? The slow transition state for AGO2 may resemble a safety 
switch since its primary cellular role is NOT to cleave targets but rather regulate 
through the binding (Figure S3.8C, k1). The requirement for a rigid transition 
state would ensure fidelity in slicing, especially when it is not the primary mode 
of regulation. Furthermore, can the strength of the seed relate back to the 
potency of siRNAs in vitro and in vivo? Massive screens performed by those 
developing therapeutic siRNAs and RNAi reagents (Reynolds et al., 2004) may 
be able to explain the added potency observed with some sequences versus 
others by relating back the seed strength pairing to a dwell time that reflects 
conformation changes, cleavage, and product release. Future studies dissecting 
known ‘hyper‑functional’ siRNAs versus poor siRNA sequences that are 
independent of RNA target secondary structure and/or RISC loading may aid in 
creating rules for the better design of siRNAs. 
Argonaute: Nature’s Programmable Regulator 
Argonaute participates in several regulatory functions in all kingdoms of life 
(Ameres and Zamore, 2013; Swarts et al., 2014b). A primary function in 
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mammals is related to post-transcriptional gene regulation but there is evidence 
for a role in the nucleus for DNA-damage response and gene activation (Meister, 
2013). The work presented in this thesis measures and further develops our 
understanding to the molecular functions of the Argonaute protein bound to a 
small RNA or DNA guide. The nucleic acid guide no longer has properties like 
protein-free nucleic acids. The association rate (kon) is accelerated and the 
dissociation rate is changed through a potential interplay of protein-nucleic acid 
interactions that are determined by the combination of base pairing position of 
the guide to the target. RNA-guided endonucleases in general can be looked at 
as regulatory factors that can quickly adapt to the changing environment of the 
cell either by quickly counteracting a viral invader sequence or specifically 
regulating a transcript during a temporal cellular event. Unlike transcription 
factors or RNA-binding proteins, Argonaute did not need to evolve a specific 
protein-based RNA-binding domain; instead Ago converts a bound RNA into 
specific functional domains (Wee et al., 2012), one being the seed, which is the 
equivalent of a binding domain. Nucleic acid pairing acceleration is a common 
attribute of all Argonautes and our measurements show it is conserved over 
2 billion years of evolutions between mice and the thermophilic eubacterium, 
Thermus thermophilus. There appears to be two major functional classes of 
Argonaute proteins, slicers and non-slicers. This distinction is not just about 
having the catalytic residues to cleave a nucleic acid targets but more a 
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combination of binding properties coupled to catalytic ability. There are 
‘professional’ slicers like TtAgo or fly AGO2 that cleave in vivo AND have binding 
affinities for perfect targets over partially complementary targets. There are 
‘dual-mode’ Argonautes like mouse and human AGO2 that can do both forms of 
regulation slicing and miRNA-based regulation. The ‘dual-mode’ of regulation is 
not fully understood and future structurally studies may reveal that there are 
specific interactions that take place with AGO2 and the target that allow these 
Argonautes to regulate one way over the other. Our kinetic measurements with 
cleaved products and pairing past the seed support this notion that Argonaute 
can ‘sense’ the type of target it is bound to. ‘Professional’ slicers may also have 
similar sets of target interactions that take place past the seed that help favor 
perfect targets and disfavor partially matched ones. The overall theme for 
Argonaute is to use base pairing to drive target identification/interaction thus 
creating an overall affinity for the target — an affinity that is linked to its evolved 
cellular function. 
Conserved properties among RNA-guided endonucleases 
In the past few years there has been a lot of excitement and research into a 
newly discovered mechanism of nucleic acid regulation that uses CRISPR 
(Clustered regularly interspaced short palindromic repeats) small RNAs (crRNAs, 
CRISPR RNAs) (Pennisi, 2013; Jiang and Marraffini, 2015). A family of three 
types of RNA-guided endonucleases known as Cas (CRISPR associated) 
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proteins bind to crRNAs and use them as guides to cleave complementary 
sequences. The Cas proteins along with their bound crRNAs are a prokaryotic 
immune system that combats bacteriophage infection by site specifically 
cleaving DNA (Jiang and Marraffini, 2015). The interest in CRISPR is not just 
about the discovery of a new for pathway of viral immunity in prokaryotes rather 
it is applying Cas proteins to cleave and edit the DNA in other organisms (Jinek 
et al., 2012). The research and therapeutic potential of CRISPR-Cas rivals the 
discovery of RNAi where instead of inducing temporal changes at the RNA level, 
CRISPR cleaves at the DNA level and thus creating a permanent change. 
 The most studied Cas proteins are the type II family, in particular Cas9. 
Cas9 uses two RNAs to guide it toward its target, the crRNA that guides Cas9 to 
its target and a tracrRNA (trans-encoded crRNA) that aids in the processing of 
the crRNA and complex formation with Cas9 (Deltcheva et al., 2011). 
Adaptations of having two separate RNAs have been made to create a single-
guide RNA (sgRNA) transcript that makes it more amenable in genome editing 
applications (Jinek et al., 2012). Several structural and biochemical studies have 
been recently reported investigating how Cas9 bound to a sgRNA finds, binds, 
and cleaves targets (Sternberg et al., 2014; Jiang and Marraffini, 2015; 
Sternberg et al., 2015; Taylor et al., 2015). Are there similarities to its ‘cousin’ 
endonuclease Argonaute? At first glance, there are several major differences 
that argue Argonaute and Cas9 are nothing alike. For example, the protein 
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domain architecture is completely different from Argonaute proteins, the Cas 
sgRNA is much longer, endogenous crRNA biogenesis is much different, and 
last but not least, Cas targets DNA. Even with so many differences, there are 
remarkable parallels in the mechanism of finding and interrogating targets that 
may represent conserved characteristics of all RNA-guided endonucleases. 
 The Cas9 protein, similar to Argonaute, searches for its target via a three-
dimensional search mechanism (Sternberg et al., 2014). A difference since Cas9 
targets DNA, which is double-stranded and precludes nucleic-nucleic acid 
hybridization/interrogation, is that target find consists of two stages. The first 
stage is Cas9 finding a PAM (protospacer adjacent motif) sequence that 
contains a characteristic NGG sequence through its PAM interacting domain 
(Mojica et al., 2009; Sternberg et al., 2014). Cas9 has an affinity for PAM 
sequences and this increases when the DNA target just contain multiple PAM 
sites (Sternberg et al., 2014). Similar to Argonaute, Cas9 shows little to no 
affinity to DNA without a PAM just like Argonaute having little to no affinity for an 
RNA that does not bear any resemblance of a seed sequence (Figure S3.5). 
When Cas9 binds to a PAM sequence it is proposed that there is local strand 
displacement or R-loop formation that allows for interrogation of the target site 
(Sternberg et al., 2014). The stretch of ssDNA exposed is ‘inspected’ for 
complementarity to the guide RNA bound to Cas9. The stretch of guide RNA 
that is proximal to the PAM and performs the initial interrogation of the target is 
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referred to as the seed, a name that is very appropriate (Semenova et al., 2011; 
Wiedenheft et al., 2011; Jinek et al., 2012). Recent structural studies of the Cas9 
protein revealed that the seed, similar to the seed created by Argonaute, is also 
in a pre-helical shape that is made by the protein (Figure 4.1 ;Jiang et al., 2015). 
Furthermore, mismatch analyses in cell culture reporter assays for the tolerance 
of mismatches between the sgRNA and target showed little tolerance of single 
or dinucleotide mismatches in any region of the seed whereas mismatches 
outside the seed have a lower impact on genome editing (Hsu et al., 2013; Qi et 
al., 2013). This result is reminiscent of our kinetic measurements that show the 
seed acts like a cooperative unit, requiring complete pairing to create a stable 
RISC-target complex.  
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Figure 4.2: Pre-organized seed of sgRNA bound to Streptococcus 
pyogenes Cas9 
The sgRNA bound to Cas9 changes the shape of the bound RNA to form a 
pre-helix, similar to Argonaute and its small RNA/DNA. The pre-helical shape is 
A-form in structure and spans nucleotides 11–20 counting starting from the 
3′ end of the sgRNA. Additionally, the REC lobe creates a kink near g15 and g16 
that is reminiscent of α-helix 7 of the L2 linker of Argonaute. This kink may 
confer functions in target site interrogation and binding fidelity. 
(Crystal structure solved by: Jiang et al., 2015)  
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Does the seed of the sgRNA created by Cas9 contain sub-domains? Elegant 
single-molecule studies by Sternberg, Redding and colleagues evaluated the 
tolerance for mismatches on Cas9-sgRNA complex binding to a DNA target to 
understand the mechanism of interrogation (Sternberg et al., 2014). Remarkably, 
Cas9 shows similar dwell times in regards to seed mismatches that take place 
at the first two nucleotides where the time bound to the target is ~1000-fold 
shorter than a fully complementary target even though there is eighteen 
contiguous base pairs past the mismatches (Sternberg et al., 2014). 
Furthermore, partial seed matches show the same effect on dwell time 
(Sternberg et al., 2014), a flattened effect, just like the observed effect 
5′ sub-domain seed mismatches have with AGO2-RISC and its RNA target 
(Figure S3.7). Future studies that systematically look at Cas9-sgRNA complex 
with seed mismatches to the target may reveal, similar to AGO2, that there is a 
cooperative effect of the seed that requires ordered and complete base pairing 
to establish a stable complex. Moreover, relating ‘professional’ slicer 
Argonautes dependence on highly complementary targets may reveal that 
similar to Cas9, there is a certain minimum requirement for contiguous base 
pairing past the seed and there is a transition point for stable 
Cas9-sgRNA-target complex formation. 
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Conclusions 
This thesis takes a detailed and quantitative look at how Argonaute proteins 
find, bind, and cleave their targets. Our studies were some of the first to use 
single-molecule TIRF microscopy in the field of small RNAs to study miRNA and 
RNAi pathways. We directly measured and showed how a protein can change 
biophysical properties of another macromolecule, nucleic acid, so that it is 
better suited for its cellular function. Furthermore, the imposed changes to the 
protein bound small RNA guide were more than originally predicted where we 
have discovered sub-domains in the previously defined functional domains of 
the guide (Wee et al., 2012) that can be stabilizing and/or de-stabilizing. The 
powerful single-molecule technique when applied to enzymology allowed us to 
take measurements that were not possible with ensemble techniques (e.g., 
monitor product release order). Direct visualization of a photostable RNA target 
allowed us to uncover that AGO-RISC, like most enzymes, has a higher affinity 
to substrates than it does to products. 
 These studies lay a foundation for future studies into understanding the 
kinetic details of other Argonaute proteins that may have different properties 
that are best suited for their cellular role. An understanding of the kinetics of 
slicer Argonautes vs. non-slicing Argonautes may help shed light on some of the 
true functions for Argonautes, especially with PIWI Argonautes that currently 
lack extracts that can reconstitute activity. Furthermore, extending our findings 
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to understand other RNA-guided endonucleases such as Cas proteins can serve 
to understand a shared enzymology with Argonautes.  
The extension of these studies in the future will help in the development 
of some of the most promising new therapeutic approaches to treat human 
diseases. Currently, siRNA-based drugs are being developed and tested in 
clinical trials and there are several plans to take the CRISPR/Cas9 genome 
editing technology in the clinic within the next few years. There are and will be 
several challenges to the use RNA-guided endonucleases as a therapy but 
mechanistic studies like those presented in this thesis lay a foundation of 
knowledge that can be built upon for more effective and safer approaches with 
the use of this remarkable biotechnology. 
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Appendix A: Argonaute Sequence Alignments 
 
 
 
 
 
 
 
 
A1. Alignment of Human and Mouse AGO family proteins 
 
A2. Alignment of Human and Mouse AGO2 proteins 
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A1. Protein alignment of mouse and human AGO proteins 
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Alignment of human and mouse AGO proteins 
Human AGO1 (NP_036331.1), AGO2 (NP_036286.2), AGO3 (NP_079128.2) and 
AGO4 (NP_060099.2) were aligned along with mouse AGO1 (NP_700452.2), 
AGO2 (NP_694818.3), AGO3 (NP_700451.2), and AGO4 (NP_694817.2) using 
T-COFFEE Expresso (BLAST using PDB database secondary structure 
;Armougom et al., 2006) and figure was generated using ENDscript to highlight 
key structural features (Robert and Gouet, 2014). Domains shown below 
alignment along with scissors to represent catalytic tetrad residues along with a 
conserved Phe in PIWI required for catalytic activity (Faehnle et al., 2013). 
Secondary structure shown is derived from PDB structure human AGO1 (above, 
4KRF ;Faehnle et al., 2013) and human AGO2 (below, 4W5N ;Schirle et al., 
2014). Red = common identity Yellow= some similarities, White = no identity. 
Differences are slight between human and mice, highlights typically are a 
difference between 2 AGO proteins and not species. 
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Amino Acid code: 
Single letter code Three letter code Amino Acid 
I Iso Isoleucine   
L Leu Leucine   
V Val Valine 
F Phe Phenylalanine   
M Met Methionine 
C Cys Cysteine  
A Ala Alanine       
G Gly Glycine   
P Pro Proline       
T Thr Threonine   
S Ser Serine        
Y Tyr Tyrosine   
W Typ Tryptophan   
Q Glu Glutamine   
N Asn Asparagine   
H His Histidine  
E Glu Glutamic acid 
D Asp Aspartic acid  
K Lys Lysine        
R Arg Arginine   
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A2. Protein alignment of Human and Mouse AGO2 
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Alignment of human and mouse AGO2 
Human AGO2 (NP_036286.2) and mouse AGO2 (NP_694818.3) were aligned 
using T-COFFEE Expresso (BLAST using PDB database secondary structure 
;Armougom et al., 2006) and figure was generated ENDscript to highlight key 
structural features (Robert and Gouet, 2014). Domains shown below alignment 
and scissors represent catalytic tetrad residues along with a conserved Phe in 
PIWI required for catalytic activity (Faehnle et al., 2013). Secondary structure is 
derived from PDB structure 4W5N (Schirle et al., 2014). White represents 
identity difference or gap between human and mouse AGO2. Gray represents 
amino acid difference has similar properties. Other colors represent 
physicochemical properties of the amino acids: Cyan = polar and positive, Red 
= polar and negative, Maroon = polar and neutral, Pink = non-polar and 
aliphatic, Blue = non-polar and aromatic, Orange = proline and glycine, Green = 
cysteine. 
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